USUBJID,AESEQ,STUDYID,DOMAIN,SITEID,SUBJID,AETERM,AEDECOD,AEBODSYS,AESEV,AESER,AESERN,AEREL,DSREASAE,ONTRTFL,TRTEMFL,AEFN,BODFN,DECODFN,SAEFN,SDECODFN,SBODFN,AEDERMFN,AESTDT,AESTDTF,AESTDY,ANLSTDY,AEENDT,AEENDY,TRTP,TRTPCD,TRTPN,AGE,AGEGRP,AGEGRPN,RACE,RACEN,SEX,SAFETY,ITT,EFFICACY,COMPLT24,AEDICT,AESCAN,AESCONG,AESDISAB,AESDTH,AESHOSP,AESLIFE,HLGTERM,HLTERM,LLTERM,LSTDOSDT,TRTDUR,TRTSTDT
01-701-1015,1.0,CDISCPILOT01,ADAE,701,1015,VERBATIM_0995,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-03,,2.0,2.0,,,Placebo,Pbo,0.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-07-02,182.0,2014-01-02
01-701-1015,2.0,CDISCPILOT01,ADAE,701,1015,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-01-03,,2.0,2.0,,,Placebo,Pbo,0.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-07-02,182.0,2014-01-02
01-701-1015,3.0,CDISCPILOT01,ADAE,701,1015,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-01-09,,8.0,8.0,2014-01-11,10.0,Placebo,Pbo,0.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-07-02,182.0,2014-01-02
01-701-1023,1.0,CDISCPILOT01,ADAE,701,1023,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-08-07,,3.0,3.0,2012-08-30,26.0,Placebo,Pbo,0.0,64.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-01,28.0,2012-08-05
01-701-1023,2.0,CDISCPILOT01,ADAE,701,1023,VERBATIM_1549,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-08-07,,3.0,3.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,LOCALIZED ERYTHEMA,2012-09-01,28.0,2012-08-05
01-701-1023,3.0,CDISCPILOT01,ADAE,701,1023,VERBATIM_1650,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2012-08-26,,22.0,22.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,AV BLOCK SECOND DEGREE,2012-09-01,28.0,2012-08-05
01-701-1023,4.0,CDISCPILOT01,ADAE,701,1023,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2012-08-07,,3.0,3.0,2012-08-30,26.0,Placebo,Pbo,0.0,64.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-01,28.0,2012-08-05
01-701-1028,1.0,CDISCPILOT01,ADAE,701,1028,VERBATIM_1157,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-07-21,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2014-01-14,180.0,2013-07-19
01-701-1028,2.0,CDISCPILOT01,ADAE,701,1028,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-08-08,,21.0,21.0,,,Xanomeline High Dose,Xan_Hi,2.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-01-14,180.0,2013-07-19
01-701-1034,1.0,CDISCPILOT01,ADAE,701,1034,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-08-27,,58.0,58.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-12-30,183.0,2014-07-01
01-701-1034,2.0,CDISCPILOT01,ADAE,701,1034,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-11-02,,125.0,125.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2014-12-30,183.0,2014-07-01
01-701-1047,1.0,CDISCPILOT01,ADAE,701,1047,VERBATIM_0130,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-02-12,,1.0,1.0,2013-02-12,1.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0109,HLT_0159,HERNIA HIATAL,2013-03-09,26.0,2013-02-12
01-701-1047,2.0,CDISCPILOT01,ADAE,701,1047,VERBATIM_0130,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-02-12,,1.0,1.0,2013-02-12,1.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0109,HLT_0159,HERNIA HIATAL,2013-03-09,26.0,2013-02-12
01-701-1047,3.0,CDISCPILOT01,ADAE,701,1047,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-03-06,,23.0,23.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-03-09,26.0,2013-02-12
01-701-1047,4.0,CDISCPILOT01,ADAE,701,1047,VERBATIM_0197,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-03-10,,27.0,27.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0721,HLT_0281,LEFT BUNDLE BRANCH BLOCK,2013-03-09,26.0,2013-02-12
01-701-1097,1.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-03,,3.0,3.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-07-09,190.0,2014-01-01
01-701-1097,2.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_0990,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-02-20,,51.0,51.0,2014-02-20,51.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0689,HLT_0123,GENERALIZED PRURITUS,2014-07-09,190.0,2014-01-01
01-701-1097,3.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_1522,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-20,,51.0,51.0,2014-02-22,53.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2014-07-09,190.0,2014-01-01
01-701-1097,4.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-02-21,,52.0,52.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-07-09,190.0,2014-01-01
01-701-1097,5.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_0758,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-03-21,,80.0,80.0,2014-03-21,80.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0689,HLT_0123,GENERALIZED PRURITUS,2014-07-09,190.0,2014-01-01
01-701-1097,6.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_0990,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-03-31,,90.0,90.0,2014-03-31,90.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0689,HLT_0123,GENERALIZED PRURITUS,2014-07-09,190.0,2014-01-01
01-701-1097,7.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_0758,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-04-19,,109.0,109.0,2014-04-20,110.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0689,HLT_0123,GENERALIZED PRURITUS,2014-07-09,190.0,2014-01-01
01-701-1097,8.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_1230,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-04-19,,109.0,109.0,2014-04-22,112.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0402,HLT_0130,SORE THROAT,2014-07-09,190.0,2014-01-01
01-701-1097,9.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_1612,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-04-19,,109.0,109.0,2014-04-22,112.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2014-07-09,190.0,2014-01-01
01-701-1097,10.0,CDISCPILOT01,ADAE,701,1097,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-02-21,,52.0,52.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-07-09,190.0,2014-01-01
01-701-1111,1.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2012-09-02,,-5.0,-4.0,2012-09-07,1.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-16,10.0,2012-09-07
01-701-1111,2.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2012-09-02,,-5.0,-4.0,2012-09-07,1.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2012-09-16,10.0,2012-09-07
01-701-1111,3.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_1224,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,,2012-07-08,,-61.0,-60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0557,HLT_0435,LOCALIZED INFECTION,2012-09-16,10.0,2012-09-07
01-701-1111,4.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2012-09-02,,-5.0,-4.0,2012-09-07,1.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-16,10.0,2012-09-07
01-701-1111,5.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2012-09-02,,-5.0,-4.0,2012-09-07,1.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2012-09-16,10.0,2012-09-07
01-701-1111,6.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_1179,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-09-07,,1.0,1.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0483,HLT_0294,URINARY URGENCY,2012-09-16,10.0,2012-09-07
01-701-1111,7.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_1614,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2012-09-13,,7.0,7.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,GENERALIZED JOINT PAIN,2012-09-16,10.0,2012-09-07
01-701-1111,8.0,CDISCPILOT01,ADAE,701,1111,VERBATIM_0034,CELLULITIS,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2012-09-13,,7.0,7.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0066,HLT_0613,CELLULITIS OF LEG,2012-09-16,10.0,2012-09-07
01-701-1115,1.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-02,,3.0,3.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-23,55.0,2012-11-30
01-701-1115,2.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-02,,3.0,3.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-23,55.0,2012-11-30
01-701-1115,3.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0212,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-26,,27.0,27.0,2012-12-26,27.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-23,55.0,2012-11-30
01-701-1115,4.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0212,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2012-12-26,,27.0,27.0,2012-12-26,27.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-23,55.0,2012-11-30
01-701-1115,5.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-12-02,,3.0,3.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-23,55.0,2012-11-30
01-701-1115,6.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-12-02,,3.0,3.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-23,55.0,2012-11-30
01-701-1115,7.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_1777,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-01-14,,46.0,46.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2013-01-23,55.0,2012-11-30
01-701-1115,8.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0434,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-01-19,,51.0,51.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-23,55.0,2012-11-30
01-701-1115,9.0,CDISCPILOT01,ADAE,701,1115,VERBATIM_0316,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-01-19,,51.0,51.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-01-23,55.0,2012-11-30
01-701-1118,1.0,CDISCPILOT01,ADAE,701,1118,VERBATIM_1139,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,52.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-09-09,182.0,2014-03-12
01-701-1130,1.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_1682,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-03-09,,23.0,23.0,2014-03-16,30.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0093,HLT_0161,URINARY TRACT INFECTION,2014-08-16,183.0,2014-02-15
01-701-1130,2.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_1401,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-09,,23.0,23.0,2014-03-09,23.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0652,HLT_0310,FEVER,2014-08-16,183.0,2014-02-15
01-701-1130,3.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_1682,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-03-09,,23.0,23.0,2014-03-16,30.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0093,HLT_0161,URINARY TRACT INFECTION,2014-08-16,183.0,2014-02-15
01-701-1130,4.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_0805,EYE SWELLING,EYE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-05-09,,84.0,84.0,2014-05-09,84.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0466,HLT_0008,EYES SWOLLEN,2014-08-16,183.0,2014-02-15
01-701-1130,5.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_0299,EYE ALLERGY,EYE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-05-09,,84.0,84.0,2014-05-09,84.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0071,HLT_0256,EYE ALLERGY,2014-08-16,183.0,2014-02-15
01-701-1130,6.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_1731,EYE PRURITUS,EYE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-05-22,,97.0,97.0,,,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0240,HLT_0523,EYE ITCHING,2014-08-16,183.0,2014-02-15
01-701-1130,7.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_0826,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,1.0,2014-05-22,,97.0,97.0,,,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING BOTH HANDS,2014-08-16,183.0,2014-02-15
01-701-1130,8.0,CDISCPILOT01,ADAE,701,1130,VERBATIM_0615,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-05-22,,97.0,97.0,,,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2014-08-16,183.0,2014-02-15
01-701-1133,1.0,CDISCPILOT01,ADAE,701,1133,VERBATIM_0995,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-27,,61.0,61.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-04-28,183.0,2012-10-28
01-701-1133,2.0,CDISCPILOT01,ADAE,701,1133,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-27,,61.0,61.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-28,183.0,2012-10-28
01-701-1133,3.0,CDISCPILOT01,ADAE,701,1133,VERBATIM_0995,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2012-12-27,,61.0,61.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-04-28,183.0,2012-10-28
01-701-1133,4.0,CDISCPILOT01,ADAE,701,1133,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2012-12-27,,61.0,61.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-28,183.0,2012-10-28
01-701-1146,1.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2013-05-16,,-4.0,-3.0,2013-06-02,14.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-06-26,38.0,2013-05-20
01-701-1146,2.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,1.0,2013-05-16,,-4.0,-3.0,2013-06-02,14.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-06-26,38.0,2013-05-20
01-701-1146,3.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-06-01,,13.0,13.0,2013-06-02,14.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-06-26,38.0,2013-05-20
01-701-1146,4.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-06-03,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2013-06-26,38.0,2013-05-20
01-701-1146,5.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0349,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-10,,22.0,22.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-06-26,38.0,2013-05-20
01-701-1146,6.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-10,,22.0,22.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-26,38.0,2013-05-20
01-701-1146,7.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0349,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-10,,22.0,22.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-06-26,38.0,2013-05-20
01-701-1146,8.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-10,,22.0,22.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-26,38.0,2013-05-20
01-701-1146,9.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0516,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-22,,34.0,34.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0085,HLT_0342,APPLICATION SITE PAIN,2013-06-26,38.0,2013-05-20
01-701-1146,10.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0347,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-26,,38.0,38.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE VESICLES,2013-06-26,38.0,2013-05-20
01-701-1146,11.0,CDISCPILOT01,ADAE,701,1146,VERBATIM_0244,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-26,,38.0,38.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-06-26,38.0,2013-05-20
01-701-1148,1.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0922,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-25,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-02-20,182.0,2013-08-23
01-701-1148,2.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-08-25,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-02-20,182.0,2013-08-23
01-701-1148,3.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_1765,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-10-12,,51.0,51.0,2013-11-10,80.0,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0217,HLT_0052,CHEST COLD,2014-02-20,182.0,2013-08-23
01-701-1148,4.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_1765,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-12,,51.0,51.0,2013-11-10,80.0,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0217,HLT_0052,CHEST COLD,2014-02-20,182.0,2013-08-23
01-701-1148,5.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0630,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-12-15,,115.0,115.0,2013-12-17,117.0,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0543,HLT_0484,FLANK PAIN,2014-02-20,182.0,2013-08-23
01-701-1148,6.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_1748,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-12-17,,117.0,117.0,2013-12-17,117.0,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0414,HLT_0550,URETHRAL CALCULUS,2014-02-20,182.0,2013-08-23
01-701-1148,7.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0847,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-01-03,,134.0,134.0,2014-01-03,134.0,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0577,HLT_0386,NOSE BLEED,2014-02-20,182.0,2013-08-23
01-701-1148,8.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0800,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2012-02-01,D,-569.0,-568.0,,,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0716,HLT_0244,INDIGESTION,2014-02-20,182.0,2013-08-23
01-701-1148,9.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0591,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2013-07-29,,-25.0,-24.0,,,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0122,HLT_0784,DEPRESSED MOOD,2014-02-20,182.0,2013-08-23
01-701-1148,10.0,CDISCPILOT01,ADAE,701,1148,VERBATIM_0022,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-12,,174.0,174.0,,,Xanomeline High Dose,Xan_Hi,2.0,57.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0490,HLT_0609,ACTINIC KERATOSIS,2014-02-20,182.0,2013-08-23
01-701-1153,1.0,CDISCPILOT01,ADAE,701,1153,VERBATIM_0156,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-10-13,,21.0,21.0,2013-11-06,45.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0769,HLT_0566,INCREASED APPETITE,2014-03-16,175.0,2013-09-23
01-701-1153,2.0,CDISCPILOT01,ADAE,701,1153,VERBATIM_0156,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-10-13,,21.0,21.0,2013-11-06,45.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0769,HLT_0566,INCREASED APPETITE,2014-03-16,175.0,2013-09-23
01-701-1180,1.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1453,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-02-12,,1.0,1.0,2013-02-12,1.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-03-18,35.0,2013-02-12
01-701-1180,2.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1453,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-02-12,,1.0,1.0,2013-02-12,1.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-03-18,35.0,2013-02-12
01-701-1180,3.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1179,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-02-15,,4.0,4.0,2013-03-19,36.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0483,HLT_0294,URINARY URGENCY,2013-03-18,35.0,2013-02-12
01-701-1180,4.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,,,,,,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-03-18,35.0,2013-02-12
01-701-1180,5.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-03-06,,23.0,23.0,2013-03-07,24.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-03-18,35.0,2013-02-12
01-701-1180,6.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1179,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-02-15,,4.0,4.0,2013-03-19,36.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0483,HLT_0294,URINARY URGENCY,2013-03-18,35.0,2013-02-12
01-701-1180,7.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1474,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,1.0,1.0,,,,1.0,2013-03-19,,36.0,36.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-03-18,35.0,2013-02-12
01-701-1180,8.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,,1.0,,,,1.0,2013-03-19,,36.0,36.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-03-18,35.0,2013-02-12
01-701-1180,9.0,CDISCPILOT01,ADAE,701,1180,VERBATIM_0709,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,,1.0,,,,1.0,2013-03-19,,36.0,36.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-03-18,35.0,2013-02-12
01-701-1181,1.0,CDISCPILOT01,ADAE,701,1181,VERBATIM_0499,AGITATION,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-12-09,,5.0,5.0,2013-12-09,5.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0170,HLT_0140,AGITATION,2013-12-09,5.0,2013-12-05
01-701-1188,1.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-16,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-03-24,38.0,2013-02-15
01-701-1188,2.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-16,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-03-24,38.0,2013-02-15
01-701-1188,3.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-02-16,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-03-24,38.0,2013-02-15
01-701-1188,4.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-02-16,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-03-24,38.0,2013-02-15
01-701-1188,5.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0252,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-03-04,,18.0,18.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0705,HLT_0420,WELTS,2013-03-24,38.0,2013-02-15
01-701-1188,6.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0252,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-03-04,,18.0,18.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0705,HLT_0420,WELTS,2013-03-24,38.0,2013-02-15
01-701-1188,7.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_0761,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-03-21,,35.0,35.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0233,HLT_0196,APPLICATION SITE URTICARIA,2013-03-24,38.0,2013-02-15
01-701-1188,8.0,CDISCPILOT01,ADAE,701,1188,VERBATIM_1569,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-03-21,,35.0,35.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0705,HLT_0420,WELTS,2013-03-24,38.0,2013-02-15
01-701-1192,1.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0819,NASAL MUCOSA BIOPSY,INVESTIGATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-08-03,,13.0,13.0,2012-08-03,13.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0396,HLT_0680,NASAL MUCOSA BIOPSY,2013-01-20,183.0,2012-07-22
01-701-1192,2.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0589,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-08-07,,17.0,17.0,2012-09-14,55.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0575,HLT_0683,SECRETION DISCHARGE,2013-01-20,183.0,2012-07-22
01-701-1192,3.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1470,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,1.0,2012-08-07,,17.0,17.0,2012-09-14,55.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA FACIAL,2013-01-20,183.0,2012-07-22
01-701-1192,4.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1421,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,NONE,,N,N,,,,,,,,2010-06-01,D,-782.0,-781.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-01-20,183.0,2012-07-22
01-701-1192,5.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0589,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2012-08-07,,17.0,17.0,2012-09-14,55.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0575,HLT_0683,SECRETION DISCHARGE,2013-01-20,183.0,2012-07-22
01-701-1192,6.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1470,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,1.0,2012-08-07,,17.0,17.0,2012-09-14,55.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA FACIAL,2013-01-20,183.0,2012-07-22
01-701-1192,7.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0919,PNEUMONIA,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-09-07,,48.0,48.0,2012-10-06,77.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0671,HLT_0251,PNEUMONIA,2013-01-20,183.0,2012-07-22
01-701-1192,8.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1050,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-09-07,,48.0,48.0,2012-09-30,71.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0211,HLT_0444,MUSCULAR WEAKNESS,2013-01-20,183.0,2012-07-22
01-701-1192,9.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1421,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,N,N,,,,,,,,2010-06-01,D,-782.0,-781.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-01-20,183.0,2012-07-22
01-701-1192,10.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0919,PNEUMONIA,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,,2012-09-07,,48.0,48.0,2012-10-06,77.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0671,HLT_0251,PNEUMONIA,2013-01-20,183.0,2012-07-22
01-701-1192,11.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1050,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,,2012-09-07,,48.0,48.0,2012-09-30,71.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0211,HLT_0444,MUSCULAR WEAKNESS,2013-01-20,183.0,2012-07-22
01-701-1192,12.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1067,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-05,,137.0,137.0,2012-12-16,148.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-20,183.0,2012-07-22
01-701-1192,13.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1444,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-05,,137.0,137.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-20,183.0,2012-07-22
01-701-1192,14.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-05,,137.0,137.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-20,183.0,2012-07-22
01-701-1192,15.0,CDISCPILOT01,ADAE,701,1192,VERBATIM_1067,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2012-12-05,,137.0,137.0,2012-12-16,148.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-20,183.0,2012-07-22
01-701-1203,1.0,CDISCPILOT01,ADAE,701,1203,VERBATIM_1020,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-03-21,,48.0,48.0,2013-03-21,48.0,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0189,HLT_0355,EYE LASER SURGERY,2013-08-03,183.0,2013-02-02
01-701-1211,1.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-11-16,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-12,59.0,2012-11-15
01-701-1211,2.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_0394,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-11-21,,7.0,7.0,2012-11-21,7.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0227,HLT_0035,SHOULDER DISLOCATION,2013-01-12,59.0,2012-11-15
01-701-1211,3.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_1643,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-11-21,,7.0,7.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0288,HLT_0527,SHOULDER PAIN,2013-01-12,59.0,2012-11-15
01-701-1211,4.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_0312,INCONTINENCE,RENAL AND URINARY DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-11-22,,8.0,8.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0503,HLT_0560,INCONTINENCE,2013-01-12,59.0,2012-11-15
01-701-1211,5.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_0995,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2012-11-29,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-12,59.0,2012-11-15
01-701-1211,6.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_0548,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2012-12-09,,25.0,25.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0118,HLT_0075,LACERATION OF FACE,2013-01-12,59.0,2012-11-15
01-701-1211,7.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_1524,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-01-11,,58.0,58.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2013-01-12,59.0,2012-11-15
01-701-1211,8.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_1509,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-01-11,,58.0,58.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0255,HLT_0296,SHORTNESS OF BREATH,2013-01-12,59.0,2012-11-15
01-701-1211,9.0,CDISCPILOT01,ADAE,701,1211,VERBATIM_0484,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,NONE,,N,Y,,,1.0,,,,,2013-01-14,,61.0,61.0,2013-01-14,61.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,Y,N,Y,HLGT_0272,HLT_0142,SUDDEN DEATH,2013-01-12,59.0,2012-11-15
01-701-1239,1.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-12,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-07-10,181.0,2014-01-11
01-701-1239,2.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0385,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,1.0,2014-01-12,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0184,HLT_0510,SKIN ODOR ABNORMAL,2014-07-10,181.0,2014-01-11
01-701-1239,3.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-01-13,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-07-10,181.0,2014-01-11
01-701-1239,4.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_1231,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-01-20,,10.0,10.0,2014-02-08,29.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-07-10,181.0,2014-01-11
01-701-1239,5.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_1231,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-01-20,,10.0,10.0,2014-02-08,29.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-07-10,181.0,2014-01-11
01-701-1239,6.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-01-12,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-07-10,181.0,2014-01-11
01-701-1239,7.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-02-20,,41.0,41.0,2014-03-12,61.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-07-10,181.0,2014-01-11
01-701-1239,8.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-02-20,,41.0,41.0,2014-03-12,61.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-07-10,181.0,2014-01-11
01-701-1239,9.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-03-01,D,50.0,50.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2014-07-10,181.0,2014-01-11
01-701-1239,10.0,CDISCPILOT01,ADAE,701,1239,VERBATIM_1306,HORDEOLUM,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-04-01,D,81.0,81.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0290,HLT_0604,STYE,2014-07-10,181.0,2014-01-11
01-701-1275,1.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2014-02-13,,7.0,7.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-05-31,114.0,2014-02-07
01-701-1275,2.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-02-23,,17.0,17.0,2014-02-23,17.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2014-05-31,114.0,2014-02-07
01-701-1275,3.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-24,,18.0,18.0,2014-06-12,126.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-05-31,114.0,2014-02-07
01-701-1275,4.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_1572,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-02-24,,18.0,18.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0488,HLT_0374,HYPERSALIVATION,2014-05-31,114.0,2014-02-07
01-701-1275,5.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0923,PAROSMIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-02-24,,18.0,18.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0471,HLT_0258,STRANGE SMELL SENSATION,2014-05-31,114.0,2014-02-07
01-701-1275,6.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-02-24,,18.0,18.0,2014-06-12,126.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-05-31,114.0,2014-02-07
01-701-1275,7.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-12,,34.0,34.0,2014-03-27,49.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-05-31,114.0,2014-02-07
01-701-1275,8.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_1612,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-03-12,,34.0,34.0,2014-03-27,49.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2014-05-31,114.0,2014-02-07
01-701-1275,9.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-03-12,,34.0,34.0,2014-03-27,49.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-05-31,114.0,2014-02-07
01-701-1275,10.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_1612,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-03-12,,34.0,34.0,2014-03-27,49.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2014-05-31,114.0,2014-02-07
01-701-1275,11.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-02-13,,7.0,7.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-05-31,114.0,2014-02-07
01-701-1275,12.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-02-24,,18.0,18.0,2014-06-12,126.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-05-31,114.0,2014-02-07
01-701-1275,13.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_1572,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-02-24,,18.0,18.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0488,HLT_0374,HYPERSALIVATION,2014-05-31,114.0,2014-02-07
01-701-1275,14.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0923,PAROSMIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-02-24,,18.0,18.0,2014-06-03,117.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0471,HLT_0258,STRANGE SMELL SENSATION,2014-05-31,114.0,2014-02-07
01-701-1275,15.0,CDISCPILOT01,ADAE,701,1275,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-02-24,,18.0,18.0,2014-06-12,126.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-05-31,114.0,2014-02-07
01-701-1287,1.0,CDISCPILOT01,ADAE,701,1287,VERBATIM_1433,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-26,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0488,HLT_0374,INCREASED SALIVATION,2014-07-26,183.0,2014-01-25
01-701-1287,2.0,CDISCPILOT01,ADAE,701,1287,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-22,,29.0,29.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-07-26,183.0,2014-01-25
01-701-1287,3.0,CDISCPILOT01,ADAE,701,1287,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-03-09,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-07-26,183.0,2014-01-25
01-701-1287,4.0,CDISCPILOT01,ADAE,701,1287,VERBATIM_1075,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-09,,166.0,166.0,2014-07-12,169.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0460,HLT_0635,RUNNY NOSE,2014-07-26,183.0,2014-01-25
01-701-1287,5.0,CDISCPILOT01,ADAE,701,1287,VERBATIM_1075,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-07-09,,166.0,166.0,2014-07-12,169.0,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0460,HLT_0635,RUNNY NOSE,2014-07-26,183.0,2014-01-25
01-701-1294,1.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,1.0,2013-03-22,,-2.0,-1.0,2013-03-23,-1.0,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-14,83.0,2013-03-24
01-701-1294,2.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-19,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-14,83.0,2013-03-24
01-701-1294,3.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-05-19,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-14,83.0,2013-03-24
01-701-1294,4.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-05-19,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-14,83.0,2013-03-24
01-701-1294,5.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-05-19,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-14,83.0,2013-03-24
01-701-1294,6.0,CDISCPILOT01,ADAE,701,1294,VERBATIM_1620,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-06-10,,79.0,79.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0701,HLT_0336,ERYTHEMATOUS RASH,2013-06-14,83.0,2013-03-24
01-701-1302,1.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0038,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-30,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0403,HLT_0283,APPLICATION SITE PERSPIRATION,2013-11-05,69.0,2013-08-29
01-701-1302,2.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0551,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-08-30,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-11-05,69.0,2013-08-29
01-701-1302,3.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0350,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-08-30,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0183,HLT_0065,STOMACH UPSET,2013-11-05,69.0,2013-08-29
01-701-1302,4.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1314,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-08-31,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0478,HLT_0314,STINGING,2013-11-05,69.0,2013-08-29
01-701-1302,5.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1612,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-09-01,,4.0,4.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2013-11-05,69.0,2013-08-29
01-701-1302,6.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1230,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-09-02,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0402,HLT_0130,SORE THROAT,2013-11-05,69.0,2013-08-29
01-701-1302,7.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0298,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-09-02,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0681,HLT_0545,PRODUCTIVE COUGH,2013-11-05,69.0,2013-08-29
01-701-1302,8.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0734,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-09-02,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0178,HLT_0456,MALAISE,2013-11-05,69.0,2013-08-29
01-701-1302,9.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0327,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-09-02,,5.0,5.0,2013-09-03,6.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZY,2013-11-05,69.0,2013-08-29
01-701-1302,10.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0183,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-09-02,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0121,HLT_0700,MYALGIA,2013-11-05,69.0,2013-08-29
01-701-1302,11.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1049,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-09-04,,7.0,7.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,LIGHTHEADEDNESS,2013-11-05,69.0,2013-08-29
01-701-1302,12.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1465,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-09-05,,8.0,8.0,2013-10-08,41.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISE,2013-11-05,69.0,2013-08-29
01-701-1302,13.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0735,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-09-15,,18.0,18.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-05,69.0,2013-08-29
01-701-1302,14.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1199,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-09-30,,33.0,33.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0577,HLT_0386,NOSE BLEED,2013-11-05,69.0,2013-08-29
01-701-1302,15.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1465,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-09-05,,8.0,8.0,2013-10-08,41.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISE,2013-11-05,69.0,2013-08-29
01-701-1302,16.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1005,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-10-15,,48.0,48.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-11-05,69.0,2013-08-29
01-701-1302,17.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-10-15,,48.0,48.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-11-05,69.0,2013-08-29
01-701-1302,18.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0734,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-09-02,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0178,HLT_0456,MALAISE,2013-11-05,69.0,2013-08-29
01-701-1302,19.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1148,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-10-23,,56.0,56.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0424,HLT_0330,RESPIRATORY TRACT CONGESTION,2013-11-05,69.0,2013-08-29
01-701-1302,20.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0358,RHINITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-10-23,,56.0,56.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0322,HLT_0239,CORYZA,2013-11-05,69.0,2013-08-29
01-701-1302,21.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0374,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-10-24,,57.0,57.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0749,HLT_0524,FOGGY FEELING IN HEAD,2013-11-05,69.0,2013-08-29
01-701-1302,22.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_0482,LISTLESS,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-10-24,,57.0,57.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0124,HLT_0657,LISTLESSNESS,2013-11-05,69.0,2013-08-29
01-701-1302,23.0,CDISCPILOT01,ADAE,701,1302,VERBATIM_1773,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-10-24,,57.0,57.0,,,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0496,HLT_0338,LIBIDO DECREASED,2013-11-05,69.0,2013-08-29
01-701-1317,1.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_0468,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2014-05-13,,-9.0,-8.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0243,HLT_0275,ONYCHOMYCOSIS,2014-11-20,183.0,2014-05-22
01-701-1317,2.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_1010,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2014-05-13,,-9.0,-8.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0341,HLT_0763,CYST,2014-11-20,183.0,2014-05-22
01-701-1317,3.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-06-23,,33.0,33.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-11-20,183.0,2014-05-22
01-701-1317,4.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-06-23,,33.0,33.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-11-20,183.0,2014-05-22
01-701-1317,5.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_1456,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-06-23,,33.0,33.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0233,HLT_0196,APPLICATION SITE URTICARIA,2014-11-20,183.0,2014-05-22
01-701-1317,6.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_0326,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-07-04,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0122,HLT_0784,DEPRESSED MOOD,2014-11-20,183.0,2014-05-22
01-701-1317,7.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_0326,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-07-04,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0122,HLT_0784,DEPRESSED MOOD,2014-11-20,183.0,2014-05-22
01-701-1317,8.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_1301,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-09-12,,114.0,114.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,TIREDNESS,2014-11-20,183.0,2014-05-22
01-701-1317,9.0,CDISCPILOT01,ADAE,701,1317,VERBATIM_0933,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-11-03,,166.0,166.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0274,HLT_0073,HOARSENESS,2014-11-20,183.0,2014-05-22
01-701-1324,1.0,CDISCPILOT01,ADAE,701,1324,VERBATIM_0013,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-10-22,,21.0,21.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-04-02,183.0,2012-10-02
01-701-1324,2.0,CDISCPILOT01,ADAE,701,1324,VERBATIM_1035,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-02,,62.0,62.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-02,183.0,2012-10-02
01-701-1324,3.0,CDISCPILOT01,ADAE,701,1324,VERBATIM_0996,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2012-12-25,,85.0,85.0,2013-01-16,107.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-04-02,183.0,2012-10-02
01-701-1324,4.0,CDISCPILOT01,ADAE,701,1324,VERBATIM_0996,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2012-12-25,,85.0,85.0,2013-01-16,107.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-04-02,183.0,2012-10-02
01-701-1341,1.0,CDISCPILOT01,ADAE,701,1341,VERBATIM_1271,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,51.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-26,22.0,2013-01-05
01-701-1341,2.0,CDISCPILOT01,ADAE,701,1341,VERBATIM_0437,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,51.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-26,22.0,2013-01-05
01-701-1341,3.0,CDISCPILOT01,ADAE,701,1341,VERBATIM_1318,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-01-26,,22.0,22.0,2013-01-30,26.0,Xanomeline Low Dose,Xan_Lo,1.0,51.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-01-26,22.0,2013-01-05
01-701-1341,4.0,CDISCPILOT01,ADAE,701,1341,VERBATIM_1791,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-01-26,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,51.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-01-26,22.0,2013-01-05
01-701-1341,5.0,CDISCPILOT01,ADAE,701,1341,VERBATIM_0810,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-01-26,,22.0,22.0,2013-01-30,26.0,Xanomeline Low Dose,Xan_Lo,1.0,51.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-01-26,22.0,2013-01-05
01-701-1360,1.0,CDISCPILOT01,ADAE,701,1360,VERBATIM_0709,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-02,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-08-05,6.0,2013-07-31
01-701-1360,2.0,CDISCPILOT01,ADAE,701,1360,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-08-02,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-08-05,6.0,2013-07-31
01-701-1360,3.0,CDISCPILOT01,ADAE,701,1360,VERBATIM_0996,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-08-05,,6.0,6.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-08-05,6.0,2013-07-31
01-701-1363,1.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-06-14,,16.0,16.0,2013-06-15,17.0,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-11-27,182.0,2013-05-30
01-701-1363,2.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-27,182.0,2013-05-30
01-701-1363,3.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-07-16,,48.0,48.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-11-27,182.0,2013-05-30
01-701-1363,4.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-27,182.0,2013-05-30
01-701-1363,5.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_1742,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-10-13,,137.0,137.0,2013-10-15,139.0,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,BACKACHE,2013-11-27,182.0,2013-05-30
01-701-1363,6.0,CDISCPILOT01,ADAE,701,1363,VERBATIM_1742,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-13,,137.0,137.0,2013-10-15,139.0,Placebo,Pbo,0.0,81.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,BACKACHE,2013-11-27,182.0,2013-05-30
01-701-1383,1.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1035,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-07,,4.0,4.0,2013-02-07,4.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-08-06,184.0,2013-02-04
01-701-1383,2.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_0725,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-02-07,,4.0,4.0,2013-02-07,4.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0085,HLT_0342,APPLICATION SITE PAIN,2013-08-06,184.0,2013-02-04
01-701-1383,3.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1157,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-03-23,,48.0,48.0,2013-03-26,51.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-08-06,184.0,2013-02-04
01-701-1383,4.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1035,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-03-23,,48.0,48.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-08-06,184.0,2013-02-04
01-701-1383,5.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_0349,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-04-12,,68.0,68.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-08-06,184.0,2013-02-04
01-701-1383,6.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1067,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-04-12,,68.0,68.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-08-06,184.0,2013-02-04
01-701-1383,7.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1035,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-03-23,,48.0,48.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-08-06,184.0,2013-02-04
01-701-1383,8.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1067,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-04-12,,68.0,68.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-08-06,184.0,2013-02-04
01-701-1383,9.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_0880,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-05-07,,93.0,93.0,2013-05-24,110.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-08-06,184.0,2013-02-04
01-701-1383,10.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_0653,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-06-24,,141.0,141.0,2013-06-24,141.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0441,HLT_0593,CHEST PRESSURE,2013-08-06,184.0,2013-02-04
01-701-1383,11.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_1739,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-06-24,,141.0,141.0,2013-06-24,141.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,FULLNESS HEAD,2013-08-06,184.0,2013-02-04
01-701-1383,12.0,CDISCPILOT01,ADAE,701,1383,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-07-17,,164.0,164.0,2013-07-26,173.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-08-06,184.0,2013-02-04
01-701-1387,1.0,CDISCPILOT01,ADAE,701,1387,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-03-18,,7.0,7.0,2014-03-18,7.0,Placebo,Pbo,0.0,87.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-03-25,14.0,2014-03-12
01-701-1387,2.0,CDISCPILOT01,ADAE,701,1387,VERBATIM_1343,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-03-18,,7.0,7.0,2014-03-18,7.0,Placebo,Pbo,0.0,87.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING,2014-03-25,14.0,2014-03-12
01-701-1392,1.0,CDISCPILOT01,ADAE,701,1392,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-03-16,,140.0,140.0,2013-03-21,145.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-04-28,183.0,2012-10-28
01-701-1392,2.0,CDISCPILOT01,ADAE,701,1392,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-03-16,,140.0,140.0,2013-03-21,145.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-04-28,183.0,2012-10-28
01-701-1415,1.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-10-21,,29.0,29.0,2013-11-04,43.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-03-24,183.0,2013-09-23
01-701-1415,2.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-21,,29.0,29.0,2013-11-04,43.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-03-24,183.0,2013-09-23
01-701-1415,3.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_1179,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-12-02,,71.0,71.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0483,HLT_0294,URINARY URGENCY,2014-03-24,183.0,2013-09-23
01-701-1415,4.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-01-21,,121.0,121.0,2014-02-10,141.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-03-24,183.0,2013-09-23
01-701-1415,5.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-01-21,,121.0,121.0,2014-02-10,141.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-03-24,183.0,2013-09-23
01-701-1415,6.0,CDISCPILOT01,ADAE,701,1415,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-09,,168.0,168.0,2014-03-09,168.0,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-03-24,183.0,2013-09-23
01-701-1442,1.0,CDISCPILOT01,ADAE,701,1442,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-10,,77.0,77.0,,,Xanomeline Low Dose,Xan_Lo,1.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-04-26,183.0,2013-10-26
01-701-1444,1.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0349,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-02-12,39.0,2013-01-05
01-701-1444,2.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-02-12,39.0,2013-01-05
01-701-1444,3.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_1572,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-01-19,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0488,HLT_0374,HYPERSALIVATION,2013-02-12,39.0,2013-01-05
01-701-1444,4.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0349,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-02-12,39.0,2013-01-05
01-701-1444,5.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0578,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-01-19,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-02-12,39.0,2013-01-05
01-701-1444,6.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_1067,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-04,,31.0,31.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-02-12,39.0,2013-01-05
01-701-1444,7.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0880,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-04,,31.0,31.0,,,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-02-12,39.0,2013-01-05
01-701-1444,8.0,CDISCPILOT01,ADAE,701,1444,VERBATIM_0365,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-02-08,,35.0,35.0,2013-02-08,35.0,Xanomeline High Dose,Xan_Hi,2.0,63.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0534,HLT_0481,TINGLING,2013-02-12,39.0,2013-01-05
01-702-1082,1.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0795,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-26,1.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0465,HLT_0417,WBC INCREASED,2013-10-13,80.0,2013-07-26
01-702-1082,2.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0831,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-26,1.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0625,HLT_0326,NEUTROPHIL COUNT INCREASED,2013-10-13,80.0,2013-07-26
01-702-1082,3.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0459,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-24,-2.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0295,HLT_0783,URINE ANALYSIS ABNORMAL,2013-10-13,80.0,2013-07-26
01-702-1082,4.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0459,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-24,-2.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0295,HLT_0783,URINE ANALYSIS ABNORMAL,2013-10-13,80.0,2013-07-26
01-702-1082,5.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0795,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-26,1.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0465,HLT_0417,WBC INCREASED,2013-10-13,80.0,2013-07-26
01-702-1082,6.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0831,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-07-07,,-19.0,-18.0,2013-07-26,1.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0625,HLT_0326,NEUTROPHIL COUNT INCREASED,2013-10-13,80.0,2013-07-26
01-702-1082,7.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0250,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-09-02,,39.0,39.0,2013-09-06,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0755,HLT_0353,RECTAL BLEEDING,2013-10-13,80.0,2013-07-26
01-702-1082,8.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_0250,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-09-02,,39.0,39.0,2013-09-06,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0755,HLT_0353,RECTAL BLEEDING,2013-10-13,80.0,2013-07-26
01-702-1082,9.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-09-09,,46.0,46.0,2013-09-24,61.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-10-13,80.0,2013-07-26
01-702-1082,10.0,CDISCPILOT01,ADAE,702,1082,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-10-12,,79.0,79.0,2013-10-31,98.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-10-13,80.0,2013-07-26
01-703-1042,1.0,CDISCPILOT01,ADAE,703,1042,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-03-04,,3.0,3.0,2013-03-05,4.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-08-31,183.0,2013-03-02
01-703-1042,2.0,CDISCPILOT01,ADAE,703,1042,VERBATIM_0377,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-03-05,,4.0,4.0,2013-03-06,5.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0469,HLT_0297,INSOMNIA,2013-08-31,183.0,2013-03-02
01-703-1076,1.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_1681,BIOPSY PROSTATE,INVESTIGATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-11-16,,23.0,23.0,2013-11-16,23.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0725,HLT_0553,BIOPSY OF PROSTATE,2013-12-24,61.0,2013-10-25
01-703-1076,2.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_0138,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-11-20,,27.0,27.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0568,HLT_0215,BENIGN PROSTATIC HYPERTROPHY,2013-12-24,61.0,2013-10-25
01-703-1076,3.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_0164,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,,,,,,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0703,HLT_0025,HYPERCHOLESTEROLEMIA,2013-12-24,61.0,2013-10-25
01-703-1076,4.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-11-23,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-24,61.0,2013-10-25
01-703-1076,5.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-11-23,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-12-24,61.0,2013-10-25
01-703-1076,6.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_1343,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-11-25,,32.0,32.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING,2013-12-24,61.0,2013-10-25
01-703-1076,7.0,CDISCPILOT01,ADAE,703,1076,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-11-23,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-24,61.0,2013-10-25
01-703-1086,1.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-09-13,,12.0,12.0,2013-01-02,123.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-12-04,94.0,2012-09-02
01-703-1086,2.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-13,,12.0,12.0,2013-01-02,123.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-12-04,94.0,2012-09-02
01-703-1086,3.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-13,,12.0,12.0,2013-01-02,123.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-12-04,94.0,2012-09-02
01-703-1086,4.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2012-10-09,,38.0,38.0,2012-10-15,44.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2012-12-04,94.0,2012-09-02
01-703-1086,5.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2012-10-09,,38.0,38.0,2012-10-15,44.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2012-12-04,94.0,2012-09-02
01-703-1086,6.0,CDISCPILOT01,ADAE,703,1086,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-13,,12.0,12.0,2013-01-02,123.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-12-04,94.0,2012-09-02
01-703-1100,1.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-04-05,,24.0,24.0,2013-04-16,35.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-09-14,186.0,2013-03-13
01-703-1100,2.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-05,,24.0,24.0,2013-04-16,35.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-09-14,186.0,2013-03-13
01-703-1100,3.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-05,,24.0,24.0,2013-04-16,35.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-09-14,186.0,2013-03-13
01-703-1100,4.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_1581,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-25,,44.0,44.0,2013-04-25,44.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0058,HLT_0432,CATARACT EXTRACTION,2013-09-14,186.0,2013-03-13
01-703-1100,5.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-05-27,,76.0,76.0,2013-06-03,83.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-09-14,186.0,2013-03-13
01-703-1100,6.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_1652,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,,N,N,,,,,,,,2013-02-28,,-13.0,-12.0,2013-09-14,186.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,LEG EDEMA,2013-09-14,186.0,2013-03-13
01-703-1100,7.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0098,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-07-17,,127.0,127.0,2013-09-14,186.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,LEG EDEMA,2013-09-14,186.0,2013-03-13
01-703-1100,8.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_1652,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,,N,N,,,,,,,,2013-02-28,,-13.0,-12.0,2013-09-14,186.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,LEG EDEMA,2013-09-14,186.0,2013-03-13
01-703-1100,9.0,CDISCPILOT01,ADAE,703,1100,VERBATIM_0098,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-07-17,,127.0,127.0,2013-09-14,186.0,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,LEG EDEMA,2013-09-14,186.0,2013-03-13
01-703-1119,1.0,CDISCPILOT01,ADAE,703,1119,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-03-16,,25.0,25.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-06-13,114.0,2013-02-20
01-703-1119,2.0,CDISCPILOT01,ADAE,703,1119,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-03-16,,25.0,25.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-06-13,114.0,2013-02-20
01-703-1119,3.0,CDISCPILOT01,ADAE,703,1119,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-04,,74.0,74.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-13,114.0,2013-02-20
01-703-1119,4.0,CDISCPILOT01,ADAE,703,1119,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-05-04,,74.0,74.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-13,114.0,2013-02-20
01-703-1175,1.0,CDISCPILOT01,ADAE,703,1175,VERBATIM_0077,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,SEVERE,N,0.0,NONE,,N,N,,,,,,,,2013-12-18,,-2.0,-1.0,,,Placebo,Pbo,0.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,HEART BLOCK SECOND DEGREE,2013-12-26,7.0,2013-12-20
01-703-1182,1.0,CDISCPILOT01,ADAE,703,1182,VERBATIM_1489,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-10-31,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-12-11,56.0,2013-10-17
01-703-1182,2.0,CDISCPILOT01,ADAE,703,1182,VERBATIM_1489,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-10-31,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-12-11,56.0,2013-10-17
01-703-1182,3.0,CDISCPILOT01,ADAE,703,1182,VERBATIM_0485,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-11-22,,37.0,37.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,DROWSINESS,2013-12-11,56.0,2013-10-17
01-703-1182,4.0,CDISCPILOT01,ADAE,703,1182,VERBATIM_0485,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-11-22,,37.0,37.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,DROWSINESS,2013-12-11,56.0,2013-10-17
01-703-1210,1.0,CDISCPILOT01,ADAE,703,1210,VERBATIM_0787,DISORIENTATION,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-04-02,,18.0,18.0,,,Placebo,Pbo,0.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0307,HLT_0299,DISORIENTATION,2013-09-06,175.0,2013-03-16
01-703-1210,2.0,CDISCPILOT01,ADAE,703,1210,VERBATIM_0965,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-04,,50.0,50.0,,,Placebo,Pbo,0.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0231,HLT_0574,DECREASED APPETITE,2013-09-06,175.0,2013-03-16
01-703-1210,3.0,CDISCPILOT01,ADAE,703,1210,VERBATIM_0965,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-04,,50.0,50.0,,,Placebo,Pbo,0.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0231,HLT_0574,DECREASED APPETITE,2013-09-06,175.0,2013-03-16
01-703-1258,1.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-08-11,,23.0,23.0,2012-08-19,31.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-01-11,176.0,2012-07-20
01-703-1258,2.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,,,,,,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-01-11,176.0,2012-07-20
01-703-1258,3.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2012-08-11,,23.0,23.0,2012-08-19,31.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-01-11,176.0,2012-07-20
01-703-1258,4.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2012-09-04,,47.0,47.0,2013-01-25,190.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-01-11,176.0,2012-07-20
01-703-1258,5.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,,,,,,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-01-11,176.0,2012-07-20
01-703-1258,6.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-04,,47.0,47.0,2013-01-25,190.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-01-11,176.0,2012-07-20
01-703-1258,7.0,CDISCPILOT01,ADAE,703,1258,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-04,,47.0,47.0,2013-01-25,190.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-01-11,176.0,2012-07-20
01-703-1295,1.0,CDISCPILOT01,ADAE,703,1295,VERBATIM_0065,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-12-28,,38.0,38.0,,,Xanomeline High Dose,Xan_Hi,2.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0587,HLT_0019,ARTHRITIS,2014-04-19,150.0,2013-11-21
01-703-1299,1.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-09-27,,16.0,16.0,2012-10-06,25.0,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-03-13,183.0,2012-09-12
01-703-1299,2.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2012-09-27,,16.0,16.0,2012-10-06,25.0,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-03-13,183.0,2012-09-12
01-703-1299,3.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0308,GLAUCOMA,EYE DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0734,HLT_0556,GLAUCOMA,2013-03-13,183.0,2012-09-12
01-703-1299,4.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0677,HYPOTENSION,VASCULAR DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-03-01,,171.0,171.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0412,HLT_0761,HYPOTENSION,2013-03-13,183.0,2012-09-12
01-703-1299,5.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0231,TACHYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-03-01,,171.0,171.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0574,HLT_0082,TACHYCARDIA,2013-03-13,183.0,2012-09-12
01-703-1299,6.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0677,HYPOTENSION,VASCULAR DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-03-01,,171.0,171.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0412,HLT_0761,HYPOTENSION,2013-03-13,183.0,2012-09-12
01-703-1299,7.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_0231,TACHYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-03-01,,171.0,171.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0574,HLT_0082,TACHYCARDIA,2013-03-13,183.0,2012-09-12
01-703-1299,8.0,CDISCPILOT01,ADAE,703,1299,VERBATIM_1262,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-03-13,,183.0,183.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,MYOCARDIAL INFARCTION,2013-03-13,183.0,2012-09-12
01-703-1335,1.0,CDISCPILOT01,ADAE,703,1335,VERBATIM_1650,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,N,0.0,NONE,,N,N,,,,,,,,2014-03-15,,-2.0,-1.0,2014-03-30,14.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,AV BLOCK SECOND DEGREE,2014-05-07,52.0,2014-03-17
01-703-1335,2.0,CDISCPILOT01,ADAE,703,1335,VERBATIM_1650,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,N,0.0,NONE,,N,N,,,,,,,,2014-03-15,,-2.0,-1.0,2014-03-30,14.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,AV BLOCK SECOND DEGREE,2014-05-07,52.0,2014-03-17
01-703-1403,1.0,CDISCPILOT01,ADAE,703,1403,VERBATIM_0293,WEIGHT DECREASED,INVESTIGATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-12-12,,1.0,1.0,2012-12-19,8.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0778,HLT_0158,WEIGHT LOSS,2012-12-13,2.0,2012-12-12
01-703-1403,2.0,CDISCPILOT01,ADAE,703,1403,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2012-12-13,,2.0,2.0,2012-12-14,3.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2012-12-13,2.0,2012-12-12
01-703-1403,3.0,CDISCPILOT01,ADAE,703,1403,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,,2012-12-13,,2.0,2.0,2012-12-14,3.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2012-12-13,2.0,2012-12-12
01-703-1403,4.0,CDISCPILOT01,ADAE,703,1403,VERBATIM_1293,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,N,Y,,1.0,1.0,,,,,2012-12-15,,4.0,4.0,2012-12-16,5.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0441,HLT_0593,CHEST TIGHTNESS,2012-12-13,2.0,2012-12-12
01-703-1403,5.0,CDISCPILOT01,ADAE,703,1403,VERBATIM_0293,WEIGHT DECREASED,INVESTIGATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,,2012-12-12,,1.0,1.0,2012-12-19,8.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0778,HLT_0158,WEIGHT LOSS,2012-12-13,2.0,2012-12-12
01-703-1439,1.0,CDISCPILOT01,ADAE,703,1439,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-04-24,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-09-11,184.0,2014-03-12
01-703-1439,2.0,CDISCPILOT01,ADAE,703,1439,VERBATIM_0583,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-04-24,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-09-11,184.0,2014-03-12
01-704-1008,1.0,CDISCPILOT01,ADAE,704,1008,VERBATIM_0895,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-01-30,,18.0,18.0,,,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING INCREASED,2013-02-21,40.0,2013-01-13
01-704-1008,2.0,CDISCPILOT01,ADAE,704,1008,VERBATIM_1299,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-02-21,,40.0,40.0,2013-02-21,40.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0433,HLT_0041,TRANSIENT ISCHEMIC ATTACKS,2013-02-21,40.0,2013-01-13
01-704-1008,3.0,CDISCPILOT01,ADAE,704,1008,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-02-25,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-02-21,40.0,2013-01-13
01-704-1009,1.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-09-05,,10.0,10.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2013-09-25,30.0,2013-08-27
01-704-1009,2.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_1562,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-09-05,,10.0,10.0,2013-09-27,32.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0178,HLT_0456,MALAISE,2013-09-25,30.0,2013-08-27
01-704-1009,3.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-09-14,,19.0,19.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-09-25,30.0,2013-08-27
01-704-1009,4.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_1562,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-05,,10.0,10.0,2013-09-27,32.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0178,HLT_0456,MALAISE,2013-09-25,30.0,2013-08-27
01-704-1009,5.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-09-17,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-09-25,30.0,2013-08-27
01-704-1009,6.0,CDISCPILOT01,ADAE,704,1009,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-09-22,,27.0,27.0,2013-09-23,28.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-09-25,30.0,2013-08-27
01-704-1010,1.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_0822,CYSTITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-02-27,,7.0,7.0,2014-03-06,14.0,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0129,HLT_0739,BLADDER INFECTION,2014-07-08,138.0,2014-02-21
01-704-1010,2.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-05,,135.0,135.0,2014-07-06,136.0,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2014-07-08,138.0,2014-02-21
01-704-1010,3.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-07-05,,135.0,135.0,2014-07-06,136.0,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-07-08,138.0,2014-02-21
01-704-1010,4.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_0274,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-06,,136.0,136.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASION NOS,2014-07-08,138.0,2014-02-21
01-704-1010,5.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_1710,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-07-06,,136.0,136.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0118,HLT_0075,SKIN TEAR,2014-07-08,138.0,2014-02-21
01-704-1010,6.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_1396,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-06,,136.0,136.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,KNEE PAIN,2014-07-08,138.0,2014-02-21
01-704-1010,7.0,CDISCPILOT01,ADAE,704,1010,VERBATIM_0689,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-07-06,,136.0,136.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISE OF HEAD,2014-07-08,138.0,2014-02-21
01-704-1017,1.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_1635,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-10-19,,14.0,14.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,MYOCARDIAL INFARCTION,2013-11-18,44.0,2013-10-06
01-704-1017,2.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_0888,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-10-19,,14.0,14.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0747,HLT_0589,VENTRICULAR SEPTAL DEFECT,2013-11-18,44.0,2013-10-06
01-704-1017,3.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_1543,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-11-01,,27.0,27.0,2013-11-08,34.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0081,HLT_0125,FLU,2013-11-18,44.0,2013-10-06
01-704-1017,4.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_1744,CARDIAC DISORDER,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-11-01,,27.0,27.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0126,HLT_0507,CARDIAC DISORDER,2013-11-18,44.0,2013-10-06
01-704-1017,5.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-11-05,,31.0,31.0,2013-11-22,48.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-11-18,44.0,2013-10-06
01-704-1017,6.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-11-05,,31.0,31.0,2013-11-22,48.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-11-18,44.0,2013-10-06
01-704-1017,7.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-11-05,,31.0,31.0,2013-11-22,48.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-11-18,44.0,2013-10-06
01-704-1017,8.0,CDISCPILOT01,ADAE,704,1017,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-11-05,,31.0,31.0,2013-11-22,48.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-11-18,44.0,2013-10-06
01-704-1025,1.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_1703,VERTIGO,EAR AND LABYRINTH DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-09-28,,2.0,2.0,2013-09-30,4.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0147,HLT_0255,VERTIGO,2013-10-24,28.0,2013-09-27
01-704-1025,2.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_0266,PALPITATIONS,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-09-28,,2.0,2.0,2013-09-30,4.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0593,HLT_0493,PALPITATIONS,2013-10-24,28.0,2013-09-27
01-704-1025,3.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_1153,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-10-11,,15.0,15.0,2013-10-25,29.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2013-10-24,28.0,2013-09-27
01-704-1025,4.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_1601,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,N,Y,,,1.0,,,,,2013-10-25,,29.0,29.0,2013-11-29,64.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0218,HLT_0612,WOLFF-PARKINSON-WHITE SYNDROME,2013-10-24,28.0,2013-09-27
01-704-1025,5.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_1153,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-11,,15.0,15.0,2013-10-25,29.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2013-10-24,28.0,2013-09-27
01-704-1025,6.0,CDISCPILOT01,ADAE,704,1025,VERBATIM_1601,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,N,Y,,,,,,,,2013-10-25,,29.0,29.0,2013-11-29,64.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0218,HLT_0612,WOLFF-PARKINSON-WHITE SYNDROME,2013-10-24,28.0,2013-09-27
01-704-1065,1.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1040,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-10-26,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0332,HLT_0012,ABDOMINAL DISCOMFORT,2013-12-22,60.0,2013-10-24
01-704-1065,2.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-10-27,,4.0,4.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-12-22,60.0,2013-10-24
01-704-1065,3.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-10-27,,4.0,4.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-22,60.0,2013-10-24
01-704-1065,4.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1335,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-11-09,,17.0,17.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-12-22,60.0,2013-10-24
01-704-1065,5.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1562,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-11-09,,17.0,17.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0178,HLT_0456,MALAISE,2013-12-22,60.0,2013-10-24
01-704-1065,6.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1115,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-11-09,,17.0,17.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-12-22,60.0,2013-10-24
01-704-1065,7.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-11-17,,25.0,25.0,2013-11-17,25.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2013-12-22,60.0,2013-10-24
01-704-1065,8.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-11-17,,25.0,25.0,2013-11-17,25.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-12-22,60.0,2013-10-24
01-704-1065,9.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-12-15,,53.0,53.0,2013-12-15,53.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-12-22,60.0,2013-10-24
01-704-1065,10.0,CDISCPILOT01,ADAE,704,1065,VERBATIM_1422,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-12-24,,62.0,62.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,BRADYCARDIA SINUS,2013-12-22,60.0,2013-10-24
01-704-1074,1.0,CDISCPILOT01,ADAE,704,1074,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-22,,1.0,1.0,,,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-03-20,58.0,2014-01-22
01-704-1074,2.0,CDISCPILOT01,ADAE,704,1074,VERBATIM_0027,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2014-02-09,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,SKIN RED,2014-03-20,58.0,2014-01-22
01-704-1093,1.0,CDISCPILOT01,ADAE,704,1093,VERBATIM_0814,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-03-30,,16.0,16.0,2013-04-13,30.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0188,HLT_0450,GLUCOSE INCREASED,2013-06-17,95.0,2013-03-15
01-704-1093,2.0,CDISCPILOT01,ADAE,704,1093,VERBATIM_0814,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-03-30,,16.0,16.0,2013-04-13,30.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0188,HLT_0450,GLUCOSE INCREASED,2013-06-17,95.0,2013-03-15
01-704-1093,3.0,CDISCPILOT01,ADAE,704,1093,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-04,,51.0,51.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-06-17,95.0,2013-03-15
01-704-1093,4.0,CDISCPILOT01,ADAE,704,1093,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-05-04,,51.0,51.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-17,95.0,2013-03-15
01-704-1114,1.0,CDISCPILOT01,ADAE,704,1114,VERBATIM_1639,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-21,,30.0,30.0,2013-02-23,32.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,REDNESS,2013-07-07,166.0,2013-01-23
01-704-1114,2.0,CDISCPILOT01,ADAE,704,1114,VERBATIM_1138,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,,2013-02-23,,32.0,32.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0036,HLT_0656,EDEMA,2013-07-07,166.0,2013-01-23
01-704-1114,3.0,CDISCPILOT01,ADAE,704,1114,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-03-23,,60.0,60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-07-07,166.0,2013-01-23
01-704-1114,4.0,CDISCPILOT01,ADAE,704,1114,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-03-23,,60.0,60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-07-07,166.0,2013-01-23
01-704-1114,5.0,CDISCPILOT01,ADAE,704,1114,VERBATIM_1543,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-06-07,,136.0,136.0,2013-06-13,142.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0081,HLT_0125,FLU,2013-07-07,166.0,2013-01-23
01-704-1120,1.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-23,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-02-01,62.0,2013-12-02
01-704-1120,2.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-12-28,,27.0,27.0,2014-02-03,64.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2014-02-01,62.0,2013-12-02
01-704-1120,3.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-23,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-02-01,62.0,2013-12-02
01-704-1120,4.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2014-01-27,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-02-01,62.0,2013-12-02
01-704-1120,5.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-01-27,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-02-01,62.0,2013-12-02
01-704-1120,6.0,CDISCPILOT01,ADAE,704,1120,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-12-28,,27.0,27.0,2014-02-03,64.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2014-02-01,62.0,2013-12-02
01-704-1135,1.0,CDISCPILOT01,ADAE,704,1135,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-08,,39.0,39.0,,,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-05-16,198.0,2013-10-31
01-704-1135,2.0,CDISCPILOT01,ADAE,704,1135,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,,,Y,Y,,,,,,,1.0,2013-12-08,,39.0,39.0,,,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-05-16,198.0,2013-10-31
01-704-1164,1.0,CDISCPILOT01,ADAE,704,1164,VERBATIM_1543,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-09-27,,9.0,9.0,2012-10-07,19.0,Placebo,Pbo,0.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0081,HLT_0125,FLU,2013-04-04,198.0,2012-09-19
01-704-1164,2.0,CDISCPILOT01,ADAE,704,1164,VERBATIM_1543,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2012-09-27,,9.0,9.0,2012-10-07,19.0,Placebo,Pbo,0.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0081,HLT_0125,FLU,2013-04-04,198.0,2012-09-19
01-704-1164,3.0,CDISCPILOT01,ADAE,704,1164,VERBATIM_0304,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-02-04,,139.0,139.0,2013-02-13,148.0,Placebo,Pbo,0.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,SWELLING OF FEET,2013-04-04,198.0,2012-09-19
01-704-1218,1.0,CDISCPILOT01,ADAE,704,1218,VERBATIM_0814,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-12-30,,42.0,42.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0188,HLT_0450,GLUCOSE INCREASED,2013-05-27,190.0,2012-11-19
01-704-1241,1.0,CDISCPILOT01,ADAE,704,1241,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,1.0,2013-08-14,,-11.0,-10.0,,,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-10-09,46.0,2013-08-25
01-704-1241,2.0,CDISCPILOT01,ADAE,704,1241,VERBATIM_0785,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-09-28,,35.0,35.0,,,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0255,HLT_0296,RESPIRATION LABORED,2013-10-09,46.0,2013-08-25
01-704-1266,1.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0396,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,,2013-10-06,,-7.0,-6.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0782,HLT_0714,HAY FEVER,2013-12-06,55.0,2013-10-13
01-704-1266,2.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-10-17,,5.0,5.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-12-06,55.0,2013-10-13
01-704-1266,3.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0096,ATRIAL FLUTTER,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-10-27,,15.0,15.0,2013-11-08,27.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0627,HLT_0477,ATRIAL FLUTTER,2013-12-06,55.0,2013-10-13
01-704-1266,4.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-11-08,,27.0,27.0,2013-12-06,55.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2013-12-06,55.0,2013-10-13
01-704-1266,5.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0096,ATRIAL FLUTTER,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-10-27,,15.0,15.0,2013-11-08,27.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0627,HLT_0477,ATRIAL FLUTTER,2013-12-06,55.0,2013-10-13
01-704-1266,6.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_1115,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-11-09,,28.0,28.0,2013-12-04,53.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-12-06,55.0,2013-10-13
01-704-1266,7.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0408,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-11-15,,34.0,34.0,2013-12-14,63.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERING,2013-12-06,55.0,2013-10-13
01-704-1266,8.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-11-15,,34.0,34.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-12-06,55.0,2013-10-13
01-704-1266,9.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-10-17,,5.0,5.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-12-06,55.0,2013-10-13
01-704-1266,10.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_1115,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-11-09,,28.0,28.0,2013-12-04,53.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-12-06,55.0,2013-10-13
01-704-1266,11.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_1287,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-06,,55.0,55.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,REDNESS,2013-12-06,55.0,2013-10-13
01-704-1266,12.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-10-17,,5.0,5.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-12-06,55.0,2013-10-13
01-704-1266,13.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-11-08,,27.0,27.0,2013-12-06,55.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2013-12-06,55.0,2013-10-13
01-704-1266,14.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0408,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-11-15,,34.0,34.0,2013-12-14,63.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERING,2013-12-06,55.0,2013-10-13
01-704-1266,15.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-11-15,,34.0,34.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-12-06,55.0,2013-10-13
01-704-1266,16.0,CDISCPILOT01,ADAE,704,1266,VERBATIM_1287,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-06,,55.0,55.0,2013-12-23,72.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,REDNESS,2013-12-06,55.0,2013-10-13
01-704-1323,1.0,CDISCPILOT01,ADAE,704,1323,VERBATIM_0002,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-07-30,,23.0,23.0,2013-08-03,27.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0408,HLT_0733,VIRAL INFECTION,2013-08-05,29.0,2013-07-08
01-704-1323,2.0,CDISCPILOT01,ADAE,704,1323,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-08-04,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-08-05,29.0,2013-07-08
01-704-1323,3.0,CDISCPILOT01,ADAE,704,1323,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-08-04,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-05,29.0,2013-07-08
01-704-1323,4.0,CDISCPILOT01,ADAE,704,1323,VERBATIM_0248,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2013-08-04,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0036,HLT_0656,EDEMA,2013-08-05,29.0,2013-07-08
01-704-1325,1.0,CDISCPILOT01,ADAE,704,1325,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-05-23,,31.0,31.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-07-04,73.0,2014-04-23
01-704-1325,2.0,CDISCPILOT01,ADAE,704,1325,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-07-04,,73.0,73.0,,,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-07-04,73.0,2014-04-23
01-704-1332,1.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-10,,2.0,2.0,2014-02-24,78.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-02-14,68.0,2013-12-09
01-704-1332,2.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2014-01-18,,41.0,41.0,2014-02-24,78.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-02-14,68.0,2013-12-09
01-704-1332,3.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,1.0,2013-12-10,,2.0,2.0,2014-02-24,78.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-02-14,68.0,2013-12-09
01-704-1332,4.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_1128,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2014-02-03,,57.0,57.0,,,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0456,HLT_0775,BURNING SENSATION,2014-02-14,68.0,2013-12-09
01-704-1332,5.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,1.0,2013-12-10,,2.0,2.0,2014-02-24,78.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-02-14,68.0,2013-12-09
01-704-1332,6.0,CDISCPILOT01,ADAE,704,1332,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-01-18,,41.0,41.0,2014-02-24,78.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-02-14,68.0,2013-12-09
01-704-1351,1.0,CDISCPILOT01,ADAE,704,1351,VERBATIM_1701,POLLAKIURIA,RENAL AND URINARY DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-10-27,,16.0,16.0,2014-04-04,175.0,Placebo,Pbo,0.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0560,HLT_0393,URINARY FREQUENCY,2014-04-18,189.0,2013-10-12
01-704-1351,2.0,CDISCPILOT01,ADAE,704,1351,VERBATIM_0867,FLATULENCE,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-10-27,,16.0,16.0,2014-04-04,175.0,Placebo,Pbo,0.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0504,HLT_0356,GAS,2014-04-18,189.0,2013-10-12
01-704-1351,3.0,CDISCPILOT01,ADAE,704,1351,VERBATIM_1701,POLLAKIURIA,RENAL AND URINARY DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-27,,16.0,16.0,2014-04-04,175.0,Placebo,Pbo,0.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0560,HLT_0393,URINARY FREQUENCY,2014-04-18,189.0,2013-10-12
01-704-1351,4.0,CDISCPILOT01,ADAE,704,1351,VERBATIM_0867,FLATULENCE,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-27,,16.0,16.0,2014-04-04,175.0,Placebo,Pbo,0.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0504,HLT_0356,GAS,2014-04-18,189.0,2013-10-12
01-704-1388,1.0,CDISCPILOT01,ADAE,704,1388,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2012-08-23,,-106.0,-105.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-06-11,187.0,2012-12-07
01-704-1435,1.0,CDISCPILOT01,ADAE,704,1435,VERBATIM_1127,PARKINSON'S DISEASE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-06,,51.0,51.0,,,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0313,HLT_0279,DISEASE PARKINSON'S,2013-01-09,54.0,2012-11-17
01-704-1445,1.0,CDISCPILOT01,ADAE,704,1445,VERBATIM_0276,COMPLETED SUICIDE,PSYCHIATRIC DISORDERS,SEVERE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-10-31,,174.0,174.0,2014-10-31,174.0,Placebo,Pbo,0.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,Y,N,N,HLGT_0013,HLT_0625,SUICIDE,2014-11-01,175.0,2014-05-11
01-705-1031,1.0,CDISCPILOT01,ADAE,705,1031,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-25,,29.0,29.0,,,Xanomeline Low Dose,Xan_Lo,1.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-05-11,166.0,2013-11-27
01-705-1059,1.0,CDISCPILOT01,ADAE,705,1059,VERBATIM_0314,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-11-02,,90.0,90.0,,,Placebo,Pbo,0.0,66.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-12-05,123.0,2013-08-05
01-705-1186,1.0,CDISCPILOT01,ADAE,705,1186,VERBATIM_0669,HYPERBILIRUBINAEMIA,HEPATOBILIARY DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-26,,19.0,19.0,,,Placebo,Pbo,0.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0087,HLT_0478,HYPERBILIRUBINEMIA,2014-01-26,19.0,2014-01-08
01-705-1199,1.0,CDISCPILOT01,ADAE,705,1199,VERBATIM_0697,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-09-17,,2.0,2.0,2013-09-29,14.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0716,HLT_0244,PYROSIS,2013-09-28,13.0,2013-09-16
01-705-1199,2.0,CDISCPILOT01,ADAE,705,1199,VERBATIM_0697,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-09-17,,2.0,2.0,2013-09-29,14.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0716,HLT_0244,PYROSIS,2013-09-28,13.0,2013-09-16
01-705-1280,1.0,CDISCPILOT01,ADAE,705,1280,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-04-20,,94.0,94.0,,,Xanomeline High Dose,Xan_Hi,2.0,56.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-07-25,190.0,2014-01-17
01-705-1281,1.0,CDISCPILOT01,ADAE,705,1281,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-01-30,,64.0,64.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-02-27,92.0,2013-11-28
01-705-1281,2.0,CDISCPILOT01,ADAE,705,1281,VERBATIM_1755,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2014-01-30,,64.0,64.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASIONS,2014-02-27,92.0,2013-11-28
01-705-1281,3.0,CDISCPILOT01,ADAE,705,1281,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2014-01-30,,64.0,64.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-02-27,92.0,2013-11-28
01-705-1292,1.0,CDISCPILOT01,ADAE,705,1292,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-10-28,,15.0,15.0,,,Xanomeline Low Dose,Xan_Lo,1.0,60.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2014-05-13,212.0,2013-10-14
01-705-1292,2.0,CDISCPILOT01,ADAE,705,1292,VERBATIM_0314,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-02-13,,123.0,123.0,,,Xanomeline Low Dose,Xan_Lo,1.0,60.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-05-13,212.0,2013-10-14
01-705-1303,1.0,CDISCPILOT01,ADAE,705,1303,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-02-05,,52.0,52.0,2014-03-03,78.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-06-02,169.0,2013-12-16
01-705-1303,2.0,CDISCPILOT01,ADAE,705,1303,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2014-02-05,,52.0,52.0,2014-03-03,78.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-06-02,169.0,2013-12-16
01-705-1303,3.0,CDISCPILOT01,ADAE,705,1303,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2014-02-05,,52.0,52.0,2014-03-03,78.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-06-02,169.0,2013-12-16
01-705-1303,4.0,CDISCPILOT01,ADAE,705,1303,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2014-02-05,,52.0,52.0,2014-03-03,78.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-06-02,169.0,2013-12-16
01-705-1310,1.0,CDISCPILOT01,ADAE,705,1310,VERBATIM_0158,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-11-14,,13.0,13.0,,,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0753,HLT_0127,PRURITIC RASH,2014-01-23,83.0,2013-11-02
01-705-1310,2.0,CDISCPILOT01,ADAE,705,1310,VERBATIM_1798,WOUND HAEMORRHAGE,VASCULAR DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2014-01-09,,69.0,69.0,,,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0162,HLT_0154,WOUND BLEEDING,2014-01-23,83.0,2013-11-02
01-705-1349,1.0,CDISCPILOT01,ADAE,705,1349,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-04-08,,30.0,30.0,2013-04-08,30.0,Placebo,Pbo,0.0,86.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-09-08,183.0,2013-03-10
01-705-1349,2.0,CDISCPILOT01,ADAE,705,1349,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-04-11,,33.0,33.0,2013-04-11,33.0,Placebo,Pbo,0.0,86.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-09-08,183.0,2013-03-10
01-705-1349,3.0,CDISCPILOT01,ADAE,705,1349,VERBATIM_1214,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-25,,169.0,169.0,,,Placebo,Pbo,0.0,86.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0259,HLT_0104,LEFT VENTRICULAR HYPERTROPHY,2013-09-08,183.0,2013-03-10
01-705-1349,4.0,CDISCPILOT01,ADAE,705,1349,VERBATIM_1153,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-25,,169.0,169.0,,,Placebo,Pbo,0.0,86.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2013-09-08,183.0,2013-03-10
01-705-1393,1.0,CDISCPILOT01,ADAE,705,1393,VERBATIM_1719,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-09-19,,13.0,13.0,2012-09-24,18.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL CRAMPS,2013-02-01,148.0,2012-09-07
01-705-1393,2.0,CDISCPILOT01,ADAE,705,1393,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,N,N,,,,,,,1.0,2011-12-05,,-277.0,-276.0,2013-02-20,167.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-02-01,148.0,2012-09-07
01-705-1393,3.0,CDISCPILOT01,ADAE,705,1393,VERBATIM_0544,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",SEVERE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-01-21,,137.0,137.0,2013-01-24,140.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),Y,N,N,N,Y,N,HLGT_0339,HLT_0597,COLON CANCER,2013-02-01,148.0,2012-09-07
01-705-1393,4.0,CDISCPILOT01,ADAE,705,1393,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,N,N,,,,,,,1.0,2011-12-05,,-277.0,-276.0,2013-02-20,167.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-02-01,148.0,2012-09-07
01-705-1431,1.0,CDISCPILOT01,ADAE,705,1431,VERBATIM_0188,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,N,N,,,,,,,1.0,2013-06-22,,-1.0,0.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0701,HLT_0336,ERYTHEMATOUS RASH,2013-12-19,180.0,2013-06-23
01-705-1431,2.0,CDISCPILOT01,ADAE,705,1431,VERBATIM_0363,ANXIETY,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-07-04,,12.0,12.0,2013-07-06,14.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,FEELING ANXIOUS,2013-12-19,180.0,2013-06-23
01-706-1041,1.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1033,ANXIETY,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,REMOTE,,N,N,,,,,,,,2012-05-01,D,-609.0,-608.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,ANXIETY ATTACK,2014-07-28,210.0,2013-12-31
01-706-1041,2.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-07,,8.0,8.0,2014-01-08,9.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-07-28,210.0,2013-12-31
01-706-1041,3.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1679,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-01-14,,15.0,15.0,2014-01-28,29.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASIONS,2014-07-28,210.0,2013-12-31
01-706-1041,4.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1106,IRRITABILITY,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-01-15,,16.0,16.0,2014-07-29,211.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0461,HLT_0627,IRRITABILITY,2014-07-28,210.0,2013-12-31
01-706-1041,5.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1679,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-01-14,,15.0,15.0,2014-01-28,29.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASIONS,2014-07-28,210.0,2013-12-31
01-706-1041,6.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2014-03-04,,64.0,64.0,2014-07-29,211.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-07-28,210.0,2013-12-31
01-706-1041,7.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1033,ANXIETY,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,N,N,,,,,,,,2012-05-01,D,-609.0,-608.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,ANXIETY ATTACK,2014-07-28,210.0,2013-12-31
01-706-1041,8.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_1106,IRRITABILITY,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-01-15,,16.0,16.0,2014-07-29,211.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0461,HLT_0627,IRRITABILITY,2014-07-28,210.0,2013-12-31
01-706-1041,9.0,CDISCPILOT01,ADAE,706,1041,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-03-04,,64.0,64.0,2014-07-29,211.0,Placebo,Pbo,0.0,64.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-07-28,210.0,2013-12-31
01-706-1049,1.0,CDISCPILOT01,ADAE,706,1049,VERBATIM_1235,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-06-03,,21.0,21.0,2013-06-03,21.0,Xanomeline High Dose,Xan_Hi,2.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0310,HLT_0440,FAINTING,2013-06-18,36.0,2013-05-14
01-706-1049,2.0,CDISCPILOT01,ADAE,706,1049,VERBATIM_0436,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,,2013-06-18,,36.0,36.0,2013-06-18,36.0,Xanomeline High Dose,Xan_Hi,2.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPAL ATTACK,2013-06-18,36.0,2013-05-14
01-706-1384,1.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-24,10.0,2012-09-15
01-706-1384,2.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,1.0,,,,1.0,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2012-09-24,10.0,2012-09-15
01-706-1384,3.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0354,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASIONS,2012-09-24,10.0,2012-09-15
01-706-1384,4.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-23,,9.0,9.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-24,10.0,2012-09-15
01-706-1384,5.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-23,,9.0,9.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2012-09-24,10.0,2012-09-15
01-706-1384,6.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,1.0,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-24,10.0,2012-09-15
01-706-1384,7.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,1.0,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2012-09-24,10.0,2012-09-15
01-706-1384,8.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0354,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,,2012-09-15,,1.0,1.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0511,HLT_0738,ABRASIONS,2012-09-24,10.0,2012-09-15
01-706-1384,9.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-23,,9.0,9.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2012-09-24,10.0,2012-09-15
01-706-1384,10.0,CDISCPILOT01,ADAE,706,1384,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-09-23,,9.0,9.0,2012-09-29,15.0,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2012-09-24,10.0,2012-09-15
01-707-1206,1.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1645,SINUS ARRHYTHMIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-11-25,,29.0,29.0,2013-12-23,57.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0630,HLT_0094,SINUS ARRHYTHMIA,2014-04-26,181.0,2013-10-28
01-707-1206,2.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1741,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-11-26,,30.0,30.0,2013-12-09,43.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0008,HLT_0404,CPK INCREASE,2014-04-26,181.0,2013-10-28
01-707-1206,3.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1588,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-12-03,,37.0,37.0,2013-12-10,44.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0032,HLT_0172,POSTNASAL DRIP,2014-04-26,181.0,2013-10-28
01-707-1206,4.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1741,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-11-26,,30.0,30.0,2013-12-09,43.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0008,HLT_0404,CPK INCREASE,2014-04-26,181.0,2013-10-28
01-707-1206,5.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1588,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-12-03,,37.0,37.0,2013-12-10,44.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0032,HLT_0172,POSTNASAL DRIP,2014-04-26,181.0,2013-10-28
01-707-1206,6.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_1645,SINUS ARRHYTHMIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-11-25,,29.0,29.0,2013-12-23,57.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0630,HLT_0094,SINUS ARRHYTHMIA,2014-04-26,181.0,2013-10-28
01-707-1206,7.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_0757,CONJUNCTIVITIS,EYE DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-02-08,,104.0,104.0,2014-02-22,118.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0335,HLT_0584,CONJUNCTIVITIS,2014-04-26,181.0,2013-10-28
01-707-1206,8.0,CDISCPILOT01,ADAE,707,1206,VERBATIM_0757,CONJUNCTIVITIS,EYE DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-02-08,,104.0,104.0,2014-02-22,118.0,Placebo,Pbo,0.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0335,HLT_0584,CONJUNCTIVITIS,2014-04-26,181.0,2013-10-28
01-708-1019,1.0,CDISCPILOT01,ADAE,708,1019,VERBATIM_0520,HEADACHE,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-12-31,,12.0,12.0,2013-12-31,12.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,FRONTAL HEADACHE,2014-01-01,13.0,2013-12-20
01-708-1019,2.0,CDISCPILOT01,ADAE,708,1019,VERBATIM_0442,STUPOR,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2014-01-01,,13.0,13.0,2014-01-01,13.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0513,HLT_0595,STUPOR,2014-01-01,13.0,2013-12-20
01-708-1019,3.0,CDISCPILOT01,ADAE,708,1019,VERBATIM_1021,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2014-01-01,,13.0,13.0,2014-01-01,13.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0433,HLT_0041,TRANSIENT ISCHEMIC ATTACKS,2014-01-01,13.0,2013-12-20
01-708-1019,4.0,CDISCPILOT01,ADAE,708,1019,VERBATIM_0911,VISION BLURRED,EYE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2014-01-01,,13.0,13.0,2014-01-01,13.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0598,HLT_0120,BLURRED VISION,2014-01-01,13.0,2013-12-20
01-708-1019,5.0,CDISCPILOT01,ADAE,708,1019,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2014-01-01,,13.0,13.0,2014-01-01,13.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2014-01-01,13.0,2013-12-20
01-708-1032,1.0,CDISCPILOT01,ADAE,708,1032,VERBATIM_0318,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-26,,18.0,18.0,2013-03-09,29.0,Xanomeline Low Dose,Xan_Lo,1.0,62.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-03-01,21.0,2013-02-09
01-708-1084,1.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_0279,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-23,,15.0,15.0,2013-05-23,15.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-11-11,187.0,2013-05-09
01-708-1084,2.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_0279,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-23,,15.0,15.0,2013-05-23,15.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-11-11,187.0,2013-05-09
01-708-1084,3.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_1635,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-06-09,,32.0,32.0,2013-06-09,32.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,MYOCARDIAL INFARCTION,2013-11-11,187.0,2013-05-09
01-708-1084,4.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_1635,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-06-09,,32.0,32.0,2013-06-09,32.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,MYOCARDIAL INFARCTION,2013-11-11,187.0,2013-05-09
01-708-1084,5.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-06-23,,46.0,46.0,2013-06-23,46.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-11-11,187.0,2013-05-09
01-708-1084,6.0,CDISCPILOT01,ADAE,708,1084,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-06-23,,46.0,46.0,2013-06-23,46.0,Xanomeline Low Dose,Xan_Lo,1.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-11-11,187.0,2013-05-09
01-708-1087,1.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_0160,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-19,,90.0,90.0,2013-01-19,90.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0140,HLT_0765,HEARTBEATS IRREGULAR,2013-04-28,189.0,2012-10-22
01-708-1087,2.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_0160,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-01-19,,90.0,90.0,2013-01-19,90.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0140,HLT_0765,HEARTBEATS IRREGULAR,2013-04-28,189.0,2012-10-22
01-708-1087,3.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-02-04,,106.0,106.0,2013-02-08,110.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-04-28,189.0,2012-10-22
01-708-1087,4.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_1743,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-02-16,,118.0,118.0,,,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-04-28,189.0,2012-10-22
01-708-1087,5.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_0160,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-03-16,,146.0,146.0,2013-03-16,146.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0140,HLT_0765,HEARTBEATS IRREGULAR,2013-04-28,189.0,2012-10-22
01-708-1087,6.0,CDISCPILOT01,ADAE,708,1087,VERBATIM_0160,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-03-16,,146.0,146.0,2013-03-16,146.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0140,HLT_0765,HEARTBEATS IRREGULAR,2013-04-28,189.0,2012-10-22
01-708-1158,1.0,CDISCPILOT01,ADAE,708,1158,VERBATIM_0499,AGITATION,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2014-02-25,,18.0,18.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0170,HLT_0140,AGITATION,2014-03-21,42.0,2014-02-08
01-708-1158,2.0,CDISCPILOT01,ADAE,708,1158,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,N,Y,,1.0,1.0,,,,1.0,2014-03-22,,43.0,43.0,2014-03-22,43.0,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-03-21,42.0,2014-02-08
01-708-1178,1.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_1110,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-12-19,,-10.0,-9.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0543,HLT_0484,FLANK PAIN,2014-04-06,99.0,2013-12-29
01-708-1178,2.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-03-01,,63.0,63.0,2014-03-08,70.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2014-04-06,99.0,2013-12-29
01-708-1178,3.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-03-09,,71.0,71.0,2014-04-06,99.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-04-06,99.0,2013-12-29
01-708-1178,4.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_1611,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-09,,71.0,71.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0747,HLT_0589,VENTRICULAR SEPTAL DEFECT,2014-04-06,99.0,2013-12-29
01-708-1178,5.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-03-09,,71.0,71.0,2014-04-06,99.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-04-06,99.0,2013-12-29
01-708-1178,6.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_0278,DIZZINESS,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-03-24,,86.0,86.0,2014-03-26,88.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0751,HLT_0619,LIGHT-HEADED,2014-04-06,99.0,2013-12-29
01-708-1178,7.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,SEVERE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-03-24,,86.0,86.0,2014-03-26,88.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2014-04-06,99.0,2013-12-29
01-708-1178,8.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_0361,CYSTITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-03-24,,86.0,86.0,2014-03-28,90.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0129,HLT_0739,BLADDER INFECTION,2014-04-06,99.0,2013-12-29
01-708-1178,9.0,CDISCPILOT01,ADAE,708,1178,VERBATIM_0340,ALCOHOL USE,SOCIAL CIRCUMSTANCES,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-24,,86.0,86.0,2014-03-24,86.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0182,HLT_0138,ALCOHOL USE,2014-04-06,99.0,2013-12-29
01-708-1213,1.0,CDISCPILOT01,ADAE,708,1213,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-02-22,,14.0,14.0,2013-02-22,14.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2013-02-22,14.0,2013-02-09
01-708-1213,2.0,CDISCPILOT01,ADAE,708,1213,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-02-22,,14.0,14.0,2013-02-22,14.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2013-02-22,14.0,2013-02-09
01-708-1216,1.0,CDISCPILOT01,ADAE,708,1216,VERBATIM_0953,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-11-06,,14.0,14.0,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2012-11-29,37.0,2012-10-24
01-708-1216,2.0,CDISCPILOT01,ADAE,708,1216,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2012-11-06,,14.0,14.0,2012-12-13,51.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2012-11-29,37.0,2012-10-24
01-708-1216,3.0,CDISCPILOT01,ADAE,708,1216,VERBATIM_0246,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2012-11-22,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0236,HLT_0105,APPLICATION SITE SWELLING,2012-11-29,37.0,2012-10-24
01-708-1216,4.0,CDISCPILOT01,ADAE,708,1216,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-11-06,,14.0,14.0,2012-12-13,51.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2012-11-29,37.0,2012-10-24
01-708-1253,1.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,N,N,,,,,,,,2013-05-06,,-1.0,0.0,2013-05-16,10.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-11-05,183.0,2013-05-07
01-708-1253,2.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0757,CONJUNCTIVITIS,EYE DISORDERS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-05-06,,-1.0,0.0,2013-05-16,10.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0335,HLT_0584,CONJUNCTIVITIS,2013-11-05,183.0,2013-05-07
01-708-1253,3.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0756,HEART RATE INCREASED,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-07,,1.0,1.0,2013-05-10,4.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0673,HLT_0646,HEART RATE INCREASED,2013-11-05,183.0,2013-05-07
01-708-1253,4.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,N,N,,,,,,,,2013-05-06,,-1.0,0.0,2013-05-16,10.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-11-05,183.0,2013-05-07
01-708-1253,5.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0757,CONJUNCTIVITIS,EYE DISORDERS,MILD,N,0.0,NONE,,N,N,,,,,,,,2013-05-06,,-1.0,0.0,2013-05-16,10.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0335,HLT_0584,CONJUNCTIVITIS,2013-11-05,183.0,2013-05-07
01-708-1253,6.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_0756,HEART RATE INCREASED,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-07,,1.0,1.0,2013-05-10,4.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0673,HLT_0646,HEART RATE INCREASED,2013-11-05,183.0,2013-05-07
01-708-1253,7.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-06-07,,32.0,32.0,2013-06-07,32.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-11-05,183.0,2013-05-07
01-708-1253,8.0,CDISCPILOT01,ADAE,708,1253,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-06-07,,32.0,32.0,2013-06-07,32.0,Placebo,Pbo,0.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-11-05,183.0,2013-05-07
01-708-1272,1.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-02-11,,6.0,6.0,2013-02-11,6.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-03-22,45.0,2013-02-06
01-708-1272,2.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0534,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SEVERE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-02-18,,13.0,13.0,2013-02-18,13.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0750,HLT_0078,LEG CRAMPS,2013-03-22,45.0,2013-02-06
01-708-1272,3.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0981,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-02-21,,16.0,16.0,2013-03-20,43.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0594,HLT_0050,VENTRICULAR BIGEMINY,2013-03-22,45.0,2013-02-06
01-708-1272,4.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_1621,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-02-27,,22.0,22.0,2013-02-27,22.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-03-22,45.0,2013-02-06
01-708-1272,5.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-01,,24.0,24.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-03-22,45.0,2013-02-06
01-708-1272,6.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-01,,24.0,24.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-03-22,45.0,2013-02-06
01-708-1272,7.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-07,,30.0,30.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-03-22,45.0,2013-02-06
01-708-1272,8.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-01,,24.0,24.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-03-22,45.0,2013-02-06
01-708-1272,9.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-01,,24.0,24.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-03-22,45.0,2013-02-06
01-708-1272,10.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-07,,30.0,30.0,2013-03-07,30.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-03-22,45.0,2013-02-06
01-708-1272,11.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0490,HOT FLUSH,VASCULAR DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-19,,42.0,42.0,2013-03-19,42.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0773,HLT_0737,HOT FLASHES,2013-03-22,45.0,2013-02-06
01-708-1272,12.0,CDISCPILOT01,ADAE,708,1272,VERBATIM_0981,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-02-21,,16.0,16.0,2013-03-20,43.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0594,HLT_0050,VENTRICULAR BIGEMINY,2013-03-22,45.0,2013-02-06
01-708-1286,1.0,CDISCPILOT01,ADAE,708,1286,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-09-12,,3.0,3.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-03-08,180.0,2013-09-10
01-708-1286,2.0,CDISCPILOT01,ADAE,708,1286,VERBATIM_0284,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-09-23,,14.0,14.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,INFERIOR MYOCARDIAL INFARCTION,2014-03-08,180.0,2013-09-10
01-708-1286,3.0,CDISCPILOT01,ADAE,708,1286,VERBATIM_0554,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-02-18,,162.0,162.0,2014-02-18,162.0,Placebo,Pbo,0.0,80.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL PAIN,2014-03-08,180.0,2013-09-10
01-708-1286,4.0,CDISCPILOT01,ADAE,708,1286,VERBATIM_0443,CONSTIPATION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-02-18,,162.0,162.0,2014-02-18,162.0,Placebo,Pbo,0.0,80.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0635,HLT_0402,CONSTIPATION,2014-03-08,180.0,2013-09-10
01-708-1296,1.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_1263,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-06-27,,14.0,14.0,2013-06-27,14.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0067,HLT_0271,LEFT ATRIAL HYPERTROPHY,2013-12-12,182.0,2013-06-14
01-708-1296,2.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_1263,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-06-27,,14.0,14.0,2013-06-27,14.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0067,HLT_0271,LEFT ATRIAL HYPERTROPHY,2013-12-12,182.0,2013-06-14
01-708-1296,3.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-09-04,,83.0,83.0,2013-09-18,97.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-12,182.0,2013-06-14
01-708-1296,4.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-09-04,,83.0,83.0,2013-09-18,97.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-12,182.0,2013-06-14
01-708-1296,5.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_0133,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-10-04,,113.0,113.0,2013-10-30,139.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-12-12,182.0,2013-06-14
01-708-1296,6.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_0133,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-10-04,,113.0,113.0,2013-10-30,139.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-12-12,182.0,2013-06-14
01-708-1296,7.0,CDISCPILOT01,ADAE,708,1296,VERBATIM_1008,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-12-07,,177.0,177.0,2013-12-07,177.0,Placebo,Pbo,0.0,57.0,<65,1.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0764,HLT_0213,PAIN IN THIGH,2013-12-12,182.0,2013-06-14
01-708-1297,1.0,CDISCPILOT01,ADAE,708,1297,VERBATIM_1038,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-04-02,,68.0,68.0,,,Xanomeline Low Dose,Xan_Lo,1.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-05-03,99.0,2013-01-25
01-708-1297,2.0,CDISCPILOT01,ADAE,708,1297,VERBATIM_0246,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-04-02,,68.0,68.0,,,Xanomeline Low Dose,Xan_Lo,1.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0236,HLT_0105,APPLICATION SITE SWELLING,2013-05-03,99.0,2013-01-25
01-708-1297,3.0,CDISCPILOT01,ADAE,708,1297,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,Y,N,Y,,1.0,1.0,,,,,2013-05-08,,104.0,104.0,,,Xanomeline Low Dose,Xan_Lo,1.0,61.0,<65,1.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-05-03,99.0,2013-01-25
01-708-1316,1.0,CDISCPILOT01,ADAE,708,1316,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-29,,160.0,160.0,,,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2014-03-01,191.0,2013-08-23
01-708-1316,2.0,CDISCPILOT01,ADAE,708,1316,VERBATIM_0178,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-15,,177.0,177.0,,,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-03-01,191.0,2013-08-23
01-708-1336,1.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_1049,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2012-12-18,,12.0,12.0,2012-12-18,12.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,LIGHTHEADEDNESS,2013-06-05,181.0,2012-12-07
01-708-1336,2.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-12,,37.0,37.0,2013-01-12,37.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-05,181.0,2012-12-07
01-708-1336,3.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0005,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-02-02,,58.0,58.0,2013-02-02,58.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,LIGHT HEADEDNESS,2013-06-05,181.0,2012-12-07
01-708-1336,4.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-10,,125.0,125.0,2013-06-05,181.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-05,181.0,2012-12-07
01-708-1336,5.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-04-10,,125.0,125.0,2013-06-05,181.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-05,181.0,2012-12-07
01-708-1336,6.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-10,,125.0,125.0,2013-06-05,181.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-05,181.0,2012-12-07
01-708-1336,7.0,CDISCPILOT01,ADAE,708,1336,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-10,,125.0,125.0,2013-06-05,181.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-05,181.0,2012-12-07
01-708-1347,1.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-18,60.0,2013-04-20
01-708-1347,2.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-06-18,60.0,2013-04-20
01-708-1347,3.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_1011,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-18,60.0,2013-04-20
01-708-1347,4.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_1691,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0236,HLT_0105,APPLICATION SITE SWELLING,2013-06-18,60.0,2013-04-20
01-708-1347,5.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-18,60.0,2013-04-20
01-708-1347,6.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-06-18,60.0,2013-04-20
01-708-1347,7.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_1011,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-18,60.0,2013-04-20
01-708-1347,8.0,CDISCPILOT01,ADAE,708,1347,VERBATIM_1691,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-13,,55.0,55.0,2013-06-25,67.0,Xanomeline High Dose,Xan_Hi,2.0,61.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0236,HLT_0105,APPLICATION SITE SWELLING,2013-06-18,60.0,2013-04-20
01-708-1348,1.0,CDISCPILOT01,ADAE,708,1348,VERBATIM_0335,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-08-18,,14.0,14.0,2013-08-31,27.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,ANTEROSEPTAL INFARCTION,2014-02-13,193.0,2013-08-05
01-708-1348,2.0,CDISCPILOT01,ADAE,708,1348,VERBATIM_0335,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-08-18,,14.0,14.0,2013-08-31,27.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,ANTEROSEPTAL INFARCTION,2014-02-13,193.0,2013-08-05
01-708-1348,3.0,CDISCPILOT01,ADAE,708,1348,VERBATIM_0445,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-12-01,,119.0,119.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-02-13,193.0,2013-08-05
01-708-1353,1.0,CDISCPILOT01,ADAE,708,1353,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-08-18,,46.0,46.0,2013-09-10,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-08-28,56.0,2013-07-04
01-708-1353,2.0,CDISCPILOT01,ADAE,708,1353,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-08-18,,46.0,46.0,2013-09-10,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-08-28,56.0,2013-07-04
01-708-1353,3.0,CDISCPILOT01,ADAE,708,1353,VERBATIM_0755,HYPOTENSION,VASCULAR DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-08-28,,56.0,56.0,2013-09-10,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0412,HLT_0761,LOW BLOOD PRESSURE,2013-08-28,56.0,2013-07-04
01-708-1372,1.0,CDISCPILOT01,ADAE,708,1372,VERBATIM_1650,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2013-04-10,,-2.0,-1.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,AV BLOCK SECOND DEGREE,2013-04-19,8.0,2013-04-12
01-708-1406,1.0,CDISCPILOT01,ADAE,708,1406,VERBATIM_0397,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-06-16,,173.0,173.0,,,Xanomeline High Dose,Xan_Hi,2.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,SWELLING OF LEGS,2014-07-02,189.0,2013-12-26
01-708-1406,2.0,CDISCPILOT01,ADAE,708,1406,VERBATIM_0896,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-06-16,,173.0,173.0,,,Xanomeline High Dose,Xan_Hi,2.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,SWELLING OF LEGS,2014-07-02,189.0,2013-12-26
01-708-1428,1.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_0847,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-11-22,,14.0,14.0,2013-11-22,14.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0577,HLT_0386,NOSE BLEED,2013-12-14,36.0,2013-11-09
01-708-1428,2.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_1038,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-14,36.0,2013-11-09
01-708-1428,3.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-12-14,36.0,2013-11-09
01-708-1428,4.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_0979,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0301,HLT_0260,APPLICATION SITE WARMTH,2013-12-14,36.0,2013-11-09
01-708-1428,5.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_1038,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-14,36.0,2013-11-09
01-708-1428,6.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_0798,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-12-14,36.0,2013-11-09
01-708-1428,7.0,CDISCPILOT01,ADAE,708,1428,VERBATIM_0979,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-10,,32.0,32.0,2013-12-21,43.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0301,HLT_0260,APPLICATION SITE WARMTH,2013-12-14,36.0,2013-11-09
01-709-1007,1.0,CDISCPILOT01,ADAE,709,1007,VERBATIM_1481,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2012-08-16,,17.0,17.0,2012-08-19,20.0,Xanomeline Low Dose,Xan_Lo,1.0,54.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2012-08-28,29.0,2012-07-31
01-709-1007,2.0,CDISCPILOT01,ADAE,709,1007,VERBATIM_1481,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-08-16,,17.0,17.0,2012-08-19,20.0,Xanomeline Low Dose,Xan_Lo,1.0,54.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2012-08-28,29.0,2012-07-31
01-709-1007,3.0,CDISCPILOT01,ADAE,709,1007,VERBATIM_0008,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-08-21,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,54.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2012-08-28,29.0,2012-07-31
01-709-1007,4.0,CDISCPILOT01,ADAE,709,1007,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,N,Y,,1.0,1.0,,,,,2012-08-30,,31.0,31.0,2012-08-30,31.0,Xanomeline Low Dose,Xan_Lo,1.0,54.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2012-08-28,29.0,2012-07-31
01-709-1020,1.0,CDISCPILOT01,ADAE,709,1020,VERBATIM_0684,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-27,,27.0,27.0,,,Xanomeline Low Dose,Xan_Lo,1.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-06-01,183.0,2012-12-01
01-709-1020,2.0,CDISCPILOT01,ADAE,709,1020,VERBATIM_1107,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-01-03,,34.0,34.0,2013-01-11,42.0,Xanomeline Low Dose,Xan_Lo,1.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-06-01,183.0,2012-12-01
01-709-1020,3.0,CDISCPILOT01,ADAE,709,1020,VERBATIM_0554,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-01-03,,34.0,34.0,2013-01-11,42.0,Xanomeline Low Dose,Xan_Lo,1.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL PAIN,2013-06-01,183.0,2012-12-01
01-709-1020,4.0,CDISCPILOT01,ADAE,709,1020,VERBATIM_0179,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-01-15,,46.0,46.0,,,Xanomeline Low Dose,Xan_Lo,1.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-06-01,183.0,2012-12-01
01-709-1029,1.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0011,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-09,,16.0,16.0,2013-02-19,57.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,SEPTAL MYOCARDIAL INFARCTION,2013-06-26,184.0,2012-12-25
01-709-1029,2.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0716,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-17,,24.0,24.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-06-26,184.0,2012-12-25
01-709-1029,3.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0262,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-01-24,,31.0,31.0,2013-02-27,65.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0750,HLT_0078,CRAMP,2013-06-26,184.0,2012-12-25
01-709-1029,4.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0011,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-01-09,,16.0,16.0,2013-02-19,57.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,SEPTAL MYOCARDIAL INFARCTION,2013-06-26,184.0,2012-12-25
01-709-1029,5.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0262,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-01-24,,31.0,31.0,2013-02-27,65.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0750,HLT_0078,CRAMP,2013-06-26,184.0,2012-12-25
01-709-1029,6.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1150,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-20,,86.0,86.0,2013-04-16,113.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,SEPTAL MYOCARDIAL INFARCTION,2013-06-26,184.0,2012-12-25
01-709-1029,7.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-03-20,,86.0,86.0,2013-04-16,113.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-06-26,184.0,2012-12-25
01-709-1029,8.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1150,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-20,,86.0,86.0,2013-04-16,113.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,SEPTAL MYOCARDIAL INFARCTION,2013-06-26,184.0,2012-12-25
01-709-1029,9.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-03-20,,86.0,86.0,2013-04-16,113.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-06-26,184.0,2012-12-25
01-709-1029,10.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1421,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-05-12,,139.0,139.0,2013-05-19,146.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-06-26,184.0,2012-12-25
01-709-1029,11.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1086,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,1.0,2013-05-12,,139.0,139.0,2013-05-19,146.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0398,HLT_0591,RED THROAT,2013-06-26,184.0,2012-12-25
01-709-1029,12.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1150,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-05-15,,142.0,142.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,SEPTAL MYOCARDIAL INFARCTION,2013-06-26,184.0,2012-12-25
01-709-1029,13.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1421,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-05-12,,139.0,139.0,2013-05-19,146.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-06-26,184.0,2012-12-25
01-709-1029,14.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_1086,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,1.0,2013-05-12,,139.0,139.0,2013-05-19,146.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0398,HLT_0591,RED THROAT,2013-06-26,184.0,2012-12-25
01-709-1029,15.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-06-12,,170.0,170.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-06-26,184.0,2012-12-25
01-709-1029,16.0,CDISCPILOT01,ADAE,709,1029,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-06-19,,177.0,177.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-26,184.0,2012-12-25
01-709-1081,1.0,CDISCPILOT01,ADAE,709,1081,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-04-07,,80.0,80.0,,,Xanomeline Low Dose,Xan_Lo,1.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-04-27,100.0,2014-01-18
01-709-1081,2.0,CDISCPILOT01,ADAE,709,1081,VERBATIM_1418,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,Y,N,Y,,1.0,1.0,,,,,2014-05-01,,104.0,104.0,,,Xanomeline Low Dose,Xan_Lo,1.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,PERIPHERAL SWELLING,2014-04-27,100.0,2014-01-18
01-709-1088,1.0,CDISCPILOT01,ADAE,709,1088,VERBATIM_0968,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-05-08,,27.0,27.0,,,Placebo,Pbo,0.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2014-10-09,181.0,2014-04-12
01-709-1088,2.0,CDISCPILOT01,ADAE,709,1088,VERBATIM_0271,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,1.0,2014-08-02,,113.0,113.0,,,Placebo,Pbo,0.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-10-09,181.0,2014-04-12
01-709-1099,1.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-11-06,,13.0,13.0,2013-11-17,24.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2014-04-25,183.0,2013-10-25
01-709-1099,2.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1069,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-11-12,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2014-04-25,183.0,2013-10-25
01-709-1099,3.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1087,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-11-12,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE VESICLES,2014-04-25,183.0,2013-10-25
01-709-1099,4.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1663,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-11-12,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-04-25,183.0,2013-10-25
01-709-1099,5.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-11-06,,13.0,13.0,2013-11-17,24.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2014-04-25,183.0,2013-10-25
01-709-1099,6.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1069,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-11-12,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2014-04-25,183.0,2013-10-25
01-709-1099,7.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1663,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-11-12,,19.0,19.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-04-25,183.0,2013-10-25
01-709-1099,8.0,CDISCPILOT01,ADAE,709,1099,VERBATIM_1217,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-23,,150.0,150.0,2014-03-23,150.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0103,HLT_0629,SKIN TAG REMOVAL,2014-04-25,183.0,2013-10-25
01-709-1102,1.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_1069,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-11,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-03-27,72.0,2013-01-15
01-709-1102,2.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_1551,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-11,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-03-27,72.0,2013-01-15
01-709-1102,3.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_1069,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-02-11,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-03-27,72.0,2013-01-15
01-709-1102,4.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_1551,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-02-11,,28.0,28.0,,,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-03-27,72.0,2013-01-15
01-709-1102,5.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_0494,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-03-20,,65.0,65.0,2013-03-26,71.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-03-27,72.0,2013-01-15
01-709-1102,6.0,CDISCPILOT01,ADAE,709,1102,VERBATIM_0181,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-03-26,,71.0,71.0,2013-03-27,72.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0576,HLT_0180,APPLICATION SITE BLISTER,2013-03-27,72.0,2013-01-15
01-709-1168,1.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_1165,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-17,,16.0,16.0,2013-09-06,36.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,IRRITATION SKIN,2013-09-26,56.0,2013-08-02
01-709-1168,2.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_1165,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-08-17,,16.0,16.0,2013-09-06,36.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,IRRITATION SKIN,2013-09-26,56.0,2013-08-02
01-709-1168,3.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-09-06,,36.0,36.0,2013-10-11,71.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2013-09-26,56.0,2013-08-02
01-709-1168,4.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_0324,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-09-06,,36.0,36.0,2013-10-11,71.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-09-26,56.0,2013-08-02
01-709-1168,5.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-09-06,,36.0,36.0,2013-10-11,71.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2013-09-26,56.0,2013-08-02
01-709-1168,6.0,CDISCPILOT01,ADAE,709,1168,VERBATIM_0324,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-09-06,,36.0,36.0,2013-10-11,71.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-09-26,56.0,2013-08-02
01-709-1217,1.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-03-06,,3.0,3.0,2013-03-06,3.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-06-11,100.0,2013-03-04
01-709-1217,2.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_0620,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-03-20,,17.0,17.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-06-11,100.0,2013-03-04
01-709-1217,3.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1036,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-03-26,,23.0,23.0,2013-06-18,107.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-06-11,100.0,2013-03-04
01-709-1217,4.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-03-27,,24.0,24.0,2013-03-27,24.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-06-11,100.0,2013-03-04
01-709-1217,5.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1077,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-03-30,,27.0,27.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0130,HLT_0289,T WAVE INVERTED,2013-06-11,100.0,2013-03-04
01-709-1217,6.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_0494,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-04-01,,29.0,29.0,2013-04-11,39.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-06-11,100.0,2013-03-04
01-709-1217,7.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_0494,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-04-01,,29.0,29.0,2013-04-11,39.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-06-11,100.0,2013-03-04
01-709-1217,8.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1036,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-03-26,,23.0,23.0,2013-06-18,107.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-06-11,100.0,2013-03-04
01-709-1217,9.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-05-17,,75.0,75.0,2013-05-18,76.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-06-11,100.0,2013-03-04
01-709-1217,10.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_1036,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-03-26,,23.0,23.0,2013-06-18,107.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-06-11,100.0,2013-03-04
01-709-1217,11.0,CDISCPILOT01,ADAE,709,1217,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-27,,85.0,85.0,2013-06-18,107.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-11,100.0,2013-03-04
01-709-1238,1.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-05-28,,14.0,14.0,2013-05-28,14.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-08-06,84.0,2013-05-15
01-709-1238,2.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_1069,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-30,,16.0,16.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-08-06,84.0,2013-05-15
01-709-1238,3.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-05-30,,16.0,16.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-08-06,84.0,2013-05-15
01-709-1238,4.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_0012,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-05-30,,16.0,16.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0457,HLT_0200,APPLICATION SITE DISCHARGE,2013-08-06,84.0,2013-05-15
01-709-1238,5.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_0163,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-05-31,,17.0,17.0,2013-05-31,17.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0131,HLT_0097,HIP FRACTURE,2013-08-06,84.0,2013-05-15
01-709-1238,6.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-06-09,,26.0,26.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-08-06,84.0,2013-05-15
01-709-1238,7.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-06-09,,26.0,26.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-08-06,84.0,2013-05-15
01-709-1238,8.0,CDISCPILOT01,ADAE,709,1238,VERBATIM_0989,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-06-28,,45.0,45.0,2013-06-28,45.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0450,HLT_0498,SKIN LESION EXCISION,2013-08-06,84.0,2013-05-15
01-709-1259,1.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0972,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-02-05,,11.0,11.0,2013-02-13,19.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0557,HLT_0435,INFECTED FINGER,2013-06-13,139.0,2013-01-26
01-709-1259,2.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0972,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-02-05,,11.0,11.0,2013-02-13,19.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0557,HLT_0435,INFECTED FINGER,2013-06-13,139.0,2013-01-26
01-709-1259,3.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0664,BLOOD URINE PRESENT,INVESTIGATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-14,,48.0,48.0,,,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0289,HLT_0458,BLOOD IN URINE,2013-06-13,139.0,2013-01-26
01-709-1259,4.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_1792,CYSTOSCOPY,INVESTIGATIONS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-03-17,,51.0,51.0,2013-03-17,51.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0041,HLT_0436,CYSTOSCOPY,2013-06-13,139.0,2013-01-26
01-709-1259,5.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0255,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-17,,51.0,51.0,2013-03-30,64.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0568,HLT_0215,ENLARGED PROSTATE,2013-06-13,139.0,2013-01-26
01-709-1259,6.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0255,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,SEVERE,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-17,,51.0,51.0,2013-03-30,64.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0568,HLT_0215,ENLARGED PROSTATE,2013-06-13,139.0,2013-01-26
01-709-1259,7.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_1401,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-13,,78.0,78.0,2013-04-14,79.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0652,HLT_0310,FEVER,2013-06-13,139.0,2013-01-26
01-709-1259,8.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_1538,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-13,,78.0,78.0,2013-04-14,79.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0011,HLT_0533,DEHYDRATION,2013-06-13,139.0,2013-01-26
01-709-1259,9.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0755,HYPOTENSION,VASCULAR DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-04-13,,78.0,78.0,2013-04-14,79.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0412,HLT_0761,LOW BLOOD PRESSURE,2013-06-13,139.0,2013-01-26
01-709-1259,10.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0913,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-04-20,,85.0,85.0,2013-06-13,139.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0111,HLT_0194,POSTURAL HYPOTENSION,2013-06-13,139.0,2013-01-26
01-709-1259,11.0,CDISCPILOT01,ADAE,709,1259,VERBATIM_0913,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-04-20,,85.0,85.0,2013-06-13,139.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0111,HLT_0194,POSTURAL HYPOTENSION,2013-06-13,139.0,2013-01-26
01-709-1285,1.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_1501,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-04-14,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,Y,N,N,N,HLGT_0547,HLT_0639,HOMONYMOUS HEMIANOPSIA,2013-05-23,61.0,2013-03-24
01-709-1285,2.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_1329,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-04-19,,27.0,27.0,2013-05-31,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-05-23,61.0,2013-03-24
01-709-1285,3.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_0886,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-04-19,,27.0,27.0,2013-05-31,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-05-23,61.0,2013-03-24
01-709-1285,4.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-19,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-05-23,61.0,2013-03-24
01-709-1285,5.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_1329,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-19,,27.0,27.0,2013-05-31,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-05-23,61.0,2013-03-24
01-709-1285,6.0,CDISCPILOT01,ADAE,709,1285,VERBATIM_0886,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-19,,27.0,27.0,2013-05-31,69.0,Xanomeline Low Dose,Xan_Lo,1.0,87.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-05-23,61.0,2013-03-24
01-709-1301,1.0,CDISCPILOT01,ADAE,709,1301,VERBATIM_0875,DIABETES MELLITUS,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-08-30,,43.0,43.0,,,Placebo,Pbo,0.0,62.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0572,HLT_0447,DIABETES,2014-01-17,183.0,2013-07-19
01-709-1306,1.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1724,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-06-16,134.0,2014-02-03
01-709-1306,2.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1492,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-06-16,134.0,2014-02-03
01-709-1306,3.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1724,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-06-16,134.0,2014-02-03
01-709-1306,4.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1492,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-06-16,134.0,2014-02-03
01-709-1306,5.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_0132,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2014-05-04,,91.0,91.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2014-06-16,134.0,2014-02-03
01-709-1306,6.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1657,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,1.0,2014-05-20,,107.0,107.0,2014-05-23,110.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0253,HLT_0430,DRUG RASH,2014-06-16,134.0,2014-02-03
01-709-1306,7.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1724,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-06-16,134.0,2014-02-03
01-709-1306,8.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_1492,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-04-20,,77.0,77.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-06-16,134.0,2014-02-03
01-709-1306,9.0,CDISCPILOT01,ADAE,709,1306,VERBATIM_0132,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-05-04,,91.0,91.0,2014-06-23,141.0,Placebo,Pbo,0.0,60.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2014-06-16,134.0,2014-02-03
01-709-1309,1.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_1060,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,1.0,2013-06-10,,-9.0,-8.0,2013-07-01,13.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0097,HLT_0500,MACULOPAPULAR RASH,2013-12-19,184.0,2013-06-19
01-709-1309,2.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0086,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,1.0,2013-06-18,,-1.0,0.0,2013-07-16,28.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0007,HLT_0549,PAPULAR RASH,2013-12-19,184.0,2013-06-19
01-709-1309,3.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-06-19,,1.0,1.0,2013-06-19,1.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-12-19,184.0,2013-06-19
01-709-1309,4.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-06-19,,1.0,1.0,2013-06-19,1.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-12-19,184.0,2013-06-19
01-709-1309,5.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0615,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-06-19,,1.0,1.0,2013-06-20,2.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2013-12-19,184.0,2013-06-19
01-709-1309,6.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0147,NIGHTMARE,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-06-19,,1.0,1.0,2013-06-20,2.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0049,HLT_0186,NIGHTMARE,2013-12-19,184.0,2013-06-19
01-709-1309,7.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_1060,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-06-20,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0097,HLT_0500,MACULOPAPULAR RASH,2013-12-19,184.0,2013-06-19
01-709-1309,8.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0522,BIOPSY,INVESTIGATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-06-26,,8.0,8.0,2013-06-26,8.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0076,HLT_0685,BIOPSY,2013-12-19,184.0,2013-06-19
01-709-1309,9.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0712,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-07-01,,13.0,13.0,2013-07-01,13.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-12-19,184.0,2013-06-19
01-709-1309,10.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_1060,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,1.0,2013-06-10,,-9.0,-8.0,2013-07-01,13.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0097,HLT_0500,MACULOPAPULAR RASH,2013-12-19,184.0,2013-06-19
01-709-1309,11.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0712,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-07-01,,13.0,13.0,2013-07-01,13.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-12-19,184.0,2013-06-19
01-709-1309,12.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0906,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-07-04,,16.0,16.0,2013-07-04,16.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0157,HLT_0114,ALLERGIC GRANULOMATOSIS,2013-12-19,184.0,2013-06-19
01-709-1309,13.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_0086,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,1.0,2013-06-18,,-1.0,0.0,2013-07-16,28.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0007,HLT_0549,PAPULAR RASH,2013-12-19,184.0,2013-06-19
01-709-1309,14.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-07-28,,40.0,40.0,,,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-12-19,184.0,2013-06-19
01-709-1309,15.0,CDISCPILOT01,ADAE,709,1309,VERBATIM_1770,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-09-06,,80.0,80.0,,,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0717,HLT_0340,FEELING COLD,2013-12-19,184.0,2013-06-19
01-709-1312,1.0,CDISCPILOT01,ADAE,709,1312,VERBATIM_0684,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-05-17,,28.0,28.0,,,Placebo,Pbo,0.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2014-10-19,183.0,2014-04-20
01-709-1312,2.0,CDISCPILOT01,ADAE,709,1312,VERBATIM_1095,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-10-19,,183.0,183.0,,,Placebo,Pbo,0.0,68.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2014-10-19,183.0,2014-04-20
01-709-1326,1.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_0684,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-01,,27.0,27.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-10-02,181.0,2013-04-05
01-709-1326,2.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_0179,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-01,,27.0,27.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-10-02,181.0,2013-04-05
01-709-1326,3.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-21,,47.0,47.0,2013-05-21,47.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-10-02,181.0,2013-04-05
01-709-1326,4.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_1537,SYNCOPE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-21,,47.0,47.0,2013-05-21,47.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPE,2013-10-02,181.0,2013-04-05
01-709-1326,5.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_1413,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-06-07,,64.0,64.0,2013-06-17,74.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0324,HLT_0718,APPLICATION SITE BLEEDING,2013-10-02,181.0,2013-04-05
01-709-1326,6.0,CDISCPILOT01,ADAE,709,1326,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-07-12,,99.0,99.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-10-02,181.0,2013-04-05
01-709-1329,1.0,CDISCPILOT01,ADAE,709,1329,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-08-25,,11.0,11.0,2013-08-25,11.0,Xanomeline High Dose,Xan_Hi,2.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-08-25,11.0,2013-08-15
01-709-1329,2.0,CDISCPILOT01,ADAE,709,1329,VERBATIM_1401,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-25,,11.0,11.0,2013-08-25,11.0,Xanomeline High Dose,Xan_Hi,2.0,70.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0652,HLT_0310,FEVER,2013-08-25,11.0,2013-08-15
01-709-1339,1.0,CDISCPILOT01,ADAE,709,1339,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2011-11-01,D,-418.0,-417.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-06-24,184.0,2012-12-23
01-709-1339,2.0,CDISCPILOT01,ADAE,709,1339,VERBATIM_0037,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-12,,141.0,141.0,,,Placebo,Pbo,0.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0298,HLT_0615,ALK PHOS RAISED,2013-06-24,184.0,2012-12-23
01-709-1424,1.0,CDISCPILOT01,ADAE,709,1424,VERBATIM_1714,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,Y,1.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,1.0,1.0,1.0,,2013-03-07,,5.0,5.0,2013-03-07,5.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0310,HLT_0440,SYNCOPE,2013-03-07,5.0,2013-03-03
01-710-1002,1.0,CDISCPILOT01,ADAE,710,1002,VERBATIM_1299,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2014-01-16,,3.0,3.0,2014-01-20,7.0,Xanomeline Low Dose,Xan_Lo,1.0,88.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0433,HLT_0041,TRANSIENT ISCHEMIC ATTACKS,2014-01-18,5.0,2014-01-14
01-710-1002,2.0,CDISCPILOT01,ADAE,710,1002,VERBATIM_1299,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2014-01-16,,3.0,3.0,2014-01-20,7.0,Xanomeline Low Dose,Xan_Lo,1.0,88.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0433,HLT_0041,TRANSIENT ISCHEMIC ATTACKS,2014-01-18,5.0,2014-01-14
01-710-1006,1.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-02-18,,9.0,9.0,2013-02-19,10.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-08-09,181.0,2013-02-10
01-710-1006,2.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_1130,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-03-01,,20.0,20.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0488,HLT_0374,SALIVATION,2013-08-09,181.0,2013-02-10
01-710-1006,3.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-03-01,,20.0,20.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-08-09,181.0,2013-02-10
01-710-1006,4.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0527,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-04-16,,66.0,66.0,2013-04-16,66.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,FELT FAINT,2013-08-09,181.0,2013-02-10
01-710-1006,5.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0575,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-17,,67.0,67.0,2013-04-19,69.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0093,HLT_0161,URINARY INFECTION,2013-08-09,181.0,2013-02-10
01-710-1006,6.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_1752,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-17,,67.0,67.0,2013-04-17,67.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0546,HLT_0439,KIDNEY STONE,2013-08-09,181.0,2013-02-10
01-710-1006,7.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-05-18,,98.0,98.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-08-09,181.0,2013-02-10
01-710-1006,8.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-06-29,,140.0,140.0,2013-07-04,145.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-08-09,181.0,2013-02-10
01-710-1006,9.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-06-29,,140.0,140.0,2013-07-04,145.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-08-09,181.0,2013-02-10
01-710-1006,10.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0364,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-08-08,,180.0,180.0,2013-08-08,180.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0446,HLT_0168,FALL,2013-08-09,181.0,2013-02-10
01-710-1006,11.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_0240,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-08-08,,180.0,180.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0585,HLT_0305,FRACTURED NOSE,2013-08-09,181.0,2013-02-10
01-710-1006,12.0,CDISCPILOT01,ADAE,710,1006,VERBATIM_1622,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-08-08,,180.0,180.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISING OF FACE,2013-08-09,181.0,2013-02-10
01-710-1021,1.0,CDISCPILOT01,ADAE,710,1021,VERBATIM_0517,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-10-10,,14.0,14.0,2013-10-10,14.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0195,HLT_0717,CHEST PAIN,2013-10-29,33.0,2013-09-27
01-710-1021,2.0,CDISCPILOT01,ADAE,710,1021,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-10-21,,25.0,25.0,2013-10-31,35.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-10-29,33.0,2013-09-27
01-710-1021,3.0,CDISCPILOT01,ADAE,710,1021,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-10-21,,25.0,25.0,2013-10-31,35.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-10-29,33.0,2013-09-27
01-710-1027,1.0,CDISCPILOT01,ADAE,710,1027,VERBATIM_0334,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2014-05-09,,71.0,71.0,2014-06-01,94.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0680,HLT_0192,COUGHING BLOOD,2014-08-29,183.0,2014-02-28
01-710-1027,2.0,CDISCPILOT01,ADAE,710,1027,VERBATIM_1647,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-05-23,,85.0,85.0,2014-06-20,113.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0410,HLT_0020,RALES,2014-08-29,183.0,2014-02-28
01-710-1027,3.0,CDISCPILOT01,ADAE,710,1027,VERBATIM_0334,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-05-09,,71.0,71.0,2014-06-01,94.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0680,HLT_0192,COUGHING BLOOD,2014-08-29,183.0,2014-02-28
01-710-1027,4.0,CDISCPILOT01,ADAE,710,1027,VERBATIM_1647,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-05-23,,85.0,85.0,2014-06-20,113.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0410,HLT_0020,RALES,2014-08-29,183.0,2014-02-28
01-710-1045,1.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_0185,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-06-22,,20.0,20.0,2013-06-22,20.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-08-13,72.0,2013-06-03
01-710-1045,2.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-07-02,,30.0,30.0,2013-07-09,37.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-08-13,72.0,2013-06-03
01-710-1045,3.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-07-02,,30.0,30.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-08-13,72.0,2013-06-03
01-710-1045,4.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-07-02,,30.0,30.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-13,72.0,2013-06-03
01-710-1045,5.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-07-02,,30.0,30.0,2013-07-09,37.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-08-13,72.0,2013-06-03
01-710-1045,6.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-07-22,,50.0,50.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-08-13,72.0,2013-06-03
01-710-1045,7.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-08-03,,62.0,62.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-08-13,72.0,2013-06-03
01-710-1045,8.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1321,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-08-13,,72.0,72.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0726,HLT_0236,SKIN PEELING,2013-08-13,72.0,2013-06-03
01-710-1045,9.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-07-02,,30.0,30.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-08-13,72.0,2013-06-03
01-710-1045,10.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-07-02,,30.0,30.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-13,72.0,2013-06-03
01-710-1045,11.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-07-22,,50.0,50.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-08-13,72.0,2013-06-03
01-710-1045,12.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-08-03,,62.0,62.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-08-13,72.0,2013-06-03
01-710-1045,13.0,CDISCPILOT01,ADAE,710,1045,VERBATIM_1321,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-08-13,,72.0,72.0,2013-08-17,76.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0726,HLT_0236,SKIN PEELING,2013-08-13,72.0,2013-06-03
01-710-1053,1.0,CDISCPILOT01,ADAE,710,1053,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-01-28,,34.0,34.0,2013-02-11,48.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-10,47.0,2012-12-26
01-710-1053,2.0,CDISCPILOT01,ADAE,710,1053,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-01-28,,34.0,34.0,2013-02-11,48.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-10,47.0,2012-12-26
01-710-1053,3.0,CDISCPILOT01,ADAE,710,1053,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-01-28,,34.0,34.0,2013-02-11,48.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-10,47.0,2012-12-26
01-710-1053,4.0,CDISCPILOT01,ADAE,710,1053,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-01-28,,34.0,34.0,2013-02-11,48.0,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-10,47.0,2012-12-26
01-710-1060,1.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_1612,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-02,,2.0,2.0,2013-01-02,2.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NASAL CONGESTION,2013-07-05,186.0,2013-01-01
01-710-1060,2.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_1504,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-01-04,,4.0,4.0,2013-01-15,15.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0469,HLT_0297,DIFFICULTY SLEEPING,2013-07-05,186.0,2013-01-01
01-710-1060,3.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_1504,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-01-04,,4.0,4.0,2013-01-15,15.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0469,HLT_0297,DIFFICULTY SLEEPING,2013-07-05,186.0,2013-01-01
01-710-1060,4.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_0685,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-21,,21.0,21.0,2013-01-21,21.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0715,HLT_0696,APPLICATION SITE INDURATION,2013-07-05,186.0,2013-01-01
01-710-1060,5.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_0458,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-01-23,,23.0,23.0,2013-01-23,23.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-07-05,186.0,2013-01-01
01-710-1060,6.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_0458,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-01-31,,31.0,31.0,2013-01-31,31.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-07-05,186.0,2013-01-01
01-710-1060,7.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_1303,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-02-08,,39.0,39.0,2013-02-08,39.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0446,HLT_0168,FALLING DOWN,2013-07-05,186.0,2013-01-01
01-710-1060,8.0,CDISCPILOT01,ADAE,710,1060,VERBATIM_1303,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-02-09,,40.0,40.0,2013-02-09,40.0,Placebo,Pbo,0.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0446,HLT_0168,FALLING DOWN,2013-07-05,186.0,2013-01-01
01-710-1070,1.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_1717,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-10-06,,29.0,29.0,,,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0279,HLT_0188,PREMATURE ATRIAL CONTRACTION,2013-01-22,137.0,2012-09-08
01-710-1070,2.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2012-12-12,,96.0,96.0,,,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2013-01-22,137.0,2012-09-08
01-710-1070,3.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-12,,96.0,96.0,,,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-01-22,137.0,2012-09-08
01-710-1070,4.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-12,,96.0,96.0,,,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-01-22,137.0,2012-09-08
01-710-1070,5.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_0985,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-01-22,,137.0,137.0,2013-01-25,140.0,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0131,HLT_0097,HIP FRACTURE,2013-01-22,137.0,2012-09-08
01-710-1070,6.0,CDISCPILOT01,ADAE,710,1070,VERBATIM_1577,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,SEVERE,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-02-05,,151.0,151.0,2013-02-10,156.0,Xanomeline High Dose,Xan_Hi,2.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0020,HLT_0354,GI BLEED,2013-01-22,137.0,2012-09-08
01-710-1077,1.0,CDISCPILOT01,ADAE,710,1077,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-12,,26.0,26.0,2013-12-12,26.0,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2014-05-18,183.0,2013-11-17
01-710-1077,2.0,CDISCPILOT01,ADAE,710,1077,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-12-27,,41.0,41.0,,,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-05-18,183.0,2013-11-17
01-710-1077,3.0,CDISCPILOT01,ADAE,710,1077,VERBATIM_0499,AGITATION,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-01-12,,57.0,57.0,,,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0170,HLT_0140,AGITATION,2014-05-18,183.0,2013-11-17
01-710-1077,4.0,CDISCPILOT01,ADAE,710,1077,VERBATIM_1309,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SEVERE,N,0.0,NONE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0587,HLT_0019,ARTHRITIS,2014-05-18,183.0,2013-11-17
01-710-1077,5.0,CDISCPILOT01,ADAE,710,1077,VERBATIM_1309,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,,,,,,,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0587,HLT_0019,ARTHRITIS,2014-05-18,183.0,2013-11-17
01-710-1083,1.0,CDISCPILOT01,ADAE,710,1083,VERBATIM_0737,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,SEVERE,N,0.0,POSSIBLE,,N,Y,1.0,1.0,1.0,,,,,2013-08-02,,12.0,12.0,2013-08-02,12.0,Placebo,Pbo,0.0,89.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,Y,Y,Y,HLGT_0688,HLT_0649,MYOCARDIAL INFARCT,2013-08-01,11.0,2013-07-22
01-710-1137,1.0,CDISCPILOT01,ADAE,710,1137,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-10-13,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-11-13,34.0,2013-10-11
01-710-1137,2.0,CDISCPILOT01,ADAE,710,1137,VERBATIM_1639,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-10-13,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,REDNESS,2013-11-13,34.0,2013-10-11
01-710-1137,3.0,CDISCPILOT01,ADAE,710,1137,VERBATIM_1703,VERTIGO,EAR AND LABYRINTH DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-11-04,,25.0,25.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0147,HLT_0255,VERTIGO,2013-11-13,34.0,2013-10-11
01-710-1137,4.0,CDISCPILOT01,ADAE,710,1137,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-11-13,,34.0,34.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-13,34.0,2013-10-11
01-710-1142,1.0,CDISCPILOT01,ADAE,710,1142,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-10-04,,3.0,3.0,2012-10-06,5.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2012-10-20,19.0,2012-10-02
01-710-1142,2.0,CDISCPILOT01,ADAE,710,1142,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2012-10-04,,3.0,3.0,2012-10-06,5.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2012-10-20,19.0,2012-10-02
01-710-1142,3.0,CDISCPILOT01,ADAE,710,1142,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2012-10-14,,13.0,13.0,2012-10-14,13.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2012-10-20,19.0,2012-10-02
01-710-1142,4.0,CDISCPILOT01,ADAE,710,1142,VERBATIM_0222,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2012-10-19,,18.0,18.0,2012-10-19,18.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0688,HLT_0649,MYOCARDIAL INFARCTION,2012-10-20,19.0,2012-10-02
01-710-1142,5.0,CDISCPILOT01,ADAE,710,1142,VERBATIM_0210,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2012-10-19,,18.0,18.0,2012-10-19,18.0,Xanomeline High Dose,Xan_Hi,2.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0687,HLT_0003,SYNCOPE VASOVAGAL,2012-10-20,19.0,2012-10-02
01-710-1154,1.0,CDISCPILOT01,ADAE,710,1154,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-04-18,,21.0,21.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-04-27,30.0,2014-03-29
01-710-1154,2.0,CDISCPILOT01,ADAE,710,1154,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2014-04-18,,21.0,21.0,,,Xanomeline Low Dose,Xan_Lo,1.0,84.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-04-27,30.0,2014-03-29
01-710-1166,1.0,CDISCPILOT01,ADAE,710,1166,VERBATIM_0992,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-03-19,,110.0,110.0,2013-03-19,110.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0446,HLT_0168,FALL,2013-03-19,110.0,2012-11-30
01-710-1166,2.0,CDISCPILOT01,ADAE,710,1166,VERBATIM_0587,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-03-19,,110.0,110.0,2013-03-19,110.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0118,HLT_0075,LACERATION OF HEAD,2013-03-19,110.0,2012-11-30
01-710-1166,3.0,CDISCPILOT01,ADAE,710,1166,VERBATIM_0455,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-03-19,,110.0,110.0,2013-03-19,110.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0310,HLT_0440,SYNCOPE,2013-03-19,110.0,2012-11-30
01-710-1166,4.0,CDISCPILOT01,ADAE,710,1166,VERBATIM_1135,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-03-19,,110.0,110.0,2013-03-20,111.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0656,HLT_0558,COMPLEX PARTIAL SEIZURES,2013-03-19,110.0,2012-11-30
01-710-1166,5.0,CDISCPILOT01,ADAE,710,1166,VERBATIM_0455,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,,,,,,,2013-03-20,,111.0,111.0,2013-03-20,111.0,Xanomeline Low Dose,Xan_Lo,1.0,81.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPE,2013-03-19,110.0,2012-11-30
01-710-1183,1.0,CDISCPILOT01,ADAE,710,1183,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2014-03-10,,115.0,115.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2014-05-17,183.0,2013-11-16
01-710-1183,2.0,CDISCPILOT01,ADAE,710,1183,VERBATIM_0166,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-03-10,,115.0,115.0,,,Placebo,Pbo,0.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0464,HLT_0419,FIRST DEGREE ATRIOVENTRICULAR BLOCK,2014-05-17,183.0,2013-11-16
01-710-1187,1.0,CDISCPILOT01,ADAE,710,1187,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-23,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-05-12,184.0,2012-11-10
01-710-1235,1.0,CDISCPILOT01,ADAE,710,1235,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-11-22,,58.0,58.0,2012-12-14,80.0,Xanomeline Low Dose,Xan_Lo,1.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2013-03-27,183.0,2012-09-26
01-710-1235,2.0,CDISCPILOT01,ADAE,710,1235,VERBATIM_0634,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-01-13,,110.0,110.0,,,Xanomeline Low Dose,Xan_Lo,1.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0288,HLT_0527,SHOULDER PAIN,2013-03-27,183.0,2012-09-26
01-710-1235,3.0,CDISCPILOT01,ADAE,710,1235,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-29,,126.0,126.0,,,Xanomeline Low Dose,Xan_Lo,1.0,56.0,<65,1.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-03-27,183.0,2012-09-26
01-710-1249,1.0,CDISCPILOT01,ADAE,710,1249,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-02-11,,46.0,46.0,2014-02-11,46.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2014-06-28,183.0,2013-12-28
01-710-1249,2.0,CDISCPILOT01,ADAE,710,1249,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-02-18,,53.0,53.0,2014-02-18,53.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2014-06-28,183.0,2013-12-28
01-710-1249,3.0,CDISCPILOT01,ADAE,710,1249,VERBATIM_0254,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-02-23,,58.0,58.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-06-28,183.0,2013-12-28
01-710-1249,4.0,CDISCPILOT01,ADAE,710,1249,VERBATIM_1202,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2014-04-24,,118.0,118.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2014-06-28,183.0,2013-12-28
01-710-1264,1.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-07-03,,21.0,21.0,2013-07-05,23.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-10-11,121.0,2013-06-13
01-710-1264,2.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-08-21,,70.0,70.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-10-11,121.0,2013-06-13
01-710-1264,3.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-08-21,,70.0,70.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-10-11,121.0,2013-06-13
01-710-1264,4.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1477,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-09-29,,109.0,109.0,2013-09-29,109.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0208,HLT_0124,COLD SWEAT,2013-10-11,121.0,2013-06-13
01-710-1264,5.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-09-29,,109.0,109.0,2013-09-29,109.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2013-10-11,121.0,2013-06-13
01-710-1264,6.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1477,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-09,,119.0,119.0,2013-10-09,119.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0208,HLT_0124,COLD SWEAT,2013-10-11,121.0,2013-06-13
01-710-1264,7.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-09,,119.0,119.0,2013-10-09,119.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2013-10-11,121.0,2013-06-13
01-710-1264,8.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1477,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-11,,121.0,121.0,2013-10-11,121.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0208,HLT_0124,COLD SWEAT,2013-10-11,121.0,2013-06-13
01-710-1264,9.0,CDISCPILOT01,ADAE,710,1264,VERBATIM_1398,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-11,,121.0,121.0,2013-10-11,121.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0161,HLT_0586,CHILLS,2013-10-11,121.0,2013-06-13
01-710-1270,1.0,CDISCPILOT01,ADAE,710,1270,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-02-23,,12.0,12.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-03-01,18.0,2014-02-12
01-710-1270,2.0,CDISCPILOT01,ADAE,710,1270,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2014-02-23,,12.0,12.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-03-01,18.0,2014-02-12
01-710-1271,1.0,CDISCPILOT01,ADAE,710,1271,VERBATIM_1509,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-11-21,,56.0,56.0,2012-11-21,56.0,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0255,HLT_0296,SHORTNESS OF BREATH,2012-11-21,56.0,2012-09-27
01-710-1271,2.0,CDISCPILOT01,ADAE,710,1271,VERBATIM_0737,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2012-11-21,,56.0,56.0,2012-11-21,56.0,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,Y,HLGT_0688,HLT_0649,MYOCARDIAL INFARCT,2012-11-21,56.0,2012-09-27
01-710-1271,3.0,CDISCPILOT01,ADAE,710,1271,VERBATIM_0571,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2012-11-21,,56.0,56.0,2012-11-26,61.0,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,Y,HLGT_0012,HLT_0365,PAROXYSMAL ATRIAL FIBRILLATION,2012-11-21,56.0,2012-09-27
01-710-1271,4.0,CDISCPILOT01,ADAE,710,1271,VERBATIM_0411,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,,1.0,,,,,2012-11-22,,57.0,57.0,,,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,Y,HLGT_0413,HLT_0511,CONGESTIVE HEART FAILURE,2012-11-21,56.0,2012-09-27
01-710-1271,5.0,CDISCPILOT01,ADAE,710,1271,VERBATIM_0078,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,REMOTE,Y,N,Y,,1.0,1.0,,,,,2012-11-22,,57.0,57.0,2012-11-26,61.0,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0102,HLT_0688,HYPONATREMIA,2012-11-21,56.0,2012-09-27
01-710-1278,1.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_0485,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-01-13,,21.0,21.0,2013-01-19,27.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,DROWSINESS,2013-02-26,65.0,2012-12-24
01-710-1278,2.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-02-07,,46.0,46.0,2013-03-03,70.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-26,65.0,2012-12-24
01-710-1278,3.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_0159,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-02-24,,63.0,63.0,2013-03-03,70.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-02-26,65.0,2012-12-24
01-710-1278,4.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_0152,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-02-24,,63.0,63.0,2013-02-26,65.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0456,HLT_0775,BURNING SENSATION,2013-02-26,65.0,2012-12-24
01-710-1278,5.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_0185,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,N,Y,,1.0,1.0,,,,,2013-03-02,,69.0,69.0,2013-03-02,69.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-02-26,65.0,2012-12-24
01-710-1278,6.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-02-07,,46.0,46.0,2013-03-03,70.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-26,65.0,2012-12-24
01-710-1278,7.0,CDISCPILOT01,ADAE,710,1278,VERBATIM_0159,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-02-24,,63.0,63.0,2013-03-03,70.0,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-02-26,65.0,2012-12-24
01-710-1300,1.0,CDISCPILOT01,ADAE,710,1300,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-01-31,,48.0,48.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-15,63.0,2012-12-15
01-710-1300,2.0,CDISCPILOT01,ADAE,710,1300,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-10,,58.0,58.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-02-15,63.0,2012-12-15
01-710-1300,3.0,CDISCPILOT01,ADAE,710,1300,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-02-10,,58.0,58.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2013-02-15,63.0,2012-12-15
01-710-1300,4.0,CDISCPILOT01,ADAE,710,1300,VERBATIM_1523,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-02-13,,61.0,61.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-02-15,63.0,2012-12-15
01-710-1314,1.0,CDISCPILOT01,ADAE,710,1314,VERBATIM_0887,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-20,,27.0,27.0,2013-05-24,31.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COMMON COLD,2013-05-23,30.0,2013-04-24
01-710-1314,2.0,CDISCPILOT01,ADAE,710,1314,VERBATIM_0887,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-05-20,,27.0,27.0,2013-05-24,31.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COMMON COLD,2013-05-23,30.0,2013-04-24
01-710-1315,1.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_0929,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,Y,N,N,,,,,,,,2013-02-26,,-1.0,0.0,2013-02-26,-1.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-07-06,130.0,2013-02-27
01-710-1315,2.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-14,,77.0,77.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-07-06,130.0,2013-02-27
01-710-1315,3.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-18,,112.0,112.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-07-06,130.0,2013-02-27
01-710-1315,4.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-18,,112.0,112.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-07-06,130.0,2013-02-27
01-710-1315,5.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-05-14,,77.0,77.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-07-06,130.0,2013-02-27
01-710-1315,6.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-06-18,,112.0,112.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-07-06,130.0,2013-02-27
01-710-1315,7.0,CDISCPILOT01,ADAE,710,1315,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,1.0,2013-06-18,,112.0,112.0,2013-07-07,131.0,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-07-06,130.0,2013-02-27
01-710-1354,1.0,CDISCPILOT01,ADAE,710,1354,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-30,,50.0,50.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-05-01,172.0,2012-11-11
01-710-1354,2.0,CDISCPILOT01,ADAE,710,1354,VERBATIM_0215,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2013-02-14,,96.0,96.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITUS,2013-05-01,172.0,2012-11-11
01-710-1358,1.0,CDISCPILOT01,ADAE,710,1358,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-12-22,,97.0,97.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-09,146.0,2012-09-17
01-710-1358,2.0,CDISCPILOT01,ADAE,710,1358,VERBATIM_0373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2012-12-22,,97.0,97.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHY,2013-02-09,146.0,2012-09-17
01-710-1358,3.0,CDISCPILOT01,ADAE,710,1358,VERBATIM_1636,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-24,,130.0,130.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0193,HLT_0351,APPLICATION SITE DESQUAMATION,2013-02-09,146.0,2012-09-17
01-710-1368,1.0,CDISCPILOT01,ADAE,710,1368,VERBATIM_1155,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-12-25,,64.0,64.0,2014-04-24,184.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0131,HLT_0097,FRACTURED HIP,2014-04-24,184.0,2013-10-23
01-710-1368,2.0,CDISCPILOT01,ADAE,710,1368,VERBATIM_1218,DELUSION,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-03-26,,155.0,155.0,,,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0565,HLT_0198,DELUSIONS,2014-04-24,184.0,2013-10-23
01-710-1368,3.0,CDISCPILOT01,ADAE,710,1368,VERBATIM_1347,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-03-26,,155.0,155.0,,,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0277,HLT_0383,INCREASED ACTIVITY,2014-04-24,184.0,2013-10-23
01-710-1368,4.0,CDISCPILOT01,ADAE,710,1368,VERBATIM_1155,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,N,0.0,NONE,,Y,Y,,,,,,,,2013-12-25,,64.0,64.0,2014-04-24,184.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0131,HLT_0097,FRACTURED HIP,2014-04-24,184.0,2013-10-23
01-710-1385,1.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1557,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-11-12,,15.0,15.0,2012-11-13,16.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0619,HLT_0692,SUPRAVENTRICULAR TACHYCARDIA,2013-02-18,113.0,2012-10-29
01-710-1385,2.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1557,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,,,,,,2012-11-12,,15.0,15.0,2012-11-13,16.0,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0619,HLT_0692,SUPRAVENTRICULAR TACHYCARDIA,2013-02-18,113.0,2012-10-29
01-710-1385,3.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1564,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2012-11-26,,29.0,29.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0464,HLT_0419,FIRST DEGREE ATRIOVENTRICULAR BLOCK,2013-02-18,113.0,2012-10-29
01-710-1385,4.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2012-12-18,,51.0,51.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-18,113.0,2012-10-29
01-710-1385,5.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1452,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-27,,60.0,60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-02-18,113.0,2012-10-29
01-710-1385,6.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,1.0,2012-12-27,,60.0,60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2013-02-18,113.0,2012-10-29
01-710-1385,7.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_0402,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2013-02-18,,113.0,113.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0012,HLT_0365,ATRIAL FIBRILLATION,2013-02-18,113.0,2012-10-29
01-710-1385,8.0,CDISCPILOT01,ADAE,710,1385,VERBATIM_1711,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-02-18,,113.0,113.0,,,Xanomeline Low Dose,Xan_Lo,1.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0030,HLT_0037,T WAVE FLATTENING OF,2013-02-18,113.0,2012-10-29
01-710-1408,1.0,CDISCPILOT01,ADAE,710,1408,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-31,,27.0,27.0,2013-02-09,36.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-07-12,189.0,2013-01-05
01-710-1408,2.0,CDISCPILOT01,ADAE,710,1408,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-01-31,,27.0,27.0,2013-02-09,36.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-07-12,189.0,2013-01-05
01-710-1408,3.0,CDISCPILOT01,ADAE,710,1408,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-02-24,,51.0,51.0,2013-05-31,147.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-07-12,189.0,2013-01-05
01-710-1408,4.0,CDISCPILOT01,ADAE,710,1408,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,1.0,2013-02-24,,51.0,51.0,2013-05-31,147.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-07-12,189.0,2013-01-05
01-711-1012,1.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0950,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-04-16,,14.0,14.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-04-29,27.0,2013-04-03
01-711-1012,2.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0905,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-04-16,,14.0,14.0,2013-05-02,30.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-29,27.0,2013-04-03
01-711-1012,3.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0950,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-04-16,,14.0,14.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-04-29,27.0,2013-04-03
01-711-1012,4.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0905,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-04-16,,14.0,14.0,2013-05-02,30.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-29,27.0,2013-04-03
01-711-1012,5.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-04-27,,25.0,25.0,,,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-04-29,27.0,2013-04-03
01-711-1012,6.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0937,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-04-29,,27.0,27.0,2013-05-01,29.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0233,HLT_0196,APPLICATION SITE URTICARIA,2013-04-29,27.0,2013-04-03
01-711-1012,7.0,CDISCPILOT01,ADAE,711,1012,VERBATIM_0905,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-04-16,,14.0,14.0,2013-05-02,30.0,Xanomeline High Dose,Xan_Hi,2.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-04-29,27.0,2013-04-03
01-711-1036,1.0,CDISCPILOT01,ADAE,711,1036,VERBATIM_0292,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-07-29,,1.0,1.0,,,Placebo,Pbo,0.0,70.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,INTERMITTENT HEADACHE,2013-02-10,197.0,2012-07-29
01-711-1036,2.0,CDISCPILOT01,ADAE,711,1036,VERBATIM_1034,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-08-04,,7.0,7.0,2012-08-12,15.0,Placebo,Pbo,0.0,70.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0760,HLT_0757,EAR INFECTION,2013-02-10,197.0,2012-07-29
01-711-1036,3.0,CDISCPILOT01,ADAE,711,1036,VERBATIM_0701,GLOSSITIS,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-08-12,,15.0,15.0,,,Placebo,Pbo,0.0,70.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0427,HLT_0250,GLOSSITIS,2013-02-10,197.0,2012-07-29
01-711-1036,4.0,CDISCPILOT01,ADAE,711,1036,VERBATIM_1034,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2012-08-04,,7.0,7.0,2012-08-12,15.0,Placebo,Pbo,0.0,70.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0760,HLT_0757,EAR INFECTION,2013-02-10,197.0,2012-07-29
01-711-1143,1.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1065,TINNITUS,EAR AND LABYRINTH DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,N,N,,,,,,,,2007-10-01,D,-2011.0,-2010.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0180,HLT_0570,TINNITUS,2013-05-30,58.0,2013-04-03
01-711-1143,2.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0872,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-04-11,,9.0,9.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0035,HLT_0727,TINGLING MOUTH,2013-05-30,58.0,2013-04-03
01-711-1143,3.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,SEVERE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-04-28,,26.0,26.0,2013-05-11,39.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-05-30,58.0,2013-04-03
01-711-1143,4.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0401,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-04-29,,27.0,27.0,2013-05-15,43.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0279,HLT_0188,ECTOPIC ATRIAL BEATS,2013-05-30,58.0,2013-04-03
01-711-1143,5.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-04-28,,26.0,26.0,2013-05-11,39.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-05-30,58.0,2013-04-03
01-711-1143,6.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1698,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-04-28,,26.0,26.0,2013-05-11,39.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD,2013-05-30,58.0,2013-04-03
01-711-1143,7.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0401,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-04-29,,27.0,27.0,2013-05-15,43.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0279,HLT_0188,ECTOPIC ATRIAL BEATS,2013-05-30,58.0,2013-04-03
01-711-1143,8.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0950,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-18,,46.0,46.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-05-30,58.0,2013-04-03
01-711-1143,9.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1328,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-05-27,,55.0,55.0,2013-05-31,59.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0753,HLT_0127,ITCHY RASH,2013-05-30,58.0,2013-04-03
01-711-1143,10.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0139,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,,2013-05-28,,56.0,56.0,2013-06-01,60.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0594,HLT_0050,PREMATURE VENTRICULAR CONTRACTIONS,2013-05-30,58.0,2013-04-03
01-711-1143,11.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_1328,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-05-27,,55.0,55.0,2013-05-31,59.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0753,HLT_0127,ITCHY RASH,2013-05-30,58.0,2013-04-03
01-711-1143,12.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0600,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-05-30,,58.0,58.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0720,HLT_0013,SUBCONJUNCTIVAL HEMORRHAGE,2013-05-30,58.0,2013-04-03
01-711-1143,13.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0856,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,MILD,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-06-01,,60.0,60.0,,,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0158,HLT_0018,CERUMEN IMPACTION,2013-05-30,58.0,2013-04-03
01-711-1143,14.0,CDISCPILOT01,ADAE,711,1143,VERBATIM_0139,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,,2013-05-28,,56.0,56.0,2013-06-01,60.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0594,HLT_0050,PREMATURE VENTRICULAR CONTRACTIONS,2013-05-30,58.0,2013-04-03
01-711-1433,1.0,CDISCPILOT01,ADAE,711,1433,VERBATIM_0342,HYPERTENSION,VASCULAR DISORDERS,MILD,N,0.0,NONE,Y,N,N,,,,,,,,2012-07-23,,-188.0,-187.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0476,HLT_0228,HYPERTENSION,2013-02-05,10.0,2013-01-27
01-711-1433,2.0,CDISCPILOT01,ADAE,711,1433,VERBATIM_0342,HYPERTENSION,VASCULAR DISORDERS,MODERATE,N,0.0,NONE,Y,N,N,,,,,,,,2012-07-23,,-188.0,-187.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0476,HLT_0228,HYPERTENSION,2013-02-05,10.0,2013-01-27
01-711-1433,3.0,CDISCPILOT01,ADAE,711,1433,VERBATIM_0281,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-02-05,,10.0,10.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0614,HLT_0205,WEAKNESS,2013-02-05,10.0,2013-01-27
01-713-1043,1.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0552,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-09-26,,12.0,12.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-03-24,191.0,2013-09-15
01-713-1043,2.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-10-11,,27.0,27.0,2013-10-11,27.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-03-24,191.0,2013-09-15
01-713-1043,3.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0782,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-10-11,,27.0,27.0,2013-10-11,27.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,EMESIS,2014-03-24,191.0,2013-09-15
01-713-1043,4.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0552,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-09-26,,12.0,12.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-03-24,191.0,2013-09-15
01-713-1043,5.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-10-11,,27.0,27.0,2013-10-11,27.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-03-24,191.0,2013-09-15
01-713-1043,6.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_0782,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-10-11,,27.0,27.0,2013-10-11,27.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,EMESIS,2014-03-24,191.0,2013-09-15
01-713-1043,7.0,CDISCPILOT01,ADAE,713,1043,VERBATIM_1581,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-03-08,,175.0,175.0,2014-03-08,175.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0058,HLT_0432,CATARACT EXTRACTION,2014-03-24,191.0,2013-09-15
01-713-1073,1.0,CDISCPILOT01,ADAE,713,1073,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-07-14,,107.0,107.0,,,Xanomeline Low Dose,Xan_Lo,1.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-10-05,190.0,2014-03-30
01-713-1141,1.0,CDISCPILOT01,ADAE,713,1141,VERBATIM_1375,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-06-21,,22.0,22.0,2013-07-15,46.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0753,HLT_0127,PRURITIC RASH,2013-07-01,32.0,2013-05-31
01-713-1141,2.0,CDISCPILOT01,ADAE,713,1141,VERBATIM_1375,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-21,,22.0,22.0,2013-07-15,46.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0753,HLT_0127,PRURITIC RASH,2013-07-01,32.0,2013-05-31
01-713-1141,3.0,CDISCPILOT01,ADAE,713,1141,VERBATIM_1583,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-06-30,,31.0,31.0,,,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,BACK PAIN,2013-07-01,32.0,2013-05-31
01-713-1141,4.0,CDISCPILOT01,ADAE,713,1141,VERBATIM_0372,DELIRIUM,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-07-01,,32.0,32.0,2013-07-15,46.0,Xanomeline High Dose,Xan_Hi,2.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,N,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0176,HLT_0376,DELIRIUM,2013-07-01,32.0,2013-05-31
01-713-1179,1.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1186,DYSURIA,RENAL AND URINARY DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-08-19,,11.0,11.0,2013-08-23,15.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0210,HLT_0637,MICTURITION BURNING,2014-02-05,181.0,2013-08-09
01-713-1179,2.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0841,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-08-22,,14.0,14.0,2013-08-22,14.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0716,HLT_0244,HEARTBURN,2014-02-05,181.0,2013-08-09
01-713-1179,3.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1682,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-28,,20.0,20.0,2013-09-08,31.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0093,HLT_0161,URINARY TRACT INFECTION,2014-02-05,181.0,2013-08-09
01-713-1179,4.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1430,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-09-05,,28.0,28.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0614,HLT_0205,LOWER EXTREMITIES WEAKNESS OF,2014-02-05,181.0,2013-08-09
01-713-1179,5.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1682,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-08-28,,20.0,20.0,2013-09-08,31.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0093,HLT_0161,URINARY TRACT INFECTION,2014-02-05,181.0,2013-08-09
01-713-1179,6.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1430,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-05,,28.0,28.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0614,HLT_0205,LOWER EXTREMITIES WEAKNESS OF,2014-02-05,181.0,2013-08-09
01-713-1179,7.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0800,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-12,,35.0,35.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0716,HLT_0244,INDIGESTION,2014-02-05,181.0,2013-08-09
01-713-1179,8.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0230,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-10-10,,63.0,63.0,2014-01-18,163.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0691,HLT_0189,PELVIC PAIN,2014-02-05,181.0,2013-08-09
01-713-1179,9.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1024,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-10-10,,63.0,63.0,2013-10-13,66.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0385,HLT_0211,STOMACH FLU,2014-02-05,181.0,2013-08-09
01-713-1179,10.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1801,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-10-10,,63.0,63.0,,,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0304,HLT_0407,GASTROOESOPHAGEAL REFLUX DISEASE,2014-02-05,181.0,2013-08-09
01-713-1179,11.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0207,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-11-23,,107.0,107.0,2013-12-02,116.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0643,HLT_0508,VAGINAL YEAST INFECTION,2014-02-05,181.0,2013-08-09
01-713-1179,12.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1707,CERVICITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-11-23,,107.0,107.0,2013-12-02,116.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0282,HLT_0651,CERVICITIS,2014-02-05,181.0,2013-08-09
01-713-1179,13.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0207,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-11-23,,107.0,107.0,2013-12-02,116.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0643,HLT_0508,VAGINAL YEAST INFECTION,2014-02-05,181.0,2013-08-09
01-713-1179,14.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_1707,CERVICITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-11-23,,107.0,107.0,2013-12-02,116.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0282,HLT_0651,CERVICITIS,2014-02-05,181.0,2013-08-09
01-713-1179,15.0,CDISCPILOT01,ADAE,713,1179,VERBATIM_0230,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-10-10,,63.0,63.0,2014-01-18,163.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0691,HLT_0189,PELVIC PAIN,2014-02-05,181.0,2013-08-09
01-713-1209,1.0,CDISCPILOT01,ADAE,713,1209,VERBATIM_0554,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-30,,4.0,4.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL PAIN,2013-11-22,180.0,2013-05-27
01-713-1209,2.0,CDISCPILOT01,ADAE,713,1209,VERBATIM_1219,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-06-02,,7.0,7.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-11-22,180.0,2013-05-27
01-713-1209,3.0,CDISCPILOT01,ADAE,713,1209,VERBATIM_0554,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-30,,4.0,4.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL PAIN,2013-11-22,180.0,2013-05-27
01-713-1209,4.0,CDISCPILOT01,ADAE,713,1209,VERBATIM_1049,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-10-31,,158.0,158.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,LIGHTHEADEDNESS,2013-11-22,180.0,2013-05-27
01-713-1256,1.0,CDISCPILOT01,ADAE,713,1256,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-10-30,,42.0,42.0,2012-10-31,43.0,Placebo,Pbo,0.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-03-25,188.0,2012-09-19
01-713-1256,2.0,CDISCPILOT01,ADAE,713,1256,VERBATIM_1298,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2012-10-30,,42.0,42.0,2012-10-31,43.0,Placebo,Pbo,0.0,71.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-03-25,188.0,2012-09-19
01-713-1269,1.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0232,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-02-02,,7.0,7.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2014-07-28,183.0,2014-01-27
01-713-1269,2.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-04-18,,82.0,82.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-07-28,183.0,2014-01-27
01-713-1269,3.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0061,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-06-01,,126.0,126.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0288,HLT_0527,SHOULDER PAIN,2014-07-28,183.0,2014-01-27
01-713-1269,4.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0389,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,1.0,2014-07-10,,165.0,165.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-07-28,183.0,2014-01-27
01-713-1269,5.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0061,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-06-01,,126.0,126.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0288,HLT_0527,SHOULDER PAIN,2014-07-28,183.0,2014-01-27
01-713-1269,6.0,CDISCPILOT01,ADAE,713,1269,VERBATIM_0389,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,1.0,2014-07-10,,165.0,165.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-07-28,183.0,2014-01-27
01-713-1448,1.0,CDISCPILOT01,ADAE,713,1448,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2014-03-19,,60.0,60.0,2014-05-23,125.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-05-16,118.0,2014-01-19
01-713-1448,2.0,CDISCPILOT01,ADAE,713,1448,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2014-03-27,,68.0,68.0,2014-05-23,125.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-05-16,118.0,2014-01-19
01-713-1448,3.0,CDISCPILOT01,ADAE,713,1448,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2014-03-19,,60.0,60.0,2014-05-23,125.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2014-05-16,118.0,2014-01-19
01-713-1448,4.0,CDISCPILOT01,ADAE,713,1448,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2014-03-27,,68.0,68.0,2014-05-23,125.0,Xanomeline Low Dose,Xan_Lo,1.0,71.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-05-16,118.0,2014-01-19
01-714-1035,1.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_0319,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-05-26,,40.0,40.0,2014-06-04,49.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0597,HLT_0751,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,2014-10-16,183.0,2014-04-17
01-714-1035,2.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_0748,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-05-26,,40.0,40.0,,,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0130,HLT_0289,T WAVE INVERSION,2014-10-16,183.0,2014-04-17
01-714-1035,3.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_1420,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-06-04,,49.0,49.0,2014-06-17,62.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0279,HLT_0188,PREMATURE ATRIAL CONTRACTION,2014-10-16,183.0,2014-04-17
01-714-1035,4.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_1153,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-06-04,,49.0,49.0,,,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2014-10-16,183.0,2014-04-17
01-714-1035,5.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_0319,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-05-26,,40.0,40.0,2014-06-04,49.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0597,HLT_0751,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,2014-10-16,183.0,2014-04-17
01-714-1035,6.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_1420,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-06-04,,49.0,49.0,2014-06-17,62.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0279,HLT_0188,PREMATURE ATRIAL CONTRACTION,2014-10-16,183.0,2014-04-17
01-714-1035,7.0,CDISCPILOT01,ADAE,714,1035,VERBATIM_1176,BRONCHITIS,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-18,,93.0,93.0,2014-07-24,99.0,Placebo,Pbo,0.0,88.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0523,HLT_0634,BRONCHITIS,2014-10-16,183.0,2014-04-17
01-714-1068,1.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_0019,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-12,,5.0,5.0,2013-08-22,15.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-10-08,62.0,2013-08-08
01-714-1068,2.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_0019,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-08-12,,5.0,5.0,2013-08-22,15.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-10-08,62.0,2013-08-08
01-714-1068,3.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_0343,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-09-20,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-10-08,62.0,2013-08-08
01-714-1068,4.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_1386,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-09-20,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-10-08,62.0,2013-08-08
01-714-1068,5.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_0343,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-09-20,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE ERYTHEMA,2013-10-08,62.0,2013-08-08
01-714-1068,6.0,CDISCPILOT01,ADAE,714,1068,VERBATIM_1386,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-09-20,,44.0,44.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-10-08,62.0,2013-08-08
01-714-1195,1.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1274,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-12,,17.0,17.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,LOOSE STOOLS,2013-10-23,181.0,2013-04-26
01-714-1195,2.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1325,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-12,,17.0,17.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING,2013-10-23,181.0,2013-04-26
01-714-1195,3.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_0907,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-05-13,,18.0,18.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-10-23,181.0,2013-04-26
01-714-1195,4.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_0352,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-05-14,,19.0,19.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,DROWSINESS,2013-10-23,181.0,2013-04-26
01-714-1195,5.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1606,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-17,,22.0,22.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE PRURITUS,2013-10-23,181.0,2013-04-26
01-714-1195,6.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1274,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-05-12,,17.0,17.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,LOOSE STOOLS,2013-10-23,181.0,2013-04-26
01-714-1195,7.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1325,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-12,,17.0,17.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING,2013-10-23,181.0,2013-04-26
01-714-1195,8.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_0907,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-13,,18.0,18.0,2013-07-17,83.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0152,HLT_0617,APPLICATION SITE REDNESS,2013-10-23,181.0,2013-04-26
01-714-1195,9.0,CDISCPILOT01,ADAE,714,1195,VERBATIM_1664,DYSURIA,RENAL AND URINARY DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-07-25,,91.0,91.0,2013-08-06,103.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0210,HLT_0637,URINATION DIFFICULTY,2013-10-23,181.0,2013-04-26
01-714-1288,1.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-12-13,,10.0,10.0,2013-12-13,10.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2014-06-17,196.0,2013-12-04
01-714-1288,2.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-12-14,,11.0,11.0,2013-12-15,12.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2014-06-17,196.0,2013-12-04
01-714-1288,3.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-01-11,,39.0,39.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-06-17,196.0,2013-12-04
01-714-1288,4.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0405,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-01-22,,50.0,50.0,2014-01-25,53.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,HEAD COLD,2014-06-17,196.0,2013-12-04
01-714-1288,5.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0910,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-01-22,,50.0,50.0,2014-01-25,53.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-06-17,196.0,2013-12-04
01-714-1288,6.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0291,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-02-24,,83.0,83.0,2014-04-08,126.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,LOW BACK PAIN,2014-06-17,196.0,2013-12-04
01-714-1288,7.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0672,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,,1.0,,,,,2014-03-08,,95.0,95.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,KNEE PAIN,2014-06-17,196.0,2013-12-04
01-714-1288,8.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_0291,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-02-24,,83.0,83.0,2014-04-08,126.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,LOW BACK PAIN,2014-06-17,196.0,2013-12-04
01-714-1288,9.0,CDISCPILOT01,ADAE,714,1288,VERBATIM_1595,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-05-27,,175.0,175.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,BRADYCARDIA SINUS,2014-06-17,196.0,2013-12-04
01-714-1375,1.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_0290,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-03-30,,33.0,33.0,2013-04-06,40.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,IRRITATION SKIN,2013-09-07,194.0,2013-02-26
01-714-1375,2.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_1599,EAR PAIN,EAR AND LABYRINTH DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-04,,38.0,38.0,2013-04-15,49.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0432,HLT_0631,EAR PAIN,2013-09-07,194.0,2013-02-26
01-714-1375,3.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_0290,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,1.0,2013-03-30,,33.0,33.0,2013-04-06,40.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,IRRITATION SKIN,2013-09-07,194.0,2013-02-26
01-714-1375,4.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_1599,EAR PAIN,EAR AND LABYRINTH DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-04-04,,38.0,38.0,2013-04-15,49.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0432,HLT_0631,EAR PAIN,2013-09-07,194.0,2013-02-26
01-714-1375,5.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-29,,93.0,93.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2013-09-07,194.0,2013-02-26
01-714-1375,6.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-06-16,,111.0,111.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-09-07,194.0,2013-02-26
01-714-1375,7.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_1586,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-29,,93.0,93.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,PRURITIS,2013-09-07,194.0,2013-02-26
01-714-1375,8.0,CDISCPILOT01,ADAE,714,1375,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-06-16,,111.0,111.0,,,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-09-07,194.0,2013-02-26
01-714-1425,1.0,CDISCPILOT01,ADAE,714,1425,VERBATIM_1758,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,2013-08-13,,-2.0,-1.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0086,HLT_0415,AV BLOCK SECOND DEGREE,2013-08-19,5.0,2013-08-15
01-715-1107,1.0,CDISCPILOT01,ADAE,715,1107,VERBATIM_0387,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-07,,71.0,71.0,2013-05-21,85.0,Xanomeline Low Dose,Xan_Lo,1.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0331,HLT_0056,CONTACT DERMATITIS,2013-05-07,71.0,2013-02-26
01-715-1107,2.0,CDISCPILOT01,ADAE,715,1107,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2013-05-13,,77.0,77.0,,,Xanomeline Low Dose,Xan_Lo,1.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-05-07,71.0,2013-02-26
01-715-1107,3.0,CDISCPILOT01,ADAE,715,1107,VERBATIM_0387,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-05-07,,71.0,71.0,2013-05-21,85.0,Xanomeline Low Dose,Xan_Lo,1.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0331,HLT_0056,CONTACT DERMATITIS,2013-05-07,71.0,2013-02-26
01-715-1207,1.0,CDISCPILOT01,ADAE,715,1207,VERBATIM_0739,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-01-10,,54.0,54.0,2013-01-10,54.0,Placebo,Pbo,0.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0546,HLT_0439,KIDNEY STONES,2013-05-27,191.0,2012-11-18
01-715-1319,1.0,CDISCPILOT01,ADAE,715,1319,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,,N,Y,1.0,1.0,1.0,,,,,2013-03-18,,30.0,30.0,2013-03-18,30.0,Xanomeline High Dose,Xan_Hi,2.0,65.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-03-05,17.0,2013-02-17
01-715-1321,1.0,CDISCPILOT01,ADAE,715,1321,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,1.0,1.0,1.0,,,,,2014-03-14,,32.0,32.0,2014-03-14,32.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-04-21,70.0,2014-02-11
01-715-1321,2.0,CDISCPILOT01,ADAE,715,1321,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2014-03-14,,32.0,32.0,2014-03-14,32.0,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-04-21,70.0,2014-02-11
01-715-1321,3.0,CDISCPILOT01,ADAE,715,1321,VERBATIM_1688,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2014-04-21,,70.0,70.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0668,HLT_0339,APPLICATION SITE REACTION,2014-04-21,70.0,2014-02-11
01-715-1321,4.0,CDISCPILOT01,ADAE,715,1321,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,NONE,Y,N,Y,,1.0,1.0,,,,,2014-04-22,,71.0,71.0,,,Xanomeline High Dose,Xan_Hi,2.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2014-04-21,70.0,2014-02-11
01-715-1405,1.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_0135,PALPITATIONS,CARDIAC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,N,Y,1.0,1.0,1.0,,,,,2013-07-08,,3.0,3.0,2013-07-08,3.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0593,HLT_0493,PALPITATIONS,2013-07-07,2.0,2013-07-06
01-715-1405,2.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_1343,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,N,Y,,1.0,1.0,,,,,2013-07-08,,3.0,3.0,2013-07-08,3.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING,2013-07-07,2.0,2013-07-06
01-715-1405,3.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,PROBABLE,Y,N,Y,,1.0,1.0,,,,,2013-07-08,,3.0,3.0,2013-07-08,3.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-07-07,2.0,2013-07-06
01-715-1405,4.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_1713,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,N,Y,,1.0,1.0,,,,,2013-07-08,,3.0,3.0,2013-07-08,3.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2013-07-07,2.0,2013-07-06
01-715-1405,5.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,N,Y,,,1.0,,,,,2013-07-13,,8.0,8.0,2013-07-13,8.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-07-07,2.0,2013-07-06
01-715-1405,6.0,CDISCPILOT01,ADAE,715,1405,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,N,0.0,NONE,Y,N,Y,,,,,,,,2013-07-13,,8.0,8.0,2013-07-13,8.0,Xanomeline Low Dose,Xan_Lo,1.0,69.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-07-07,2.0,2013-07-06
01-716-1024,1.0,CDISCPILOT01,ADAE,716,1024,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-08-20,,43.0,43.0,2012-09-27,81.0,Placebo,Pbo,0.0,87.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-01-20,196.0,2012-07-09
01-716-1024,2.0,CDISCPILOT01,ADAE,716,1024,VERBATIM_1552,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,,2012-08-20,,43.0,43.0,2012-09-27,81.0,Placebo,Pbo,0.0,87.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0709,HLT_0036,COLD SYMPTOMS,2013-01-20,196.0,2012-07-09
01-716-1024,3.0,CDISCPILOT01,ADAE,716,1024,VERBATIM_0087,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,,2012-12-16,,161.0,161.0,,,Placebo,Pbo,0.0,87.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0221,HLT_0698,EMPHYSEMA,2013-01-20,196.0,2012-07-09
01-716-1026,1.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1115,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2014-04-17,,16.0,16.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2014-10-16,198.0,2014-04-02
01-716-1026,2.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2014-04-17,,16.0,16.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-10-16,198.0,2014-04-02
01-716-1026,3.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1077,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-04-18,,17.0,17.0,2014-07-31,121.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0130,HLT_0289,T WAVE INVERTED,2014-10-16,198.0,2014-04-02
01-716-1026,4.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1034,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-16,,106.0,106.0,2014-07-25,115.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0760,HLT_0757,EAR INFECTION,2014-10-16,198.0,2014-04-02
01-716-1026,5.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1711,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-07-31,,121.0,121.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0030,HLT_0037,T WAVE FLATTENING OF,2014-10-16,198.0,2014-04-02
01-716-1026,6.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1077,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-04-18,,17.0,17.0,2014-07-31,121.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0130,HLT_0289,T WAVE INVERTED,2014-10-16,198.0,2014-04-02
01-716-1026,7.0,CDISCPILOT01,ADAE,716,1026,VERBATIM_1034,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2014-08-15,,136.0,136.0,2014-08-27,148.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0760,HLT_0757,EAR INFECTION,2014-10-16,198.0,2014-04-02
01-716-1044,1.0,CDISCPILOT01,ADAE,716,1044,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-05-21,,25.0,25.0,2013-05-26,30.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-11-03,191.0,2013-04-27
01-716-1044,2.0,CDISCPILOT01,ADAE,716,1044,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-21,,25.0,25.0,2013-05-26,30.0,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-11-03,191.0,2013-04-27
01-716-1044,3.0,CDISCPILOT01,ADAE,716,1044,VERBATIM_1524,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-10-15,,172.0,172.0,,,Placebo,Pbo,0.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2013-11-03,191.0,2013-04-27
01-716-1063,1.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0056,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,N,Y,,,1.0,,,,,2014-05-09,,366.0,366.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-08-25,109.0,2013-05-09
01-716-1063,2.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0885,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-07-01,,54.0,54.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,TIREDNESS,2013-08-25,109.0,2013-05-09
01-716-1063,3.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-07-04,,57.0,57.0,2013-07-28,81.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-25,109.0,2013-05-09
01-716-1063,4.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-07-04,,57.0,57.0,2013-07-28,81.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-25,109.0,2013-05-09
01-716-1063,5.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0749,RESTLESSNESS,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2013-07-28,,81.0,81.0,2013-07-31,84.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0510,HLT_0427,RESTLESSNESS,2013-08-25,109.0,2013-05-09
01-716-1063,6.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_1091,LETHARGY,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,,2013-07-31,,84.0,84.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0448,HLT_0027,LETHARGY,2013-08-25,109.0,2013-05-09
01-716-1063,7.0,CDISCPILOT01,ADAE,716,1063,VERBATIM_0749,RESTLESSNESS,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,,2013-07-28,,81.0,81.0,2013-07-31,84.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0510,HLT_0427,RESTLESSNESS,2013-08-25,109.0,2013-05-09
01-716-1071,1.0,CDISCPILOT01,ADAE,716,1071,VERBATIM_1251,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-07-13,,36.0,36.0,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0628,HLT_0231,SLEEP EXCESSIVE,2013-08-01,55.0,2013-06-08
01-716-1071,2.0,CDISCPILOT01,ADAE,716,1071,VERBATIM_1745,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-07-13,,36.0,36.0,,,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,TIREDNESS,2013-08-01,55.0,2013-06-08
01-716-1071,3.0,CDISCPILOT01,ADAE,716,1071,VERBATIM_1714,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,,2013-07-31,,54.0,54.0,2013-07-31,54.0,Xanomeline High Dose,Xan_Hi,2.0,78.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0310,HLT_0440,SYNCOPE,2013-08-01,55.0,2013-06-08
01-716-1094,1.0,CDISCPILOT01,ADAE,716,1094,VERBATIM_0096,ATRIAL FLUTTER,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-01-19,,32.0,32.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0627,HLT_0477,ATRIAL FLUTTER,2013-01-24,37.0,2012-12-19
01-716-1094,2.0,CDISCPILOT01,ADAE,716,1094,VERBATIM_1728,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-01-19,,32.0,32.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0597,HLT_0751,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,2013-01-24,37.0,2012-12-19
01-716-1094,3.0,CDISCPILOT01,ADAE,716,1094,VERBATIM_1723,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-01-19,,32.0,32.0,,,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0747,HLT_0589,VENTRICULAR SEPTAL DEFECT,2013-01-24,37.0,2012-12-19
01-716-1103,1.0,CDISCPILOT01,ADAE,716,1103,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-07-09,,112.0,112.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-09-20,185.0,2014-03-20
01-716-1103,2.0,CDISCPILOT01,ADAE,716,1103,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-07-09,,112.0,112.0,2014-07-16,119.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2014-09-20,185.0,2014-03-20
01-716-1103,3.0,CDISCPILOT01,ADAE,716,1103,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-07-09,,112.0,112.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-09-20,185.0,2014-03-20
01-716-1103,4.0,CDISCPILOT01,ADAE,716,1103,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-08-17,,151.0,151.0,2014-08-24,158.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2014-09-20,185.0,2014-03-20
01-716-1103,5.0,CDISCPILOT01,ADAE,716,1103,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-08-17,,151.0,151.0,2014-08-24,158.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2014-09-20,185.0,2014-03-20
01-716-1108,1.0,CDISCPILOT01,ADAE,716,1108,VERBATIM_1095,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-04-12,,60.0,60.0,,,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0220,HLT_0610,ST SEGMENT DEPRESSED,2013-08-10,180.0,2013-02-12
01-716-1108,2.0,CDISCPILOT01,ADAE,716,1108,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-05-01,,79.0,79.0,,,Placebo,Pbo,0.0,86.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-08-10,180.0,2013-02-12
01-716-1151,1.0,CDISCPILOT01,ADAE,716,1151,VERBATIM_0742,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-02-19,,19.0,19.0,2013-03-22,50.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),Y,N,N,N,N,N,HLGT_0507,HLT_0245,MALIGNANT FIBROUS HISTIOCYTOMA,2013-05-11,100.0,2013-02-01
01-716-1151,2.0,CDISCPILOT01,ADAE,716,1151,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-03-15,,43.0,43.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-05-11,100.0,2013-02-01
01-716-1151,3.0,CDISCPILOT01,ADAE,716,1151,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-03-15,,43.0,43.0,,,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-05-11,100.0,2013-02-01
01-716-1151,4.0,CDISCPILOT01,ADAE,716,1151,VERBATIM_0742,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MILD,N,0.0,NONE,Y,Y,Y,,,,,,,,2013-02-19,,19.0,19.0,2013-03-22,50.0,Xanomeline Low Dose,Xan_Lo,1.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),Y,N,N,N,N,N,HLGT_0507,HLT_0245,MALIGNANT FIBROUS HISTIOCYTOMA,2013-05-11,100.0,2013-02-01
01-716-1157,1.0,CDISCPILOT01,ADAE,716,1157,VERBATIM_1539,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-10-17,,16.0,16.0,2013-11-04,34.0,Xanomeline Low Dose,Xan_Lo,1.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-04-04,185.0,2013-10-02
01-716-1157,2.0,CDISCPILOT01,ADAE,716,1157,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-10-25,,24.0,24.0,,,Xanomeline Low Dose,Xan_Lo,1.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-04-04,185.0,2013-10-02
01-716-1157,3.0,CDISCPILOT01,ADAE,716,1157,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-10-25,,24.0,24.0,,,Xanomeline Low Dose,Xan_Lo,1.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-04-04,185.0,2013-10-02
01-716-1157,4.0,CDISCPILOT01,ADAE,716,1157,VERBATIM_1539,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-10-17,,16.0,16.0,2013-11-04,34.0,Xanomeline Low Dose,Xan_Lo,1.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2014-04-04,185.0,2013-10-02
01-716-1160,1.0,CDISCPILOT01,ADAE,716,1160,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-09,,35.0,35.0,,,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-10-11,190.0,2013-04-05
01-716-1160,2.0,CDISCPILOT01,ADAE,716,1160,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-09,,35.0,35.0,,,Placebo,Pbo,0.0,83.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-10-11,190.0,2013-04-05
01-716-1167,1.0,CDISCPILOT01,ADAE,716,1167,VERBATIM_0658,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,1.0,2012-11-17,,41.0,41.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCH,2013-04-12,187.0,2012-10-08
01-716-1167,2.0,CDISCPILOT01,ADAE,716,1167,VERBATIM_1412,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2012-11-17,,41.0,41.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0484,HLT_0658,SWELLING,2013-04-12,187.0,2012-10-08
01-716-1167,3.0,CDISCPILOT01,ADAE,716,1167,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,1.0,2012-12-03,,57.0,57.0,,,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2013-04-12,187.0,2012-10-08
01-716-1167,4.0,CDISCPILOT01,ADAE,716,1167,VERBATIM_1451,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-10,,154.0,154.0,2013-04-10,185.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0765,HLT_0473,ALLERGY,2013-04-12,187.0,2012-10-08
01-716-1167,5.0,CDISCPILOT01,ADAE,716,1167,VERBATIM_1451,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-10,,154.0,154.0,2013-04-10,185.0,Xanomeline Low Dose,Xan_Lo,1.0,68.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0765,HLT_0473,ALLERGY,2013-04-12,187.0,2012-10-08
01-716-1177,1.0,CDISCPILOT01,ADAE,716,1177,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,N,N,,,,,,,1.0,2014-08-24,,-9.0,-8.0,,,Placebo,Pbo,0.0,72.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2015-03-05,185.0,2014-09-02
01-716-1189,1.0,CDISCPILOT01,ADAE,716,1189,VERBATIM_0460,HALLUCINATION,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-11-24,,47.0,47.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0649,HLT_0026,HALLUCINATION,2013-02-27,142.0,2012-10-09
01-716-1189,2.0,CDISCPILOT01,ADAE,716,1189,VERBATIM_1218,DELUSION,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,NONE,Y,Y,Y,,,1.0,,,,,2012-11-24,,47.0,47.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0565,HLT_0198,DELUSIONS,2013-02-27,142.0,2012-10-09
01-716-1189,3.0,CDISCPILOT01,ADAE,716,1189,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-01-05,,89.0,89.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-27,142.0,2012-10-09
01-716-1189,4.0,CDISCPILOT01,ADAE,716,1189,VERBATIM_0154,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",SEVERE,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-02-07,,122.0,122.0,,,Xanomeline High Dose,Xan_Hi,2.0,81.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),Y,N,N,N,N,N,HLGT_0190,HLT_0412,PROSTATE CANCER,2013-02-27,142.0,2012-10-09
01-716-1229,1.0,CDISCPILOT01,ADAE,716,1229,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-02-20,,1.0,1.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-03-31,40.0,2013-02-20
01-716-1229,2.0,CDISCPILOT01,ADAE,716,1229,VERBATIM_1044,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,MILD,N,0.0,NONE,Y,Y,Y,,1.0,1.0,,,,,2013-03-06,,15.0,15.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0430,HLT_0210,HIGH CHOLESTEROL,2013-03-31,40.0,2013-02-20
01-716-1298,1.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,1.0,1.0,1.0,,,,1.0,2013-04-22,,15.0,15.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-06-28,82.0,2013-04-08
01-716-1298,2.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-04-22,,15.0,15.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-28,82.0,2013-04-08
01-716-1298,3.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-06-08,,62.0,62.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2013-06-28,82.0,2013-04-08
01-716-1298,4.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-04-22,,15.0,15.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-06-28,82.0,2013-04-08
01-716-1298,5.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-04-22,,15.0,15.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-06-28,82.0,2013-04-08
01-716-1298,6.0,CDISCPILOT01,ADAE,716,1298,VERBATIM_1655,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-06-08,,62.0,62.0,2013-07-06,90.0,Xanomeline Low Dose,Xan_Lo,1.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0267,HLT_0752,BLISTERS,2013-06-28,82.0,2013-04-08
01-716-1308,1.0,CDISCPILOT01,ADAE,716,1308,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-09-20,,24.0,24.0,,,Placebo,Pbo,0.0,76.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-10-07,41.0,2013-08-28
01-716-1311,1.0,CDISCPILOT01,ADAE,716,1311,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-05-28,,15.0,15.0,2014-09-22,132.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-09-21,131.0,2014-05-14
01-716-1311,2.0,CDISCPILOT01,ADAE,716,1311,VERBATIM_0554,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-07-22,,70.0,70.0,2014-08-02,81.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0419,HLT_0217,ABDOMINAL PAIN,2014-09-21,131.0,2014-05-14
01-716-1311,3.0,CDISCPILOT01,ADAE,716,1311,VERBATIM_1041,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-08-02,,81.0,81.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0245,HLT_0040,ULCER,2014-09-21,131.0,2014-05-14
01-716-1311,4.0,CDISCPILOT01,ADAE,716,1311,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-05-28,,15.0,15.0,2014-09-22,132.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-09-21,131.0,2014-05-14
01-716-1364,1.0,CDISCPILOT01,ADAE,716,1364,VERBATIM_0658,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-08-18,,46.0,46.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCH,2014-01-09,190.0,2013-07-04
01-716-1364,2.0,CDISCPILOT01,ADAE,716,1364,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-09-02,,61.0,61.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-01-09,190.0,2013-07-04
01-716-1373,1.0,CDISCPILOT01,ADAE,716,1373,VERBATIM_0384,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-12-14,,1.0,1.0,,,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0506,HLT_0265,COGNITIVE IMPAIRMENT,2013-02-27,76.0,2012-12-14
01-716-1373,2.0,CDISCPILOT01,ADAE,716,1373,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2012-12-15,,2.0,2.0,,,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-02-27,76.0,2012-12-14
01-716-1418,1.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_1341,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-05,,1.0,1.0,2013-05-07,3.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0705,HLT_0420,WELTS,2013-11-20,200.0,2013-05-05
01-716-1418,2.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-05,,1.0,1.0,,,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2013-11-20,200.0,2013-05-05
01-716-1418,3.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_1341,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-05,,1.0,1.0,2013-05-07,3.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0705,HLT_0420,WELTS,2013-11-20,200.0,2013-05-05
01-716-1418,4.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-05-07,,3.0,3.0,,,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-11-20,200.0,2013-05-05
01-716-1418,5.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-07-01,D,58.0,58.0,2013-09-26,145.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-20,200.0,2013-05-05
01-716-1418,6.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0911,VISION BLURRED,EYE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-07-01,D,58.0,58.0,2013-10-04,153.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0598,HLT_0120,BLURRED VISION,2013-11-20,200.0,2013-05-05
01-716-1418,7.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-07-01,D,58.0,58.0,2013-09-26,145.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-20,200.0,2013-05-05
01-716-1418,8.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0911,VISION BLURRED,EYE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-07-01,D,58.0,58.0,2013-10-04,153.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0598,HLT_0120,BLURRED VISION,2013-11-20,200.0,2013-05-05
01-716-1418,9.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-26,,145.0,145.0,2013-11-11,191.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-20,200.0,2013-05-05
01-716-1418,10.0,CDISCPILOT01,ADAE,716,1418,VERBATIM_0301,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-26,,145.0,145.0,2013-11-11,191.0,Xanomeline High Dose,Xan_Hi,2.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0344,HLT_0064,HEADACHE,2013-11-20,200.0,2013-05-05
01-716-1441,1.0,CDISCPILOT01,ADAE,716,1441,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2014-05-11,,110.0,110.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-07-22,182.0,2014-01-22
01-716-1447,1.0,CDISCPILOT01,ADAE,716,1447,VERBATIM_0056,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-01,,17.0,17.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2014-06-17,184.0,2013-12-16
01-716-1447,2.0,CDISCPILOT01,ADAE,716,1447,VERBATIM_0300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-01-14,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0192,HLT_0284,ERYTHEMA,2014-06-17,184.0,2013-12-16
01-716-1447,3.0,CDISCPILOT01,ADAE,716,1447,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-01-14,,30.0,30.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2014-06-17,184.0,2013-12-16
01-716-1447,4.0,CDISCPILOT01,ADAE,716,1447,VERBATIM_0366,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-03-14,,89.0,89.0,,,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0130,HLT_0289,T WAVE INVERTED,2014-06-17,184.0,2013-12-16
01-716-1447,5.0,CDISCPILOT01,ADAE,716,1447,VERBATIM_0517,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-04-05,,111.0,111.0,2014-04-09,115.0,Xanomeline High Dose,Xan_Hi,2.0,72.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0195,HLT_0717,CHEST PAIN,2014-06-17,184.0,2013-12-16
01-717-1004,1.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1678,ENURESIS,RENAL AND URINARY DISORDERS,MODERATE,N,0.0,POSSIBLE,,N,N,,,,,,,,2013-05-01,D,-258.0,-257.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0623,HLT_0107,BED WETTING,2014-07-16,184.0,2014-01-14
01-717-1004,2.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1666,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,,2014-01-13,,-1.0,0.0,2014-02-10,28.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,SOFT STOOLS,2014-07-16,184.0,2014-01-14
01-717-1004,3.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1357,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-15,,2.0,2.0,2014-02-18,36.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-07-16,184.0,2014-01-14
01-717-1004,4.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0214,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-01-15,,2.0,2.0,2014-02-08,26.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0460,HLT_0635,RUNNY NOSE,2014-07-16,184.0,2014-01-14
01-717-1004,5.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-01-15,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2014-07-16,184.0,2014-01-14
01-717-1004,6.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-01-15,,2.0,2.0,2014-02-09,27.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-16,184.0,2014-01-14
01-717-1004,7.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1280,ANXIETY,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-01-15,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,ANXIETY,2014-07-16,184.0,2014-01-14
01-717-1004,8.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0793,IRRITABILITY,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-01-15,,2.0,2.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0461,HLT_0627,IRRITABILITY,2014-07-16,184.0,2014-01-14
01-717-1004,9.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0214,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-01-15,,2.0,2.0,2014-02-08,26.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0460,HLT_0635,RUNNY NOSE,2014-07-16,184.0,2014-01-14
01-717-1004,10.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1666,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,,N,N,,,,,,,,2014-01-13,,-1.0,0.0,2014-02-10,28.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,SOFT STOOLS,2014-07-16,184.0,2014-01-14
01-717-1004,11.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-01-15,,2.0,2.0,2014-02-09,27.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-16,184.0,2014-01-14
01-717-1004,12.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1357,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-01-15,,2.0,2.0,2014-02-18,36.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0280,HLT_0701,COUGH,2014-07-16,184.0,2014-01-14
01-717-1004,13.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-03-09,,55.0,55.0,2014-03-15,61.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-16,184.0,2014-01-14
01-717-1004,14.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-03-09,,55.0,55.0,2014-03-15,61.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-16,184.0,2014-01-14
01-717-1004,15.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-04-08,,85.0,85.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2014-07-16,184.0,2014-01-14
01-717-1004,16.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2014-04-21,,98.0,98.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-16,184.0,2014-01-14
01-717-1004,17.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_1583,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-05-21,,128.0,128.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,BACK PAIN,2014-07-16,184.0,2014-01-14
01-717-1004,18.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0942,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,,2014-06-03,,141.0,141.0,2014-06-10,148.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0540,HLT_0542,WOUND NOS,2014-07-16,184.0,2014-01-14
01-717-1004,19.0,CDISCPILOT01,ADAE,717,1004,VERBATIM_0942,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,,2014-06-03,,141.0,141.0,2014-06-10,148.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0540,HLT_0542,WOUND NOS,2014-07-16,184.0,2014-01-14
01-717-1109,1.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0156,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-01-29,,3.0,3.0,2014-07-16,171.0,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0769,HLT_0566,INCREASED APPETITE,2014-07-28,183.0,2014-01-27
01-717-1109,2.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2014-02-15,,20.0,20.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-07-28,183.0,2014-01-27
01-717-1109,3.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0895,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-02-15,,20.0,20.0,2014-02-17,22.0,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,SWEATING INCREASED,2014-07-28,183.0,2014-01-27
01-717-1109,4.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_1524,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-02-20,,25.0,25.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2014-07-28,183.0,2014-01-27
01-717-1109,5.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0377,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2014-02-22,,27.0,27.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0469,HLT_0297,INSOMNIA,2014-07-28,183.0,2014-01-27
01-717-1109,6.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0990,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2014-03-04,,37.0,37.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0689,HLT_0123,GENERALIZED PRURITUS,2014-07-28,183.0,2014-01-27
01-717-1109,7.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0760,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2014-04-18,,82.0,82.0,,,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0594,HLT_0050,PREMATURE VENTRICULAR CONTRACTIONS,2014-07-28,183.0,2014-01-27
01-717-1109,8.0,CDISCPILOT01,ADAE,717,1109,VERBATIM_0156,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2014-01-29,,3.0,3.0,2014-07-16,171.0,Xanomeline High Dose,Xan_Hi,2.0,84.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0769,HLT_0566,INCREASED APPETITE,2014-07-28,183.0,2014-01-27
01-717-1174,1.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-01-26,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-07-24,184.0,2013-01-22
01-717-1174,2.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-02-03,,13.0,13.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-07-24,184.0,2013-01-22
01-717-1174,3.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_0377,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-04-17,,86.0,86.0,2013-04-19,88.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0469,HLT_0297,INSOMNIA,2013-07-24,184.0,2013-01-22
01-717-1174,4.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_0426,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,N,0.0,REMOTE,,Y,Y,,,1.0,,,,1.0,2013-04-25,,94.0,94.0,2013-04-26,95.0,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2013-07-24,184.0,2013-01-22
01-717-1174,5.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-01-26,,5.0,5.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-07-24,184.0,2013-01-22
01-717-1174,6.0,CDISCPILOT01,ADAE,717,1174,VERBATIM_0216,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-02-03,,13.0,13.0,,,Xanomeline High Dose,Xan_Hi,2.0,73.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0695,HLT_0778,ITCHING,2013-07-24,184.0,2013-01-22
01-717-1201,1.0,CDISCPILOT01,ADAE,717,1201,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-12-19,,1.0,1.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-02-21,65.0,2013-12-19
01-717-1201,2.0,CDISCPILOT01,ADAE,717,1201,VERBATIM_1197,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-01-15,,28.0,28.0,,,Placebo,Pbo,0.0,85.0,>80,3.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0234,HLT_0077,HAIR LOSS,2014-02-21,65.0,2013-12-19
01-717-1344,1.0,CDISCPILOT01,ADAE,717,1344,VERBATIM_1164,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,N,0.0,REMOTE,,Y,Y,1.0,1.0,1.0,,,,,2014-02-01,,22.0,22.0,2014-02-06,27.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0549,HLT_0118,NOSE CONGESTION,2014-03-14,63.0,2014-01-11
01-717-1344,2.0,CDISCPILOT01,ADAE,717,1344,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2014-02-01,,22.0,22.0,2014-02-18,39.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2014-03-14,63.0,2014-01-11
01-717-1344,3.0,CDISCPILOT01,ADAE,717,1344,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2014-02-01,,22.0,22.0,2014-02-18,39.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2014-03-14,63.0,2014-01-11
01-717-1344,4.0,CDISCPILOT01,ADAE,717,1344,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2014-02-28,,49.0,49.0,2014-03-01,50.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2014-03-14,63.0,2014-01-11
01-717-1344,5.0,CDISCPILOT01,ADAE,717,1344,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2014-02-28,,49.0,49.0,2014-03-01,50.0,Placebo,Pbo,0.0,64.0,<65,1.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2014-03-14,63.0,2014-01-11
01-717-1357,1.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0529,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,,1994-04-01,D,-6970.0,-6969.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-10-14,167.0,2013-05-01
01-717-1357,2.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-05-23,,23.0,23.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-10-14,167.0,2013-05-01
01-717-1357,3.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0286,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-05-29,,29.0,29.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0137,HLT_0661,ANKLE EDEMA,2013-10-14,167.0,2013-05-01
01-717-1357,4.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0707,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-06-11,,42.0,42.0,2013-10-15,168.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0403,HLT_0283,APPLICATION SITE PERSPIRATION,2013-10-14,167.0,2013-05-01
01-717-1357,5.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-23,,23.0,23.0,,,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2013-10-14,167.0,2013-05-01
01-717-1357,6.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-07-07,,68.0,68.0,2013-07-08,69.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-10-14,167.0,2013-05-01
01-717-1357,7.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,,2013-07-22,,83.0,83.0,2013-07-22,83.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-10-14,167.0,2013-05-01
01-717-1357,8.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_1533,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-10,,102.0,102.0,2013-08-10,102.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,DIZZINESS,2013-10-14,167.0,2013-05-01
01-717-1357,9.0,CDISCPILOT01,ADAE,717,1357,VERBATIM_0707,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-06-11,,42.0,42.0,2013-10-15,168.0,Xanomeline High Dose,Xan_Hi,2.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0403,HLT_0283,APPLICATION SITE PERSPIRATION,2013-10-14,167.0,2013-05-01
01-717-1446,1.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1480,ANXIETY,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-09-15,,15.0,15.0,2013-09-16,16.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,ANXIETY AGGRAVATED,2014-03-03,184.0,2013-09-01
01-717-1446,2.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1480,ANXIETY,PSYCHIATRIC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-09-15,,15.0,15.0,2013-09-16,16.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0570,HLT_0559,ANXIETY AGGRAVATED,2014-03-03,184.0,2013-09-01
01-717-1446,3.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1630,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,1.0,2013-09-19,,19.0,19.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0384,HLT_0583,SKIN IRRITATION,2014-03-03,184.0,2013-09-01
01-717-1446,4.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-10-06,,36.0,36.0,2014-03-03,184.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2014-03-03,184.0,2013-09-01
01-717-1446,5.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1706,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,1.0,,,,1.0,2013-10-07,,37.0,37.0,2013-10-11,41.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-03-03,184.0,2013-09-01
01-717-1446,6.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1706,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,1.0,2013-10-07,,37.0,37.0,2013-10-11,41.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0198,HLT_0762,RASH,2014-03-03,184.0,2013-09-01
01-717-1446,7.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1240,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,,2014-01-13,,135.0,135.0,2014-01-14,136.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0478,HLT_0314,STINGING,2014-03-03,184.0,2013-09-01
01-717-1446,8.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_1240,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,,2014-01-28,,150.0,150.0,,,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0478,HLT_0314,STINGING,2014-03-03,184.0,2013-09-01
01-717-1446,9.0,CDISCPILOT01,ADAE,717,1446,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-10-06,,36.0,36.0,2014-03-03,184.0,Xanomeline Low Dose,Xan_Lo,1.0,75.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2014-03-03,184.0,2013-09-01
01-718-1066,1.0,CDISCPILOT01,ADAE,718,1066,VERBATIM_1714,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-07-16,,10.0,10.0,2013-07-20,14.0,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPE,2013-07-16,10.0,2013-07-07
01-718-1066,2.0,CDISCPILOT01,ADAE,718,1066,VERBATIM_0499,AGITATION,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,N,Y,,1.0,1.0,,,,,2013-07-18,,12.0,12.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0170,HLT_0140,AGITATION,2013-07-16,10.0,2013-07-07
01-718-1066,3.0,CDISCPILOT01,ADAE,718,1066,VERBATIM_1714,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,N,Y,,,,,,,,2013-07-30,,24.0,24.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPE,2013-07-16,10.0,2013-07-07
01-718-1066,4.0,CDISCPILOT01,ADAE,718,1066,VERBATIM_1651,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,REMOTE,Y,N,Y,,1.0,1.0,,,,,2013-07-30,,24.0,24.0,,,Xanomeline Low Dose,Xan_Lo,1.0,79.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0004,HLT_0582,INFLAMMATION LOCALIZED,2013-07-16,10.0,2013-07-07
01-718-1079,1.0,CDISCPILOT01,ADAE,718,1079,VERBATIM_1524,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2012-10-05,,17.0,17.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2012-10-31,43.0,2012-09-19
01-718-1079,2.0,CDISCPILOT01,ADAE,718,1079,VERBATIM_1567,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2012-10-05,,17.0,17.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-10-31,43.0,2012-09-19
01-718-1079,3.0,CDISCPILOT01,ADAE,718,1079,VERBATIM_1567,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2012-10-05,,17.0,17.0,,,Xanomeline Low Dose,Xan_Lo,1.0,67.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2012-10-31,43.0,2012-09-19
01-718-1101,1.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0897,VOMITING,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-03-06,,18.0,18.0,2013-03-06,18.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0350,HLT_0016,VOMITING,2013-07-31,165.0,2013-02-17
01-718-1101,2.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-04-13,,56.0,56.0,2013-05-12,85.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-07-31,165.0,2013-02-17
01-718-1101,3.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0149,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-04-14,,57.0,57.0,2013-07-06,140.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-07-31,165.0,2013-02-17
01-718-1101,4.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-04-13,,56.0,56.0,2013-05-12,85.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-07-31,165.0,2013-02-17
01-718-1101,5.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0706,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,1.0,,,,,2013-07-06,,140.0,140.0,,,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0688,HLT_0649,INFERIOR MYOCARDIAL INFARCTION,2013-07-31,165.0,2013-02-17
01-718-1101,6.0,CDISCPILOT01,ADAE,718,1101,VERBATIM_0149,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-04-14,,57.0,57.0,2013-07-06,140.0,Xanomeline High Dose,Xan_Hi,2.0,82.0,>80,3.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,PERSPIRATION EXCESSIVE,2013-07-31,165.0,2013-02-17
01-718-1139,1.0,CDISCPILOT01,ADAE,718,1139,VERBATIM_0731,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-06-03,,16.0,16.0,2013-07-16,59.0,Placebo,Pbo,0.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,SLEEPINESS,2013-11-17,183.0,2013-05-19
01-718-1139,2.0,CDISCPILOT01,ADAE,718,1139,VERBATIM_0731,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-06-03,,16.0,16.0,2013-07-16,59.0,Placebo,Pbo,0.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,SLEEPINESS,2013-11-17,183.0,2013-05-19
01-718-1139,3.0,CDISCPILOT01,ADAE,718,1139,VERBATIM_1126,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-11-16,,182.0,182.0,2013-11-16,182.0,Placebo,Pbo,0.0,77.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0588,HLT_0148,DIARRHEA,2013-11-17,183.0,2013-05-19
01-718-1150,1.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0125,BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,1.0,1.0,1.0,,,,,2013-02-16,,29.0,29.0,2013-03-17,58.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0294,HLT_0640,BRADYCARDIA,2013-07-29,192.0,2013-01-19
01-718-1150,2.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-03-06,,47.0,47.0,2013-03-26,67.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-07-29,192.0,2013-01-19
01-718-1150,3.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0479,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-03-15,,56.0,56.0,2013-03-15,56.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-07-29,192.0,2013-01-19
01-718-1150,4.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0125,BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-02-16,,29.0,29.0,2013-03-17,58.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0294,HLT_0640,BRADYCARDIA,2013-07-29,192.0,2013-01-19
01-718-1150,5.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0579,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,N,0.0,NONE,,Y,Y,,,,,,,,2013-03-06,,47.0,47.0,2013-03-26,67.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0489,HLT_0520,UPPER RESPIRATORY INFECTION,2013-07-29,192.0,2013-01-19
01-718-1150,6.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0125,BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-10,,112.0,112.0,2013-07-07,170.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0294,HLT_0640,BRADYCARDIA,2013-07-29,192.0,2013-01-19
01-718-1150,7.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_1319,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-06-09,,142.0,142.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0376,HLT_0754,CARBOHYDRATE CRAVING,2013-07-29,192.0,2013-01-19
01-718-1150,8.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_1031,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-06-16,,149.0,149.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-07-29,192.0,2013-01-19
01-718-1150,9.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0125,BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-05-10,,112.0,112.0,2013-07-07,170.0,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0294,HLT_0640,BRADYCARDIA,2013-07-29,192.0,2013-01-19
01-718-1150,10.0,CDISCPILOT01,ADAE,718,1150,VERBATIM_0796,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,N,0.0,POSSIBLE,,N,Y,,,1.0,,,,,2013-07-31,,194.0,194.0,,,Placebo,Pbo,0.0,73.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0500,HLT_0644,SINUS BRADYCARDIA,2013-07-29,192.0,2013-01-19
01-718-1170,1.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_1049,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-10-07,,22.0,22.0,2013-10-07,22.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0751,HLT_0619,LIGHTHEADEDNESS,2013-10-12,27.0,2013-09-16
01-718-1170,2.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_0889,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-10-11,,26.0,26.0,2013-10-12,27.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0005,HLT_0587,DIAPHORESIS,2013-10-12,27.0,2013-09-16
01-718-1170,3.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_1174,BODY TEMPERATURE INCREASED,INVESTIGATIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-10-11,,26.0,26.0,2013-10-12,27.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0351,HLT_0734,TEMPERATURE ELEVATION,2013-10-12,27.0,2013-09-16
01-718-1170,4.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_0342,HYPERTENSION,VASCULAR DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-10-11,,26.0,26.0,2013-10-12,27.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0476,HLT_0228,HYPERTENSION,2013-10-12,27.0,2013-09-16
01-718-1170,5.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_1714,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,Y,1.0,PROBABLE,Y,Y,Y,,,1.0,1.0,1.0,1.0,,2013-10-12,,27.0,27.0,2013-10-13,28.0,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0310,HLT_0440,SYNCOPE,2013-10-12,27.0,2013-09-16
01-718-1170,6.0,CDISCPILOT01,ADAE,718,1170,VERBATIM_0258,AGITATION,PSYCHIATRIC DISORDERS,SEVERE,N,0.0,POSSIBLE,Y,N,Y,,1.0,1.0,,,,,2013-10-16,,31.0,31.0,,,Xanomeline Low Dose,Xan_Lo,1.0,80.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0170,HLT_0140,INCREASED AGITATION,2013-10-12,27.0,2013-09-16
01-718-1250,1.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0272,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-10-09,,19.0,19.0,2013-11-15,56.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0101,HLT_0541,UNSTEADINESS,2014-01-31,133.0,2013-09-21
01-718-1250,2.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0992,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,REMOTE,Y,Y,Y,,1.0,1.0,,,,,2013-10-09,,19.0,19.0,2013-10-09,19.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0446,HLT_0168,FALL,2014-01-31,133.0,2013-09-21
01-718-1250,3.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_1794,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,N,0.0,REMOTE,Y,Y,Y,,,1.0,,,,,2013-10-15,,25.0,25.0,2013-11-02,43.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISING OF FACE,2014-01-31,133.0,2013-09-21
01-718-1250,4.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0272,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-09,,19.0,19.0,2013-11-15,56.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0101,HLT_0541,UNSTEADINESS,2014-01-31,133.0,2013-09-21
01-718-1250,5.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_1794,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-10-15,,25.0,25.0,2013-11-02,43.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISING OF FACE,2014-01-31,133.0,2013-09-21
01-718-1250,6.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0272,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,,,,,,2013-10-09,,19.0,19.0,2013-11-15,56.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0101,HLT_0541,UNSTEADINESS,2014-01-31,133.0,2013-09-21
01-718-1250,7.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_1794,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,N,0.0,REMOTE,Y,Y,Y,,,,,,,,2013-10-15,,25.0,25.0,2013-11-02,43.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0381,HLT_0713,BRUISING OF FACE,2014-01-31,133.0,2013-09-21
01-718-1250,8.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0425,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,,1.0,,,,,2013-11-15,,56.0,56.0,2013-11-15,56.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0015,HLT_0315,INCOORDINATION,2014-01-31,133.0,2013-09-21
01-718-1250,9.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0414,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,1.0,1.0,,,,1.0,2013-12-29,,100.0,100.0,2014-02-19,152.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-01-31,133.0,2013-09-21
01-718-1250,10.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0414,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-29,,100.0,100.0,2014-02-19,152.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-01-31,133.0,2013-09-21
01-718-1250,11.0,CDISCPILOT01,ADAE,718,1250,VERBATIM_0414,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-12-29,,100.0,100.0,2014-02-19,152.0,Xanomeline Low Dose,Xan_Lo,1.0,82.0,>80,3.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-01-31,133.0,2013-09-21
01-718-1254,1.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_1282,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2013-07-13,,4.0,4.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,PAIN IN HIP,2014-01-09,184.0,2013-07-10
01-718-1254,2.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_0209,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-07-25,,16.0,16.0,2013-07-25,16.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,KNEE PAIN,2014-01-09,184.0,2013-07-10
01-718-1254,3.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_0209,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-07-25,,16.0,16.0,2013-07-25,16.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0610,HLT_0375,KNEE PAIN,2014-01-09,184.0,2013-07-10
01-718-1254,4.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_1032,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-08-13,,35.0,35.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0273,HLT_0121,APPLICATION SITE DISCOLORATION,2014-01-09,184.0,2013-07-10
01-718-1254,5.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_0777,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-08-13,,35.0,35.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2014-01-09,184.0,2013-07-10
01-718-1254,6.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_0118,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-09-03,,56.0,56.0,2013-09-19,72.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,SOMNOLENCE,2014-01-09,184.0,2013-07-10
01-718-1254,7.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_0118,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-09-03,,56.0,56.0,2013-09-19,72.0,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,SOMNOLENCE,2014-01-09,184.0,2013-07-10
01-718-1254,8.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_1319,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,,,Y,Y,,1.0,1.0,,,,,2013-10-31,,114.0,114.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0376,HLT_0754,CARBOHYDRATE CRAVING,2014-01-09,184.0,2013-07-10
01-718-1254,9.0,CDISCPILOT01,ADAE,718,1254,VERBATIM_1056,DYSPHAGIA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,,,Y,Y,,1.0,1.0,,,,,2013-10-31,,114.0,114.0,,,Xanomeline Low Dose,Xan_Lo,1.0,78.0,65-80,2.0,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0405,HLT_0563,SWALLOWING DIFFICULT,2014-01-09,184.0,2013-07-10
01-718-1328,1.0,CDISCPILOT01,ADAE,718,1328,VERBATIM_1195,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-03-23,,51.0,51.0,2013-03-25,53.0,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-04-18,77.0,2013-02-01
01-718-1328,2.0,CDISCPILOT01,ADAE,718,1328,VERBATIM_0504,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-03-23,,51.0,51.0,2013-03-25,53.0,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE BURNING,2013-04-18,77.0,2013-02-01
01-718-1328,3.0,CDISCPILOT01,ADAE,718,1328,VERBATIM_1406,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-02,,61.0,61.0,2013-04-21,80.0,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-04-18,77.0,2013-02-01
01-718-1328,4.0,CDISCPILOT01,ADAE,718,1328,VERBATIM_1406,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-04-02,,61.0,61.0,2013-04-21,80.0,Xanomeline High Dose,Xan_Hi,2.0,86.0,>80,3.0,CAUCASIAN,1.0,M,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-04-18,77.0,2013-02-01
01-718-1355,1.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0931,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,1.0,1.0,1.0,,,,1.0,2013-03-08,,9.0,9.0,2013-03-22,23.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0017,HLT_0005,SKIN EROSION,2013-08-29,183.0,2013-02-28
01-718-1355,2.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0931,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-03-08,,9.0,9.0,2013-03-22,23.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0017,HLT_0005,SKIN EROSION,2013-08-29,183.0,2013-02-28
01-718-1355,3.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0331,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,N,0.0,NONE,,N,N,,,,,,,1.0,,,,,,,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0257,HLT_0480,ATOPIC DERMATITIS,2013-08-29,183.0,2013-02-28
01-718-1355,4.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_1524,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-04-17,,49.0,49.0,,,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0329,HLT_0642,CONFUSION,2013-08-29,183.0,2013-02-28
01-718-1355,5.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0873,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-04-27,,59.0,59.0,2013-04-27,59.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-08-29,183.0,2013-02-28
01-718-1355,6.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0306,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-12,,74.0,74.0,2013-05-12,74.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-08-29,183.0,2013-02-28
01-718-1355,7.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0622,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-16,,78.0,78.0,2013-05-16,78.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-08-29,183.0,2013-02-28
01-718-1355,8.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0404,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-05-20,,82.0,82.0,2013-05-20,82.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-08-29,183.0,2013-02-28
01-718-1355,9.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0066,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-05-25,,87.0,87.0,,,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0254,HLT_0160,SLEEPINESS,2013-08-29,183.0,2013-02-28
01-718-1355,10.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0592,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-06-23,,116.0,116.0,2013-08-13,167.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0668,HLT_0339,APPLICATION SITE REACTION,2013-08-29,183.0,2013-02-28
01-718-1355,11.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0592,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-06-23,,116.0,116.0,2013-08-13,167.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0668,HLT_0339,APPLICATION SITE REACTION,2013-08-29,183.0,2013-02-28
01-718-1355,12.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0342,HYPERTENSION,VASCULAR DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2013-08-15,,169.0,169.0,2013-08-29,183.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0476,HLT_0228,HYPERTENSION,2013-08-29,183.0,2013-02-28
01-718-1355,13.0,CDISCPILOT01,ADAE,718,1355,VERBATIM_0342,HYPERTENSION,VASCULAR DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,,,,,,,2013-08-15,,169.0,169.0,2013-08-29,183.0,Placebo,Pbo,0.0,79.0,65-80,2.0,CAUCASIAN,1.0,M,Y,Y,Y,Y,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0476,HLT_0228,HYPERTENSION,2013-08-29,183.0,2013-02-28
01-718-1371,1.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_0555,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,POSSIBLE,Y,Y,Y,1.0,1.0,1.0,,,,,2013-05-09,,14.0,14.0,2013-05-11,16.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0181,HLT_0043,FATIGUE,2013-08-01,98.0,2013-04-26
01-718-1371,2.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-05-09,,14.0,14.0,2013-05-11,16.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-08-01,98.0,2013-04-26
01-718-1371,3.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,Y,Y,Y,,,1.0,,,,1.0,2013-05-24,,29.0,29.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-08-01,98.0,2013-04-26
01-718-1371,4.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_0245,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,SEVERE,Y,1.0,NONE,Y,Y,Y,,1.0,1.0,1.0,1.0,1.0,,2013-06-02,,38.0,38.0,2013-06-05,41.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,Y,N,HLGT_0719,HLT_0603,PARTIAL SEIZURES WITH SECONDARY GENERALIZATION,2013-08-01,98.0,2013-04-26
01-718-1371,5.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_0057,"HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,MODERATE,N,0.0,POSSIBLE,Y,Y,Y,,1.0,1.0,,,,,2013-06-02,,38.0,38.0,2013-06-03,39.0,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0663,HLT_0369,VISUAL HALLUCINATIONS,2013-08-01,98.0,2013-04-26
01-718-1371,6.0,CDISCPILOT01,ADAE,718,1371,VERBATIM_1336,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,Y,Y,Y,,,,,,,1.0,2013-05-24,,29.0,29.0,,,Xanomeline High Dose,Xan_Hi,2.0,69.0,65-80,2.0,CAUCASIAN,1.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0346,HLT_0061,APPLICATION SITE IRRITATION,2013-08-01,98.0,2013-04-26
01-718-1427,1.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1583,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,N,0.0,NONE,,Y,Y,1.0,1.0,1.0,,,,,2012-12-18,,2.0,2.0,2012-12-18,2.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0508,HLT_0115,BACK PAIN,2013-02-11,57.0,2012-12-17
01-718-1427,2.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,REMOTE,,Y,Y,,1.0,1.0,,,,,2012-12-26,,10.0,10.0,2012-12-26,10.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
01-718-1427,3.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0320,AMNESIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,1.0,1.0,,,,,2013-01-01,,16.0,16.0,2013-01-19,34.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0641,HLT_0501,SHORT-TERM MEMORY LOSS,2013-02-11,57.0,2012-12-17
01-718-1427,4.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1111,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-01-03,,18.0,18.0,2013-01-09,24.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
01-718-1427,5.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1091,LETHARGY,NERVOUS SYSTEM DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,1.0,,,,,2013-01-05,,20.0,20.0,2013-01-05,20.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0448,HLT_0027,LETHARGY,2013-02-11,57.0,2012-12-17
01-718-1427,6.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0775,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-01-16,,31.0,31.0,2013-01-16,31.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
01-718-1427,7.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0320,AMNESIA,NERVOUS SYSTEM DISORDERS,MILD,N,0.0,NONE,,Y,Y,,,,,,,,2013-01-01,,16.0,16.0,2013-01-19,34.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0641,HLT_0501,SHORT-TERM MEMORY LOSS,2013-02-11,57.0,2012-12-17
01-718-1427,8.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1111,NAUSEA,GASTROINTESTINAL DISORDERS,SEVERE,N,0.0,PROBABLE,,Y,Y,,,,,,,,2013-01-21,,36.0,36.0,2013-01-24,39.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
01-718-1427,9.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1408,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,1.0,1.0,,,,1.0,2013-01-27,,42.0,42.0,2013-01-28,43.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-02-11,57.0,2012-12-17
01-718-1427,10.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1435,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,1.0,,,,1.0,2013-01-27,,42.0,42.0,2013-01-27,42.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-02-11,57.0,2012-12-17
01-718-1427,11.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1408,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-01-27,,42.0,42.0,2013-01-28,43.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0338,HLT_0317,APPLICATION SITE ITCHING,2013-02-11,57.0,2012-12-17
01-718-1427,12.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1216,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,N,0.0,PROBABLE,,Y,Y,,,,,,,1.0,2013-01-29,,44.0,44.0,,,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0241,HLT_0343,APPLICATION SITE RASH,2013-02-11,57.0,2012-12-17
01-718-1427,13.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1250,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,1.0,1.0,,,,,2013-02-04,,50.0,50.0,2013-02-25,71.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0231,HLT_0574,DECREASED APPETITE,2013-02-11,57.0,2012-12-17
01-718-1427,14.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0943,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-02-04,,50.0,50.0,2013-02-25,71.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
01-718-1427,15.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_1250,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-02-04,,50.0,50.0,2013-02-25,71.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0231,HLT_0574,DECREASED APPETITE,2013-02-11,57.0,2012-12-17
01-718-1427,16.0,CDISCPILOT01,ADAE,718,1427,VERBATIM_0943,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,N,0.0,POSSIBLE,,Y,Y,,,,,,,,2013-02-04,,50.0,50.0,2013-02-25,71.0,Xanomeline High Dose,Xan_Hi,2.0,74.0,65-80,2.0,"AFRICAN DESCENT (NEGRO, BLACK)",2.0,F,Y,Y,Y,N,MedDRA version 8.0 (partially masked by request of MSSO),N,N,N,N,N,N,HLGT_0326,HLT_0742,NAUSEA,2013-02-11,57.0,2012-12-17
